Obstructive Sleep Apnea Pathophysiology, Comorbidities, and Consequences
SLEEP DISORDERS
Advisory Board Antonio Cule...
145 downloads
2501 Views
5MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
Obstructive Sleep Apnea Pathophysiology, Comorbidities, and Consequences
SLEEP DISORDERS
Advisory Board Antonio Culebras, M.D. Professor of Neurology Upstate Medical University Consultant, The Sleep Center Community General Hospital Syracuse, New York, U.S.A.
Anna Ivanenko, M.D., Ph.D. Loyola University Medical Center Department of Psychiatry and Behavioral Neuroscience Maywood, Illinois, U.S.A.
Clete A. Kushida, M.D., Ph.D., RPSGT Director, Stanford Center for Human Sleep Research Associate Professor, Stanford University Medical Center Stanford University Center of Excellence for Sleep Disorders Stanford, California, U.S.A.
Nathaniel F. Watson, M.D. University of Washington Sleep Disorders Center Harborview Medical Center Seattle, Washington, U.S.A.
1. Clinician’s Guide to Pediatric Sleep Disorders, edited by Mark A. Richardson and Norman R. Friedman 2. Sleep Disorders and Neurologic Diseases, Second Edition, edited by Antonio Culebras 3. Obstructive Sleep Apnea: Pathophysiology, Comorbidities, and Consequences, edited by Clete A. Kushida 4. Obstructive Sleep Apnea: Diagnosis and Treatment, edited by Clete A. Kushida
Obstructive Sleep Apnea Pathophysiology, Comorbidities, and Consequences
Edited by
Clete A. Kushida
Stanford University Stanford, California, USA
Cover art (middle panel) courtesy of Brian Palmer, DDS. Informa Healthcare USA, Inc. 52 Vanderbilt Avenue New York, NY 10017 © 2007 by Informa Healthcare USA, Inc. Informa Healthcare is an Informa business No claim to original U.S. Government works Printed in the United States of America on acid-free paper 10 9 8 7 6 5 4 3 2 1 International Standard Book Number-10: 0-8493-9180-6 (Hardcover) International Standard Book Number-13: 978-0-8493-9180-4 (Hardcover) This book contains information obtained from authentic and highly regarded sources. Reprinted material is quoted with permission, and sources are indicated. A wide variety of references are listed. Reasonable efforts have been made to publish reliable data and information, but the author and the publisher cannot assume responsibility for the validity of all materials or for the consequence of their use. No part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers For permission to photocopy or use material electronically from this work, please access www. copyright.com (http://www.copyright.com/) or contact the Copyright Clearance Center, Inc. (CCC) 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400. CCC is a not-for-profit organization that provides licenses and registration for a variety of users. For organizations that have been granted a photocopy license by the CCC, a separate system of payment has been arranged. Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent to infringe.
Library of Congress Cataloging-in-Publication Data Obstructive sleep apnea: Pathophysiology, comorbidities, and consequences / edited by Clete A. Kushida. p. ; cm. -- (Sleep disorders ; 3) Includes bibliographical references and index. ISBN-13: 978-0-8493-9180-4 (hb : alk. paper) ISBN-10: 0-8493-9180-6 (hb : alk. paper) 1. Sleep apnea syndromes. I. Kushida, Clete Anthony, 1960- II. Title: Pathophysiology, comorbidities, and consequences. III. Series: Sleep disorders (New York, N.Y.) ; 3. [DNLM: 1. Sleep Apnea, Obstructive--physiopathology. 2. Sleep Apnea, Obstructive--complications. WF 143 O139 2007] RC737.5.O267 2007 616.2’09--dc22
Visit the Informa Web site at www.informa.com and the Informa Healthcare Web site at www.informahealthcare.com
2007000615
Preface
When in doubt, pressurize the snout. —attributed to Philip R. Westbrook
I often thought of this mantra during my on-call nights when, as a Stanford sleep medicine fellow, I was awakened from sleep by a technologist informing me that one of the clinic patients had repetitive obstructive apneas with significant oxygen desaturations. The technologist would typically ask, can I start the patient on CPAP? Invariably, I would mutter a drowsy “yes,” often chiding myself that on the previous day I should have clearly written the respiratory thresholds for starting continuous positive airway pressure on the patient’s sleep-study order sheet. This anecdote illustrates the fact that continuous positive airway pressure has become such an important and ubiquitous treatment for obstructive sleep apnea since its development over a quarter century ago. The modern sleep specialist has new diagnostic tools and other treatments, such as upper airway surgery and oral appliances, for patients with obstructive sleep apnea; nevertheless, our field is still in its adolescence with respect to the diagnosis and treatment of obstructive sleep apnea and other sleep disorders. The reader might wonder why a neurologist is editing a two-volume set of books on obstructive sleep apnea, since it is a sleep-related breathing disorder and would therefore appear to be within the domain of pulmonary physicians. However, besides pulmonologists, neurologists, psychiatrists, internists, pediatricians, and otolaryngologists have entered the field of sleep medicine. Many clinicians now treat patients with sleep disorders on a full-time basis. Sleep medicine has truly become multidisciplinary, and a sleep clinician is expected to diagnose and treat a wide range of sleep disorders, from insomnia to restless legs syndrome, that were previously referred by internists to other specialists. It is indeed a testament to the ever-increasing knowledge base on obstructive sleep apnea that there is a need for a two-volume set of books on this topic. This book covers the pathophysiology, comorbidities, and consequences of obstructive sleep apnea, with sections exploring the features, factors, and characteristics of this disorder as well as its associations and consequences. The second volume, Obstructive Sleep Apnea: Diagnosis and Treatment, focuses on the diagnosis and treatment of obstructive sleep apnea, and includes a section on special conditions, disorders, and clinical issues. The authors and I have tried to conform the conditions and disorders described in this book to the second edition of the International Classification of Sleep Disorders: Diagnostic & Coding Manual published by the American Academy of Sleep Medicine in 2006, although some terms, such as obstructive sleep apnea syndrome and sleep-disordered breathing, have been retained in a few statements when appropriate. We have also tried to discuss new entities and findings such as complex sleep apnea, oxidative stress, cyclic alternating pattern, and adaptive servo-ventilation. However, given the rapidity with which the area of sleep medicine is advancing, it is highly conceivable that two volumes might not be sufficient to cover the topic of obstructive sleep apnea in just a few short years! iii
iv
Preface
These books could not exist without the excellent contributions of a talented group of international authors; their detailed and comprehensive works are greatly appreciated. I am deeply indebted to the renowned and true pioneers of our field of sleep, William Dement, Christian Guilleminault, Sonia Ancoli-Israel, Chris Gillin, and Allan Rechtschaffen, who served as my mentors through various stages of my career. In all of my endeavors, I can always count on my parents, Samiko and Hiroshi Kushida, to assist me; these books were no exception. I have been very fortunate to serve, along with Dr. Dement, as Principal Investigator of the multicenter, randomized, double-blind, placebo-controlled Apnea Positive Pressure Long-Term Efficacy Study, sponsored by the National Heart, Lung, and Blood Institute of the National Institutes of Health. To date, this is the largest controlled trial funded by the National Institutes of Health in the field of sleep. This book is dedicated not only to my parents but also to the marvelous core team of the Apnea Positive Pressure Long-Term Efficacy Study, consisting of William Dement, Pamela Hyde, Deborah Nichols, Eileen Leary, Tyson Holmes, Dan Bloch, as well as National Heart, Lung, and Blood Institute officials (Michael Twery and Gail Weinmann), site directors, co-ordinators, consultants, committee members, key Stanford site personnel (Chia-Yu Cardell, Rhonda Wong, Pete Silva, Jennifer Blair), Data and Safety Monitoring Board members, and other personnel without whom this project could not have functioned in such a meticulous and efficient manner. It is my sincere hope that the reader will strive to become expert in the field of sleep. Although there is always room for improvement, awareness of sleep disorders by patients, physicians, and the general public is at an all-time high. However, available funding for sleep research and the number of young investigators interested in a career in basic or clinical sleep research are areas that need enhancement. The interested reader can directly contribute to this field in several ways: applying for membership in the American Academy of Sleep Medicine or Sleep Research Society, serving on committees in these organizations, becoming board certified in sleep medicine, submitting a sleep-related grant proposal to the National Institutes of Health, and/or just simply learning more about sleep and its disorders. Lastly, etched forever in my memory is a sticker posted on the door of Mary Carskadon’s former office at Stanford that contained words to live by: “Be alert. The world needs more lerts.” Clete A. Kushida
Contents
Preface . . . . iii Contributors . . . . vii 1. Perspectives 1 Clete A. Kushida SECTION I: FEATURES, FACTORS, AND CHARACTERISTICS 2. History 11 Michael Zupancic and Peretz Lavie 3. Epidemiology Kin M. Yuen
27
4. Ontogeny 39 Timothy F. Hoban and Donald L. Bliwise 5. Phylogeny and Animal Models: An Uninhibited Survey 61 Todd D. Morgan and John E. Remmers 6. Upper Airway Anatomy 81 Avery Tung 7. Physiology and Dynamics of the Upper Airway 93 Jingtao Huang and Carole L. Marcus 8. Upper Airway Pathology 111 John G. Park and Teofilo Lee-Chiong 9. Control of Breathing in Sleep 125 Curtis A. Smith, Jerome A. Dempsey, Steven R. Barczi, and Ailiang Xie 10. Arousal from Sleep 149 Péter Halász 11. Pathogenesis 171 Anh Tu Duy Nguyen, Susie Yim, and Atul Malhotra 12. Risk Factors 197 Kannan Ramar and Christian Guilleminault 13. Familial and Genetic Factors 223 Sanjay R. Patel and Peter V. Tishler v
vi 14. The Spectrum of Sleep-Disordered Breathing 245 Adnan Habib and Barbara Phillips SECTION II: ASSOCIATIONS AND CONSEQUENCES 15. Morbidity and Mortality 259 Christine Won and Dominique Robert 16. Central and Autonomic Nervous Systems 275 Ian M. Colrain and John Trinder 17. Cardiac Arrhythmias and Congestive Heart Failure 293 Sheree Chen and T. Douglas Bradley 18. Hypertension and the Cardiovascular System 323 Rohit Budhiraja and Stuart F. Quan 19. Endocrine Function and Glucose Metabolism 337 Katherine Stamatakis and Naresh M. Punjabi 20. Obesity 355 Mark Eric Dyken, Mohsin Ali, Shekar Raman, and Kim E. Eppen 21. Mood and Behavior 377 Mark S. Aloia and Amanda Schurle Bruce 22. Sleepiness 393 Douglas B. Kirsch and Ronald D. Chervin 23. Health-Related Quality-of-Life 415 Cheryl A. Moyer, Jeffrey S. Moyer, and Ronald D. Chervin 24. Driving Risk and Accidents 443 Patricia Sagaspe and Pierre Philip 25. Economic and Societal Impact 451 Valérie Wittmann and Daniel O. Rodenstein Index . . . . 473
Contents
Contributors
Mohsin Ali State University of New York, Upstate Medical Center, Syracuse, New York, U.S.A. Mark S. Aloia Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado, U.S.A. Steven R. Barczi Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, U.S.A. Donald L. Bliwise Sleep Disorders Center, Department of Neurology, Emory University Medical School, Atlanta, Georgia, U.S.A. T. Douglas Bradley Department of Medicine, Toronto General Hospital of the University Health Network, Toronto, Ontario, Canada Amanda Schurle Bruce Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado, U.S.A. Rohit Budhiraja Division of Pulmonary and Critical Care Medicine, Southern Arizona VA Healthcare System, Tucson, Arizona, U.S.A. Sheree Chen
Kaiser Permanente, Vallejo, California, U.S.A.
Ronald D. Chervin Sleep Disorders Center, Department of Neurology, University of Michigan, Ann Arbor, Michigan, U.S.A. Ian M. Colrain Human Sleep Research Program, SRI International, Menlo Park, California, U.S.A. Jerome A. Dempsey The John Rankin Laboratory of Pulmonary Medicine, Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, U.S.A. Mark Eric Dyken Sleep Disorders Center, Department of Neurology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, U.S.A. Kim E. Eppen
University of Iowa Hospitals and Clinics, Iowa City, Iowa, U.S.A.
Christian Guilleminault Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University, Stanford, California, U.S.A. Adnan Habib The Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kentucky College of Medicine, Lexington, Kentucky, U.S.A. Péter Halász Department of Neurology, National Institute of Psychiatry and Neurology, Budapest, Hungary Timothy F. Hoban The Michael S. Aldrich Sleep Disorders Center, Departments of Pediatrics and Neurology, University of Michigan, Ann Arbor, Michigan, U.S.A. vii
viii
Contributors
Jingtao Huang Sleep Center, The Childrens’ Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, U.S.A. Douglas B. Kirsch Division of Sleep Medicine, Department of Internal Medicine, Brigham and Women’s Hospital/Harvard Medical School, Boston, Massachusetts, U.S.A. Clete A. Kushida Stanford University, Stanford, California, U.S.A. Peretz Lavie
Sleep Medicine Center, Rambam Medical Center, Haifa, Israel
Teofilo Lee-Chiong National Jewish Medical and Research Center, Denver, Colorado, U.S.A. Atul Malhotra Sleep Disorders Program, Brigham and Women’s Hospital, Boston, Massachusetts, U.S.A. Carole L. Marcus Sleep Center, The Childrens’ Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, U.S.A. Todd D. Morgan
Scripps Memorial Hospital, Encinitas, California, U.S.A.
Cheryl A. Moyer Global REACH, Department of Medical Education, University of Michigan Medical School, Ann Arbor, Michigan, U.S.A. Jeffrey S. Moyer Division of Head and Neck Surgery, Department of Otolaryngology, University of Michigan Hospital, Ann Arbor, Michigan, U.S.A. Anh Tu Duy Nguyen Sleep Disorders Program, Brigham and Women’s Hospital, Boston, Massachusetts, U.S.A. John G. Park
Mayo Clinic College of Medicine, Rochester, Minnesota, U.S.A.
Sanjay R. Patel Sleep and Epidemiology Research Center, Department of Medicine, Case Western Reserve University, Cleveland, Ohio, U.S.A. Pierre Philip Clinique du Sommeil CHU Pellegrin, Université Bordeaux 2, CNRS UMR-5227, Bordeaux, France Barbara Phillips The Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kentucky College of Medicine, Lexington, Kentucky, U.S.A. Naresh M. Punjabi Department of Epidemiology and Medicine, Johns Hopkins University, Baltimore, Maryland, U.S.A. Stuart F. Quan Arizona Respiratory Center, University of Arizona College of Medicine, Tucson, Arizona, U.S.A. Shekar Raman University of Iowa Hospitals and Clinics, Iowa City, Iowa, U.S.A. Kannan Ramar Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University, Stanford, California, U.S.A. John E. Remmers Respiratory Research Group, University of Calgary, Calgary, Alberta, Canada Dominique Robert Emergency and Intensive Care Department, Edouard Herriot Hospital, Lyon, France
ix
Contributors
Daniel O. Rodenstein Service de Pneumologie, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium Patricia Sagaspe Clinique du Sommeil CHU Pellegrin, INRETS, Bordeaux, France Curtis A. Smith The John Rankin Laboratory of Pulmonary Medicine, Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, U.S.A. Katherine Stamatakis Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland, U.S.A. Peter V. Tishler Partners Center for Genetics and Genomics, Channing Laboratory, Brigham and Women’s Hospital/Harvard Medical School, Boston, Massachusetts, U.S.A. John Trinder Department of Psychology, University of Melbourne, Parkville, Victoria, Australia Avery Tung
University of Chicago Hospitals, Chicago, Illinois, U.S.A.
Valérie Wittmann Service de Pneumologie, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium Christine Won Stanford University Center of Excellence for Sleep Disorders, Stanford, California, U.S.A. Ailiang Xie Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, U.S.A. Susie Yim Sleep Disorders Program, Brigham and Women’s Hospital, Boston, Massachusetts, U.S.A. Kin M. Yuen Stanford University Center of Excellence for Sleep Disorders, Stanford, California, U.S.A. Michael Zupancic Department of Neurology, University of Michigan Sleep Disorders Center, Ann Arbor, Michigan, U.S.A.
1
Perspectives Clete A. Kushida Stanford University, Stanford, California, U.S.A.
There are more than a few primary, fundamental questions in the field of sleep that remain unanswered. Research into our field is still in its infancy, with only a little over 50 years since the discovery of rapid eye movement (REM) sleep that initiated the systematic, scientific exploration of sleep and its disorders. Any list of the most important questions to resolve in sleep would probably contain the following: ■ ■ ■ ■
Why do we sleep (i.e., what is the function of sleep)? Where is sleep controlled in the brain? What determines the onset of sleep? How can we cure obstructive sleep apnea?
Of these content areas, the question that has direct clinical relevance is the one regarding obstructive sleep apnea (OSA). Sleep apnea is also arguably the most important disorder of sleep, since it is the one sleep disorder that the majority of sleep clinicians spend the bulk of their time diagnosing and treating and it has serious consequences to the affected individual and society as well. Unfortunately, the current therapies either do not effectively treat this disorder or enable high patient adherence in a large proportion of patients. However, there is hope as technology and molecular procedures, such as those involving stem cells, advance and improve over time. Since Terry Young’s landmark epidemiology study published in 1993 (1) showed that a quarter of men and about 10% of women between the ages of 30 and 60 years have polysomnographic evidence of OSA, we know that it is one of the more highly prevalent diseases in the world. Although the pathogenesis of this disorder has not been conclusively demonstrated, risk factors for the development of OSA, such as obesity, craniofacial disproportion, and ventilatory control abnormalities, have been identified. The first-line treatment modality for OSA is nasal continuous positive airway pressure (CPAP), which was invented a little over 25 years ago. This consists of a portable device that provides a fan-generated continuous flow of air into the upper airway via a mask fitted over the nose; this airflow splints open the airway, thereby preventing its collapse. CPAP does have its limitations, particularly in terms of patient adherence that often stems from discomfort due to the mask. Randomized controlled clinical trials (Table 1) that evaluated adherence to both sham and active CPAP interventions and reported hours of use, have demonstrated that the mean nightly active CPAP use was 4.46 hours (2). Surprisingly, OSA patients on sham CPAP were slightly better in their mean nightly sham CPAP use (4.85 hours) (2). Despite the limitations of CPAP, it is the most commonly prescribed treatment for OSA. CPAP has been shown to decrease abnormal respiratory events and arousals; however, there is some controversy whether sleep architecture is significantly improved (3,4). Nevertheless, untreated OSA has been associated with hypertension, 1
32 52/49 23/18 20/14 21/18 32/37 20/16 29/25 27/18 66/59 24/23 20/18 15/13 53/51 16/16 21/18
4 wk 4 wk 1 wk 1 wk 1 wk 4 wk 1 wk 6 wk 35 days 6 mo 6 wk 10 days 8 wk 4 wk 9 wk 1 wk
Duration
Control — 4.6 >5 5.2 ± 1.2 >5 5.0 4.9 ± 0.3 4 ± 0.5 4.9–5.2 — 4.5 ± 2 Unknown — 4.5 ± 2.4 5.4 ± 2.2 >5
Active 3.7 ± 0.4 5.4 >5 5.6 ± 1.1 >5 5.6 5.5 ± 0.3 5 ± 0.4 5.8–5.9 4.8 ± 2.2 4.25 ± 2 Unknown 3.5 ± 2.1 4.9 ± 2.0 5.5 ± 2.0 >5
Adherence (hr)
N/A 0.035 — n.s. — n.s. n.s. n.s. n.s. N/A N/A n.s. N/A n.s. n.s. —
Diff
Placebo tablet, AHI = 49 ± 1.5, crossover Sham (1 cmH2O), O2 desaturations for OSA diagnosis Sham (2 cmH2O), AHI 56.4 vs. 44.2 Sham (2 cmH2O), AHI 45.9 vs. 35.2 Sham (2 cmH2O), AHI 53.6 vs. 41.7 Sham (1 cmH2O), O2 desaturations for OSA diagnosis Sham (2 cmH2O), AHI 4.36 vs. 56.8 Sham, AHI ≥ 30, ESS < 10 Sham (0–1 cmH2O), AHI 62.1 vs. 68.1 Sleep hygiene + weight loss, AHI 20 vs. 21 Sham, AHI 50.5 vs. 57.1 Sham (2 cmH2O), AHI 54 vs. 39 Placebo tablet, AHI 12.9 ± 6.3 Sham (1 cmH2O), O2 desaturations for OSA diagnosis Sham (3–4 cmH2O), AHI 62.5 vs. 65 Sham (2 cmH2O), AHI 53.6 vs. 41.7
Type of control and OSA criteria
Abbreviations: AHI, apnea-hypopnea index; ESS, Epworth sleepiness scale; N/A, not applicable; n.s., not significant; OSA, obstructive sleep apnea; ref, reference.
Engleman (1994) (44) Jenkinson (1999) (35) Loredo (1999) (3) Yu (1999) (38) Dimsdale (2000) (53) Hack (2000) (51) Bardwell (2001) (54) Barbe (2001) (52) Henke (2001) (55) Monasterio (2001) (56) Montserrat (2001) (57) Ziegler (2001) (58) Barnes (2002) (59) Pepperell (2002) (60) Becker (2003) (61) Profant (2003) (62)
n
Adherence Data from Controlled Trials
Primary author (year) (ref)
TABLE 1
2 Kushida
Perspectives
3
myocardial infarction, cardiac failure, stroke, cardiac dysrhythmias, increased risk for industrial and motor vehicle accidents, and sudden death (5,6). In fact, data from the Sleep Heart Health Study, a multi-center observational project funded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH), showed a linear relationship between severity of sleep-disordered breathing (SDB) and hypertension (7,8). There is also an emerging body of evidence (9,10) that neurocognitive abilities, especially in the domains of attention, working memory, and executive function, may be impaired with OSA. The major studies on the effects of OSA on neurocognitive function are summarized in Table 2. The neurocognitive function tests administered to the OSA subjects are typically segregated into the domains of attention and psychomotor (A/P) function, learning and memory (L/M), and executive and frontallobe (E/F) function. Engleman et al. (10) reviewed some of the case-control studies in Table 2; review of these studies indicated that community-acquired subjects with mild average indices of SDB showed slight attentional and executive function impairment. Those studies with moderate and severe SDB indices revealed moderate and large impairment in all three areas of neurocognitive function. However, relatively small sample sizes and inadequate control groups handicapped these earlier studies. In addition, newer technologies, such as the Sustained Attention Metric (11–18) and functional magnetic resonance imaging (MRI) have not been used to systematically evaluate neurocognitive function in OSA patients. The etiology of the decline in neurocognitive function with OSA is unknown. The theory that the hypoxemia of OSA is responsible for this decline is controversial; prior research on OSA patients (19) and hypoxemic chronic obstructive pulmonary disease (COPD) patients (20,21) failed to find a relationship between measures of hypoxemia and neurocognitive function. However, other investigators (22) have found that OSA patients with hypoxemia were significantly more cognitively impaired than OSA patients without hypoxemia. Another theory is that the decline in neurocognitive function with OSA is related to sleepiness. This does not appear to be completely true; OSA patients performed worse in neuropsychological tests than both healthy volunteers and patients with other disorders of excessive sleepiness (19). Perhaps the most parsimonious explanation is that these OSA-related neurocognitive deficits are the result of a combination of both hypoxemia and decreased vigilance; some investigators (23,24) found that these deficits in OSA patients were associated with both of these variables. CPAP has been shown to improve neurocognitive function in a few studies with limited sample sizes. These studies have demonstrated improvements in tests of A/P function (25,26), tests of L/M (25), as well as in tests of E/F function (27). However, other investigators have detected persistent deficits in similar measures of psychomotor, short-term memory, and executive function with CPAP use, indicating that some deficits may be due to irreversible anoxic central nervous system damage (28–31). The etiology of the daytime sleepiness associated with OSA is unknown. It is widely believed that the SDB of OSA results in brief arousals from sleep, which, in turn, fragments sleep and produces daytime sleepiness. However, this hypothesis has not been adequately tested, and there is controversy regarding whether it is accurate (26,32,33). Regardless of the etiology of this sleepiness, this symptom is a primary criterion for the diagnosis of OSA. CPAP has been demonstrated to improve the sleepiness associated with OSA both in long-term
CS CC CC CS CS CS CC CC CC CH CC RCT RCT RCT RCT RCT RCT RCT RCT RCT RCT
Findley (1986) (22)
Greenberg (1987) (19) Bédard (1991) (23)
Presty (1991) (63) Cheshire (1992) (64)
Telakivi (1993) (65) Ingram (1994) (66) Naëgelé (1995) (67) Verstraeten (1996) (68) Kim (1997) (69)
Redline (1997) (70) Engleman (1997) (71) Engleman (1998) (45) Engleman (1999) (40) Hack (2000) (51) Barbé (2001) (52) Bardwell (2001) (54) Henke (2001) (55) Monasterio (2001) (56) Barnes (2002) (59) Barnes (2004) (72)
32/20 16 23 34 59 29/25 36 46 42 42 80
31 16/43 17/17 26/22 199/642
119 29
14/14 20/10
26
n
Mild–mod Mild Mod–severe Mild Mild–severe Severe Mod–severe Mod–severe Mild–mod Mild–mod Mild–mod
Mild–severe Mild–severe Severe Mild–severe Mild–severe
Mild–severe Mod–severe
Severe Mod–severe
Severe
OSA severity
Conclusions Improved in 4/8 A/P, L/M, and E/F tests for hypoxemic vs. non-hypoxemic OSA subjects Improveda in 7/14 A/P and E/F tests vs. controls Improveda in 7/9 A/P and 2/4 E/F tests; decreasea in 5/6 L/M tests (only severe cases) Improveda in A/P and L/M tests for those OSA patients with severe hypoxia Correlationa between AHI and 1/2 EF tests and IQ decrease; no correlation in 3 A/P or 1 L/M tests No correlation between hypoxia or sleepiness and 7 A/P, L/M, and E/F tests No difference in OSA vs. controls subjects ≥ 54 yrs for 1 A/P test Improveda in 1/4 A/P tests, 8/10 L/M tests, and 3/9 E/F tests vs. controls No differences in OSA vs. insomnia subjects for 6 A/P, L/M, or E/F tests Negative associationa between log AHI and psychomotor efficiency in 8 A/P, L/M, or E/F tests Improveda in 1/4 A/P tests, 0/3 L/M tests, and 1/5 E/F tests vs. controls Improveda mental flexibility Improveda in 2/3 A/P tests, 0/2 L/M tests, and 0/4 E/F tests vs. controls Improveda in 1/3 A/P tests and 1/3 E/F tests vs. controls Improved driving simulation No difference in active vs. sham CPAP groups for 8 A/P, L/M, and E/F tests Improveda in 1/2 A/P tests, 0/4 L/M tests, and 0/2 E/F tests vs. controls Improveda in 2/3 A/P tests, 3/3 L/M tests, and 2/3 E/F tests vs. controls Improveda in 0/4 A/P tests, 0/2 L/M tests, and 0/8 E/F tests vs. controls Improveda in 0/3 A/P tests, 0/2 L/M tests, and 1/4 E/F tests vs. controls Improveda in 0/2 A/P and 2/5 E/F tests vs. controls
a
a
Significance level, p < 0.05. OSA severity by average apnea-hypopnea index (AHI), with mild = 5–15 events/hr, moderate = 15–30 events/hr, and severe >30 events/hr. Abbreviations: A/P, tests of attention and psychomotor function; CC, case-control; CH, cohort; CPAP, continuous positive airway pressure; CS, case series; E/F, tests of executive and frontal lobe function; IQ, intelligence quotient; L/M, tests of learning and memory; OSA, obstructive sleep apnea; RCT, randomized control trial; ref, reference.
Study type
Review of Studies on Neurocognitive Function in OSA Patients
Primary author (year) (ref)
TABLE 2
4 Kushida
Perspectives
5
studies (34) and in comparisons with subtherapeutic CPAP (35); however, in the former limited studies, this improvement did not approach the baseline levels of controls without OSA. The effects of CPAP on mood states in OSA patients are largely unknown. The results have been mixed, with some studies reporting improvement (36,37), others revealing significant improvement in both active CPAP and placebo groups (38), or finally others showing no significant effects (25,39). However, these studies were limited by their use of small sample sizes, standard and nonstandard indices of mood state, and different types of controls. Quality of life assessment has become an integral component of health outcomes research. This assessment is still in its infancy for the evaluation of sleep apnea patients. Nevertheless, a few studies with small sample sizes have documented significant improvement in quality of life indices following CPAP treatment in OSA patients (26,35,40,41). Up to the present time, there has never been a multicenter, randomized, double-blind, placebo-controlled, long-term study to systematically investigate the therapeutic effectiveness of CPAP, despite its widespread use as the primary treatment for OSA (42) and the perception by the majority of patients with OSA that it is a successful treatment for this disorder (43). To date, the efficacy of CPAP has generally been evaluated against control groups that do not meet the requirements of placebo groups since the controls are not subjected to the same instrumental constraints (44–47) as the experimental group. This lack of adequate placebocontrolled studies combined with the patient costs of CPAP, has called into question the usefulness of CPAP as a primary therapy for OSA (48,49). The NHLBI-funded, multicenter Apnea Positive Pressure Long-term Efficacy Study (APPLES), under the leadership of Dr. William C. Dement and Dr. Clete A. Kushida is designed to examine this question. Although there is some evidence as described above that OSA affects these areas of human function and that these effects may be reversed with CPAP, it has never been evaluated in a comprehensive, systematic, and well-controlled manner. The primary goal of APPLES is to test the hypothesis that CPAP therapy results in significant, stable, and longterm benefits to neurocognitive function, mood, sleepiness, and quality of life in patients with OSA. The study evaluates this hypothesis by administering a comprehensive yet novel test battery containing measures of neurocognitive function, mood, sleepiness, and quality of life on over a thousand OSA subjects in the United States assigned to either active or sham (subtherapeutic) CPAP therapy in a double-blinded and randomized manner (50). Subtherapeutic CPAP has been used successfully as a placebo in a few studies (3,35,51,52). For APPLES, the use of the active vs. sham CPAP devices will evaluate the long-term benefits of CPAP therapy for a six-month period. The major risk of the study is that the subjects randomized to the sham CPAP condition are without effective treatment for a seven-month period from the time of enrollment into the study. However, this period of subtherapeutic treatment for OSA appears brief considering that OSA remains largely undiagnosed and untreated by physicians, there is a significant delay from appearance of symptoms to seeking treatment on the part of the patient, and the majority of sleep clinics and laboratories have very lengthy waiting lists. We are also incorporating functional magnetic resonance imaging (fMRI) in APPLES, because the use of these technologies will assist us in determining if OSA-related neurocognitive deficits are associated with changes in cortical activation, and whether CPAP can reverse these changes.
6
Kushida
If, as anticipated, we find that CPAP usage results in improved daily function for OSA patients, the most important benefit of the study includes advancing the knowledge that CPAP can effectively treat the debilitating consequences of OSA in the areas of neurocognitive function, mood, sleepiness, and quality of life. We further anticipate providing the necessary evidence to symptomatic individuals and health care providers that CPAP has a lasting positive impact on the nature of this sleep-related breathing disorder. APPLES is designed to evaluate neurocognitive function, mood, sleepiness, and quality-of-life in OSA patients; however, there are other known consequences of OSA, which impact the cardiac, cardiovascular, and endocrine systems, as well as affecting a patient’s alertness, mental state, and driving ability. These individual and societal domains of human existence that are affected by OSA are described in this two-volume set of books on obstructive sleep apnea. In addition, these books also discuss upper airway surgery, oral appliances, and adjunctive and alternative treatments, all of which constitute the other major therapeutic approaches for OSA. It is the sincere hope of this author that these books will stimulate further research into the effects and consequences of OSA as well as its treatment, so that we can successfully diagnose and cure the majority of patients with this debilitating disease. REFERENCES 1. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328:1230–1235. 2. Gay P, Weaver T, Loube D, et al. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep 2006; 29(3):381–401. 3. Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure vs placebo continuous positive airway pressure on sleep quality in obstructive sleep apnea. Chest 1999; 116:1545–1549. 4. Fietze I, Quispe-Bravo S, Hansch T, et al. Arousals and sleep stages in patients with obstructive sleep apnoea syndrome: Changes under nCPAP treatment. J Sleep Res 1997; 6(2):128–133. 5. Weiss JW, Launois SH, Anand A. Cardiorespiratory changes in sleep-disordered breathing. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. Philadelphia: WB Saunders, 2000:859–868. 6. Findley LJ, Unverzagt ME, Suratt PM. Automobile accidents involving patients with obstructive sleep apnea. Am Rev Respir Dis 1988; 138:337. 7. Quan SF, Howard BV, Iber C, et al. The Sleep Heart Health Study: design, rationale, and methods. Sleep 1997; 20(12):1077–1085. 8. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000; 283(14): 1829–1836. 9. Décary A, Rouleau I, Montplaisir J. Cognitive deficits associated with sleep apnea syndrome: A proposed neuropsychological test battery. Sleep 2000; 23(3):369–381. 10. Engleman HM, Kingshott RN, Martin SE, et al. Cognitive function in the sleep apnea/ hypopnea syndrome (SAHS). Sleep 2000; 23(suppl 4):S102–S108. 11. Gevins A, Smith ME. Detecting transient cognitive impairment with EEG pattern recognition methods. Aviat Space Environ Med 1999; 70:1018–1024. 12. Gevins A, Smith ME, Leong H, et al. Monitoring working memory load during computerbased tasks with EEG pattern recognition methods. Hum Factors 1998; 40:79–91. 13. Gevins A, Smith ME, McEvoy L, et al. High resolution EEG mapping of cortical activation related to working memory: effects of task difficulty, type of processing, and practice. Cereb Cortex 1997; 7:374–385. 14. Gevins A, Smith ME, Le J, et al. High resolution evoked potential imaging of the cortical dynamics of human working memory. EEG Clin Neurophysiol 1996; 98:327–348.
Perspectives
7
15. Gevins A, Leong H, Smith ME, et al. Mapping cognitive brain function with modern high-resolution electroencephalography. TINS 1995; 18:429–436. 16. Gevins AS, Bressler SL, Cutillo BA, et al. Effects of prolonged mental work on functional brain topography. Electroencephalography and Clinical Neurophysiology 1990; 76:339–350. 17. Gevins A, Smith ME. Neurophysiological measures of working memory and individual differences in cognitive ability and cognitive style. Cereb Cortex 2000; 10(9):829–839. 18. McEvoy LK, Smith ME, Gevins A. Test-retest reliability of cognitive EEG. Clinical Neurophysiology 2000; 111(3):457–463. 19. Greenberg GD, Watson RK, Deptula D. Neuropsychological dysfunction in sleep apnea. Sleep 1987; 10(3):254–262. 20. Fix AJ, Golden CJ, Daughton D, et al. Neuropsychological deficits among patients with chronic obstructive pulmonary disease. Int J Neurosci 1982; 16:99–105. 21. Grant I, Heaton RK, McSweeny AJ, et al. Neuropsychological findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 1982; 142:1470–1476. 22. Findley LJ, Barth JT, Powers DC, et al. Cognitive impairment in patients with obstructive sleep apnea and associated hypoxemia. Chest 1986; 90(5):686–690. 23. Bédard M-A, Montplaisir J, Richer F, et al. Obstructive sleep apnea syndrome: pathogenesis of neuropsychological deficits. J Clin Exper Neuropsychol 1991; 13(6):950–964. 24. Valencia-Flores M, Bliwise DL, Guilleminault C, et al. Cognitive function in patients with sleep apnea after acute nocturnal nasal continuous positive airway pressure (CPAP) treatment: sleepiness and hypoxemia effects. J Clin Exp Neuropsychol 1996; 18(2):197–210. 25. Borak J, Cieslicki JK, Koziej M, et al. Effects of CPAP treatment on psychological status in patients with severe obstructive sleep apnoea. J Sleep Res 1996; 5(2):123–127. 26. Kingshott RN, Vennelle M, Hoy CJ, et al. Predictors of improvements in daytime function outcomes with CPAP therapy. Am J Respir Crit Care Med 2000; 161:866–871. 27. Feuerstein C, Naëgelé B, Pepin JL, et al. Frontal lobe-related cognitive functions in patients with sleep apnea syndrome before and after treatment. Acta Neurol Belg 1997; 97(2):96–107. 28. Montplaisir J, Bédard MA, Richer F, et al. Neurobehavioral manifestations in obstructive sleep apnea syndrome before and after treatment with continuous positive airway pressure. Sleep 1992; 15:S17–S19. 29. Bédard M-A, Montplaisir J, Malo J, et al. Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). J Clin Exp Neuropsychol 1993; 15(2):330–341. 30. Kotterba S, Rasche K, Widdig W, et al. Neuropsychological investigations and eventrelated potentials in obstructive sleep apnea syndrome before and during CPAP-therapy. J Neurol Sci 1998; 159:45–50. 31. Naëgelé B, Pépin J-L, Lévy P, et al. Cognitive executive dysfunction in patients with obstructive sleep apnea syndrome (OSAS) after CPAP treatment. Sleep 1998; 21(4):392–397. 32. Kingshott RN, Engleman HM, Deary IJ, et al. Does arousal frequency predict daytime function? Eur Respir J 1998; 12(6):1264–1270. 33. Martin SE, Engleman HM, Deary IJ, et al. The effect of sleep fragmentation on daytime function. Am J Respir Crit Care Med 1996; 153(4 pt 1):1328–1332. 34. Sforza E, Krieger J. Daytime sleepiness after long-term continuous positive airway pressure (CPAP) treatment in obstructive sleep apnea syndrome. J Neurol Sci 1992; 110(1-2):21–26. 35. Jenkinson C, Davies RJ, Mullins R, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999; 353:2100–2105. 36. Derderian SS, Bridenbaugh RH, Rajagopal KR. Neuropsychologic symptoms in obstructive sleep apnea improve after treatment with nasal continuous positive airway pressure. Chest 1988; 94(5):1023–1027. 37. Yamamoto H, Akashiba T, Kosaka N, et al. Long-term effects of nasal continuous positive airway pressure on daytime sleepiness, mood and traffic accidents in patients with obstructive sleep apnoea. Respir Med 2000; 94(1):87–90. 38. Yu BH, Ancoli-Israel S, Dimsdale JE. Effect of CPAP treatment on mood states in patients with sleep apnea. J Psychiatr Res 1999; 33:427–432.
8
Kushida
39. Munoz A, Mayoralas LR, Barbe F, et al. Long-term effects of CPAP on daytime functioning in patients with sleep apnoea syndrome. Eur Respir J 2000; 15(4):676–681. 40. Engleman HM, Kingshott RN, Wraith PK, et al. Randomized placebo-controlled crossover trial of CPAP for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159(2):461–467. 41. Jenkinson C, Stradling J, Petersen S. Comparison of three measures of quality of life outcome in the evaluation of continuous positive airway pressure therapy for sleep apnoea. J Sleep Res 1997; 6:199–204. 42. Sullivan CE, Issa F, Berthon-Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 1:862–865. 43. Hoffstein V, Viner S, Mateika S, et al. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Patient compliance, perception of benefits, and side effects. Am Rev Respir Dis 1992; 145(4 Pt 1):841–845. 44. Engleman HM, Martin SE, Deary IJ, et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 1994; 343:572–575. 45. Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ. Randomized placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998; 53:341–345. 46. Ballester E, Badia JR, Hernandez L, et al. Evidence of the effectiveness of CPAP in the treatment of sleep apnoea/hypopnoea syndrome. Am J Respir Crit Care Med 1999; 159:495–501. 47. Lojander J, Kajaste S, Maasilta P, et al. Cognitive function and treatment of obstructive sleep apnea syndrome. J Sleep Res 1999; 8:71–76. 48. Wright, J, Johns R, Watt I, et al. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airway pressure: a systematic review of the research evidence. BMJ 1997; 314:851–860. 49. Stradling J. Sleep apnoea and the misuse of evidence-based medicine. Lancet 1997; 349:201–202. 50. Kushida CA, Nichols DA, Quan SF. The Apnea Positive Pressure Long-term Efficacy Study (APPLES): rationale, design, methods, and procedures. J Clin Sleep Med 2006; 2(3):288–300. 51. Hack M, Davies RJ, Mullins R, et al. Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnoea. Thorax 2000; 55:224–231. 52. Barbe F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. A randomized, controlled trial. Ann Intern Med 2001; 134:1015–1023. 53. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000; 35:144–147. 54. Bardwell WA, Ancoli-Israel S, Berry CC, et al. Neuropsychological effects of one-week continuous positive airway pressure treatment in patients with obstructive sleep apnea: a placebo-controlled study. Psychosom Med 2001; 63:579–584. 55. Henke KG, Grady JJ, Kuna ST. Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apnea/hypopnea syndrome. A randomized, placebo-controlled trial. Am J Respir Crit Care Med 2001; 163:911–917. 56. Monasterio C, Vidal S, Duran J, et al. Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 164:939–943. 57. Montserrat JM, Ferrer M, Hernandez L, et al. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. Am J Respir Crit Care Med 2001; 164:608–613. 58. Ziegler MG, Mills PJ, Loredo JS, et al. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 2001; 120:887–893. 59. Barnes M, Houston D, Worsnop CJ, et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165:773–780.
Perspectives
9
60. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359:204–210. 61. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107:68–73. 62. Profant J, Ancoli-Israel S, Dimsdale JE. A randomized, controlled trial of 1 week of continuous positive airway pressure treatment on quality of life. Heart Lung 2003; 32:52–58. 63. Presty SK, Barth JT, Suratt PM, et al. Effects of nocturnal hypoxemia on neurocognitive performance in obstructive sleep apne. Am J R Crit 1991; 143:A384. 64. Cheshire K, Engleman H, Deary I, et al. Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. Arch Intern Med 1992; 152:538–541. 65. Telakivi T, Kajaste S, Partinen M, et al. Cognitive function in obstructive sleep apnea. Sleep 1993; 16:S74–S75. 66. Ingram F, Henke KG, Levin HS, et al. Sleep apnea and vigilance performance in a communitydwelling older sample. Sleep 1994; 17(3):248–252. 67. Naëgelé B, Thouvard V, Pépin J-L, et al. Deficits of cognitive executive functions in patients with sleep apnea syndrome. Sleep 1995; 18(1):43–52. 68. Verstraeten E, Cluydts R, Verbraecken J, et al. Neuropsychological functioning and determinants of morning alertness in patients with obstructive sleep apnea syndrome. J Int Neuropsychol Soc 1996; 2:306–314. 69. Kim JC, Young T, Matthews CG, et al. Sleep-disordered breathing and neuropsychological deficits: a population-based study. Am J Respir Crit Care Med 1997; 156:1813–1819. 70. Redline S, Strauss ME, Adams N, et al. Neuropsychological function in mild sleepdisordered breathing. Sleep 1997; 20(2):160–167. 71. Engleman HM, Martin SE, Deary IJ, et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Thorax 1997; 52:114–119. 72. Barnes M, McEvoy RD, Banks S, et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170:656–664.
Section I: Features, Factors, and Characteristics
2
History Michael Zupancic Department of Neurology, University of Michigan Sleep Disorders Center, Ann Arbor, Michigan, U.S.A.
Peretz Lavie Sleep Medicine Center, Rambam Medical Center, Haifa, Israel
PRETWENTIETH CENTURY LITERATURE Obstructive sleep apnea (OSA) is a common disorder that affects one of four men and one of 11 women in the world (1). Though it has been described since the 1970s, it was not until 20 years later that its prevalence and importance as a public health problem was widely recognized. How has this disorder, with clear signs and symptoms, been hiding in plain view for so many years? Features of OSA have been described for more than 100 years and interestingly enough, they first appeared in fictional literature. William Shakespeare (2), for instance, was aware of the connection between obesity and sleepiness when describing the picturesque Sir John Falstaff in Henry IV (Fig. 1). Falstaff was well known for his corpulence and propensity for napping and was occasionally found, “fast asleep behind the arras, and snoring like a horse.” Charles Dickens’ character Joe, from The Pickwick Papers (1835) (3), is described as “a wonderfully fat boy” who falls asleep easily and against his will (Fig. 2). When we first meet Joe, he is standing up asleep after knocking vigorously on a door. When asked why he knocked relentlessly, Joe explains it is to prevent himself from falling asleep. Dickens’ description of Joe caught the eye of several physicians who independently coined the term “Pickwickian syndrome.” Of these physicians, the most cited is Sir William Osler (4) (Fig. 3). In the eighth edition of his celebrated textbook Principles and Practice of Medicine, published in 1914, he used the term “Pickwickian syndrome” to describe obese and sleepy patients, in homage to Dickens’ character Joe. George Catlin (5) (Fig. 4), a nineteenth-century lawyer, artist, and amateur anthropologist hinted of sleep-disordered breathing in his book The Breath of Life published in 1861. He noted that American Indians were healthier than EuropeanAmericans because he observed that they breathed through their noses when asleep. Catlin claimed that breathing through the mouth while asleep caused snoring, a feeling of tiredness in the morning, headaches upon waking, and a strong desire to carry on sleeping. Moreover, he was convinced that breathing through the mouth while asleep caused more illnesses, and even death. Catlin concluded his book by suggesting that the sides of the cribs and cradles of babies be inscribed with the words “shut your mouth” to promote health (5). Some of Catlin’s paintings also show the virtues of breathing through the nose while asleep. In 1818, John Cheyne (6) (Fig. 5), a Dublin physician, was among the first to describe sleep-disordered breathing in the medical literature. Observing a patient dying from heart disease, he noted an irregular breathing pattern and paralysis when asleep. In 1854, William Stokes (7) (Fig. 6), who also practiced in Dublin, 11
12
Zupancic and Lavie
FIGURE 1 Artist rendering of William Shakespeare’s character, Sir John Falstaff in Henry IV (c. 1596–1597).
FIGURE 2 Artist (Hablot Knight BrownePhiz) rendering of Charles Dickens’ character, Joe, in The Pickwick Papers (c. 1836–1837).
13
History
FIGURE 3
Sir William Osler (1849–1919).
FIGURE 4 George Catlin (1796–1872).
14
Zupancic and Lavie
FIGURE 5
John Cheyne, MD (1777–1836).
described a similar case of abnormal breathing in a heart patient. Today, periodic breathing in heart failure patients is named “Cheyne-Stokes breathing” after these two sharp-eyed Dublin physicians. W. H. Broadbent (8), a physician from St. Mary’s Hospital in London, was one of the first to describe what we term today “obstructive sleep apnea” in an article published in The Lancet in 1877. He described a strange case of sleep-disordered breathing that was “similar to Cheyne-Stokes breathing.” But from the very detailed description of this patient, it is clear there was more than periodic breathing, since this patient’s snoring “ceased at regular intervals, and the pause was so long as to excite attention, and indeed alarm.” Broadbent concluded his article by declaring: “All the theories that have attempted to explain this phenomenon are inadequate and I have none of my own” (8).
FIGURE 6 William Stokes, MD (1804–1878).
History
15
The second case of OSA described in a medical arena occurred 11 years later on February 8, 1889 by Richard Caton of Liverpool (9), who has gained his place in medical history as the discoverer of the brain’s electrical activity. He presented an interesting case to the Clinical Society of London, a case he erroneously described as one of narcolepsy. The patient, a 37-year-old poulterer, complained of great sleepiness that appeared at the same time as a marked increase in his weight. The poulterer’s sleepiness was so severe that he sank into sleep even when at work. While serving customers in his shop, he would fall asleep as he stood by the counter and would awaken to find himself holding in his hand the duck or chicken which he had been selling to a customer fifteen minutes earlier. Caton’s description of the poulterer’s sleep clearly alludes to his diagnosis: “When in sound sleep a very peculiar state of the glottis is observed, a spasmodic closure entirely suspending respiration. The thorax and abdomen are seen to heave from fruitless contractions of the inspiratory and expiratory muscles; their efforts increase in violence for about a minute or a minute and a half, the skin meantime becoming more and more cyanosed, until at last, when the condition to the onlooker is most alarming, the glottic obstruction yields, a series of long inspirations and expirations follows, and cyanosis disappears.” “This acute dyspnoeic attack does not awaken the patient . . . .” “If in the midst of the dyspnoeic attack he is forcibly aroused, the glottic spasm at once relaxes. The night nurses state that these attacks go on throughout the night” (9). Caton attributed the patient’s abnormal sleep to be the result of a toxin that acted only on the glottal muscles. Following treatment with various drugs, and after weight loss, the patient’s condition improved in both his level of daytime alertness and his sleep (9). Alexander Morrison (10) described a similar case in 1889 of a 63-year-old man who suffered from sleepiness and described cyanotic episodes when the patient slept. Though Broadbent, Caton, and Morrison accurately described the sleep of people suffering from sleep apnea, and further described debilitating sleepiness during the day, none of them claimed that the problem was a disorder unique to sleep. At the time, physicians did not ascribe much importance to excessive daytime sleepiness unless it was related to a specific illness or damage to the central nervous system. In fact, it was not until the middle of the 20th century that the scientific viewpoint of sleep began to change from that of the 2000-year-old school of thought introduced by Galen, who described sleep as a passive state created by the disconnection of the brain from the rest of the body parts and the external environment. BURWELL ET AL.’S POKER PLAYER AND THE FIRST SLEEP RECORDINGS OF PICKWICKIAN PATIENTS One of the articles most often mistakenly quoted as the first to “describe” sleep apnea is “Extreme Obesity Associated with Alveolar Hypoventilation—A Pickwickian Syndrome,” published in 1956 by Bickelmann et al. (11). This article describes an obese man whose daytime sleepiness became so severe after gaining weight that he fell asleep playing poker while holding a “full house,” which prompted him to seek medical care. Though this story is memorable, and the article correctly shows the effect sleep apnea can have on daytime sleepiness, it incorrectly identified the source of sleepiness as increased carbon dioxide secondary to lack of respiratory effort, rather than disrupted nocturnal sleep. In fact, throughout the paper there is no mention of the patient’s nocturnal sleep (11). Werner Gerardy and Dieter Herberg performed the first physiological recordings in a sleeping Pickwickian patient at the Ludolf-Krehl Clinic of the Heidelberg
16
Zupancic and Lavie
University Hospital. In 1959, Gerardy performed an electroencephalogram on an obese patient who had been admitted because of reduced work capacity and frequent migraines upon awakening. During the one-hour examination the patient fell asleep. Gerardy described the sleeping patient as having periodic breathing. During the onset of these events Gerardy noted that patient’s tongue fell back and airflow ceased, despite increased movements of the thorax; upon waking, the patient’s tongue moved forward as he resumed breathing. Additionally, Gerardy noted the cardiac arrhythmia that occurs with obstructive apneas with the heart rate decelerating during the suspension of breathing, and its dramatic acceleration with renewal of breathing. In 1960, Gerardy, Herberg, and Hans Manfred Kuhn described their findings in the first sleep recording of Pickwickian patients (12). Though they were innovative in describing the breathing and heart rate changes during obstructive apneas, their explanation for the suspension of breathing during sleep was no different from before. They believed it was secondary to high carbon dioxide from shallow and inefficient breathing, and attributed the tongue moving backward as a sign of deep sleep rather than that of obstruction (12). Two years later Daniel Drachman and Robert Gumnit (13) of the U.S. National Institutes of Health published an article that led to further advancements in the understanding of sleep apnea. They examined the daytime sleep of a female Pickwickian patient who worked as an ice cream vendor and who had become sleepier and heavier over the course of several years. When examining the patient’s sleep, they described similar findings as Gerardy et al., but were the first to note a drop in oxygen saturation level during the breathing events (13). Despite these innovations in understanding sleep in Pickwickian patients, they still believed these abnormal breathing events were secondary to elevated carbon dioxide rather than closure of the airway (13). Wolfgang Kuhl (14), a German neurologist and his department head Richard Jung helped pioneer the understanding of obstructive sleep apnea. In 1964, they presented their findings of a Pickwickian patient’s nocturnal sleep at the annual meeting of the European Neurological Society. They were the first to conclude that the daytime sleepiness of a Pickwickian patient was secondary to recurring interruptions in sleep rather than carbon dioxide poisoning. This put the understanding of the Pickwickian syndrome in an entirely different light. Kuhl’s recordings clearly showed that the syndrome originated not in shallow and inefficient breathing or heart disease, but in a disorder in the normal course of sleep. This important conclusion shifted the Pickwickian syndrome from primarily a pulmonary and internal medicine domain to the field of neurology (14). Henri Gastaut attended this conference and was greatly impressed by Kuhl’s conclusion. Gastaut was the head of the Neurobiological Research Unit in Marseilles. After attending this conference Gastaut recruited Bernard Duron, a young researcher well versed in respiratory function and neurophysiology, and they set up recording instruments to evaluate the sleep of Pickwickian patients. In addition to monitoring the patient’s respiratory efforts through thorax movements and respiratory muscle activity (as done by Kuhl), they also measured airflow with respiratory sensors at the patient’s nostrils and mouth. With this innovative monitoring technique, Duron’s recordings revealed that blockage of the upper airway during sleep was the etiology of the apneas (15). They concluded that apneas were not secondary to dysfunction of the brain’s respiratory center as proposed by Jung and Kuhl. Gastaut’s group also was the first to describe three different types of apneas: obstructive apneas, central apneas, and mixed apneas. Later, Daniel Kurtz and Jean
History
17
Krieger of Strasbourg defined and added a further type of sleep-disordered breathing, the hypopnea (15). Elio Lugaresi (Fig. 7), a former student of Gastaut, and Giorgio Coccagna (16) were two neurologists who also were influenced by Kuhl’s lecture at the 1964 European Neurological Conference. They studied Pickwickian patients’ sleep in Bologna and came to similar conclusions as Duron and Gastaut that apneas were caused from upper airway obstruction. Additionally, Lugaresi’s group showed that systemic and pulmonary blood pressure varied greatly during and following obstructive apneas, with a drop in blood pressure at the start of an apnea and a dramatic rise in blood pressure once breathing resumed (16). FIRST TREATMENT ATTEMPTS Though weight loss was identified early as a treatment to improve nocturnal sleep and daytime function in Pickwickian patients, many patients were unable to succeed with losing the necessary weight, and they continued to suffer from daytime sleepiness. Several sleep researchers theorized that tracheostomy would be an effective treatment to bypass the sleep-related breathing obstruction. However, due to potentially serious complications, physicians were leery of being the first to perform tracheostomies on a Pickwickian patient. Chance intervened when a Pickwickian patient of Wolfgang Kuhl sank into a protracted coma as a result of what was diagnosed as carbon dioxide poisoning. This Pickwickian patient was the first to undergo tracheostomy and the patient recovered almost immediately from his coma. Additionally, he made a complete recovery from his sleep-disordered breathing and his daytime alertness became normal. On hearing about Kuhl’s case, Lugaresi et al. (17) managed to convince the surgical staff of Bologna to perform emergency tracheostomies on several Pickwickian patients. Within a short time six patients underwent the procedure and all of them showed
FIGURE 7 Elio Lugaresi, MD (center) with William C. Dement, MD, PhD (left) and Christian Guilleminault, MD (right) (c. 1983). Source: Photograph courtesy of William C. Dement, MD, PhD.
18
Zupancic and Lavie
great improvement in their sleep-disordered breathing, daytime alertness, and systemic and pulmonary blood pressures. Though tracheostomy for sleep-disordered breathing was an effective treatment for Pickwickian patients, it was rarely performed outside of Europe for several years. One of the first patients to undergo a tracheostomy was Raymond M., a pediatric patient admitted to Stanford University Medical Center for uncontrolled hypertension. After undergoing an extensive and unrevealing medical workup Raymond’s physicians asked Christian Guilleminault (Fig. 8) to evaluate an “unrelated symptom” of daytime sleepiness that his mother had noted for years. A subsequent sleep study revealed that the patient had OSA and in late 1972 he underwent a tracheostomy as encouraged by Dr. Guilleminault. Several days following treatment the patient’s daytime sleepiness and hypertension resolved. In 1973, Bill Orr and N. K. Imes began evaluating the sleep of patients hospitalized in the intensive care unit (ICU) of Oklahoma City Presbyterian Hospital. They discovered a relatively large number of patients with sleep-disordered breathing and they performed tracheostomies, with subsequent improvements in sleep and daytime function. Another successful report came from Canada when Meir Kryger saw his first case of sleep apnea in 1973. The patient was an obese man hospitalized for “epileptic attacks” that occurred during sleep. While studying the patient’s sleep, Kryger noted that the “epileptic attacks” were in fact prolonged apneas. After undergoing a tracheostomy this drowsy, obese, “epileptic” patient was cured (18). SLEEP APNEA IN THIN PERSONS Until the early 1970s, it was generally accepted that sleep-disordered breathing occurred solely in obese patients. Christian Guilleminault and William Dement (Fig. 8) at Stanford University changed this perception completely when they proved that obesity is not a prerequisite for the existence of these disorders. One patient who presented to the Stanford Sleep Laboratory was a slender man with complaints of difficulty falling asleep and frequent awakenings overnight. In the course of their
FIGURE 8 William C. Dement, MD, PhD (left) and Christian Guilleminault, MD (right) (c. 1997). Source: Photograph courtesy of William C. Dement, MD, PhD.
History
19
recordings, Guilleminault and Dement noted that this patient’s heartbeat was irregular. Upon entering the bedroom they noted that this slender man was having apneas hundreds of times a night which were associated with the irregular heartbeat. Guilleminault and Dement decided that monitoring breathing during sleep should be done on all patients examined at the Stanford Sleep Laboratory, regardless of their diagnosis, complaint, and body size. To their great surprise, it quickly became clear that many patients referred for sleep testing due to complaints of tiredness, daytime sleepiness, and even insomnia were, in fact, suffering from breathing disorders in their sleep—often with no connection at all to their body weight. Guilleminault and Dement also showed that sleep apnea occurs in children and that treating the apnea could lower elevated blood pressure (19–21). In 1977 Guilleminault and Dement (22) published an article summarizing their sleep study findings, including breathing recordings in 250 patients referred to the Stanford Sleep Laboratory. In 35 of them, the sleep recordings showed evidence of breathing disorders [as defined as an apnea-hypopnea index (AHI) > 30], even though not one of the patients had complained of breathing problems during sleep in their prerecording interviews. The subsequently published article was the first to use the term “sleep apnea syndrome” and the authors also suggested a definition of it in accordance with their laboratory findings. This study also revealed that sleep apnea occurred more frequently in men, with only one woman among the 35 sleep apnea subjects. Another important finding was that 16 of the sleep apnea subjects had hypertension and three had pathological signs on electrocardiographic recording (22). FIRST MAJOR INTERNATIONAL CONFERENCE OF RESPIRATORY SLEEP DISORDERS In July 1977, an international group of eminent researchers and specialists in sleep and pulmonary physiology gathered at the Kroc Foundation in Santa Ynez Valley, California, to examine the accumulated knowledge on respiratory sleep disorders. Several important topics were presented which furthered the understanding of obstructive sleep apnea. One important lecturer was Eliot Phillipson (23), from Toronto, who studied breathing in normal sleeping dogs. Phillipson reported that during non-rapid eye movement (NREM) sleep in dogs, an increase in carbon dioxide concentration caused a gradual increase in their breathing rate and volume until they awakened. However, in rapid eye movement (REM) sleep, breathing was almost entirely unaffected by carbon dioxide concentration and was inherently unstable, varying moment-to-moment. Phillipson claimed that in NREM sleep, breathing was under the control of the automatic, or metabolic, breathing mechanism located in the brainstem’s respiratory center. In REM sleep, Phillipson believed that breathing was controlled by the “voluntary” respiratory center located in the frontal lobe. According to Phillipson (24,25), the wakefulness mechanism, located close to the respiratory center in the brainstem, protected a sleep apnea patient from suffocating during an apnea episode. Another important topic discussed at this conference was the exact location of the upper airway blockage and why it occurs. Elliot Weitzman (Fig. 9), a leading sleep researcher and founder of the Sleep Disorders Center at the Montefiore Medical Center in the Bronx, New York, showed by fluoroscopy that the cause of the blockage was a collapse of the side walls of the pharynx and a backward movement of the base of the tongue. This “landslide” always occurred at the end of exhalation
20
Zupancic and Lavie
FIGURE 9 Elliot D. Weitzman, M.D. (1930– 1983). Source: Photograph courtesy of William C. Dement, MD, PhD.
and before the next inhalation, presumably from the suction created from movements of the diaphragm and respiratory muscles (26). Ron Harper complemented Weitzman’s observation by noting that during an apnea episode there is a reduction of the tongue muscle’s electrical activity facilitating its backward movement. Weitzman’s collapse theory was innovative in that it suggested airway collapse was not an active process as had been previously believed. This topic was hotly debated during the conference with multiple theories concerning the etiology of airway collapse. This seminal meeting heralded the change in attitude of the medical community toward the importance of breathing disorders in sleep. SLEEP APNEA OVER THE PAST TWENTY-FIVE YEARS The 1980s were an important decade in sleep apnea research. There continued to be a greater understanding of the physiology of sleep and pathophysiology of obstructive sleep apnea. Several studies demonstrated the importance of pressure sensors in the upper airway in maintaining normal respiration during sleep. In 1982, Eliot Phillipson noted prolonged central apneas in normal subjects after applying lidocaine spray to airway receptors in the nose and pharynx. David White, Director of the Sleep Disorders Program at the Brigham and Women’s Hospital in Boston, Massachusetts, also showed the importance of airway receptors in the nose. When his group administered local anesthesia to the nostrils in normal subjects, they noted a four-fold increase in apneas (27). Dr. White’s group also made the important discovery that the muscle activity of upper airway dilator muscles was abnormal in OSA patients. Neurophysiologic studies of these pharyngeal muscles revealed greater muscle activity in OSA patients than in controls during waking hours. With sleep onset, there was a great diminution
History
21
in tonic muscle activity of these muscles in OSA patients compared with controls (28). Additionally, White’s group demonstrated that pharyngeal receptors are abnormal in OSA patients, suggesting that damage to these receptors, perhaps by “benign snoring,” is important in the pathogenesis of OSA. In 1983, Lavie (29) published an article in Sleep, which indicated there was likely a link between OSA and hypertension. In evaluating the polysomnograms and records of industrial workers referred for complaints of daytime sleepiness and chronic fatigue, 36.3% of workers with more than 10 apneas per hour had hypertension compared to 7.4% of those without OSA. Terry Young et al. (1) brought OSA to the attention of the general medical community by examining the prevalence of asymptomatic and symptomatic OSA in civil service workers in Wisconsin. This study, published in 1993, was the first major epidemiologic study in the United States assessing OSA. It evaluated over 600 civil workers with extensive questionnaires and by polysomnography. The study’s findings were quite dramatic and revealed that the prevalence of OSA (as defined by an AHI ≥ 5 per hour) is high in the United States, occurring in 24% of men and 9% of women in the 30- to 60-year age range. When complaints of daytime sleepiness were taken into account, it was determined that 2% of women and 4% of men sampled had symptomatic OSA. Young’s study was published in the New England Journal of Medicine and gained worldwide attention. The association between OSA and cardiovascular disease is rapidly becoming more established. In 2000, data derived from the Wisconsin Cohort Study (30) showed that OSA was an independent risk factor in developing hypertension four years after the diagnosis of OSA. The Sleep Heart Health Study (31) was a large epidemiologic study conducted from October 1995 to February 1998 that examined the association of cardiovascular disease and risk factors by evaluating a multiethnic cohort of over 6400 women and men over the age of 40 years. Patients enrolled in this study underwent home polysomnography and physical exams, and completed extensive questionnaires. Data from this study published in 2001 showed that OSA is an independent risk factor in the development of cardiovascular disease, with a higher proportion of coronary artery disease, stroke, and heart failure occurring in OSA patients compared to individuals without OSA. More recently, data published in 2006 from a subgroup of this cohort demonstrated that people with severe OSA have a two- to fourfold increased risk of complex cardiac arrhythmias when compared to those without OSA (32). OSA is also associated with other significant health-related consequences and comorbidities. In a study published in Sleep in 1999, Meir Kryger et al. (33) compared health service utilization for a 10-year interval prior to diagnosis of 181 OSA patients to those of randomly selected age-, gender-, and geographically-matched controls from the general population. Although there is a slim possibility that their findings reflected risk factors that predispose to OSA (e.g., obesity, alcohol usage), they found that OSA patients used approximately twice as many health care services (as defined by physician claims and overnight stays in hospital) in the 10 years prior to their OSA diagnosis. Kryger’s group concluded that by the time patients are finally diagnosed for OSA, they have already been heavy users of health services for several years. Literature regarding OSA as a public safety issue has been published over the past decade. OSA not only results in increased drowsiness, but also negatively affects concentration and attention; qualities which are critically important for driver safety. Larry Findley (34), from The University of Virginia, published a study
22
Zupancic and Lavie
in 1998 comparing the driving records of OSA patients to those without this disease. The results of this study were profound, showing a sevenfold greater rate of automobile accidents in patients with OSA than those without OSA. In 1999, Antonio Jimenez et al. (35) published an important and influential article regarding OSA and automobile accidents in the New England Journal of Medicine. He and his colleagues examined the sleep of 102 drivers in Spain who had received medical treatment following traffic accidents and compared the results to a control group. The prevalence of sleep apnea syndrome was six times higher in the group of drivers injured in car accidents compared to the controls, suggesting OSA is a risk factor for automobile accidents. John Stradling’s group (36) from Oxford, England demonstrated that sleep apnea patients performed poorer while driving in automobile simulators as compared to controls, having problems with both staying in their lane and in noticing changes along their route, especially in limited visibility conditions. Though there is a good body of literature suggesting OSA contributes to automobile accidents, Spain (prompted by Jimenez’s article) is the only country mandating OSA patients to undergo treatment to maintain their driving privileges. SLEEP APNEA IN CHILDREN In 1976, Christian Guilleminault and William Dement (37) from Stanford were the first to describe pediatric OSA in a case series of eight patients published in the journal Pediatrics. In this article they described that the pediatric patients with OSA often suffered from hypertension, daytime somnolence, hyperactivity, learning difficulties, nocturnal enuresis, and weight abnormalities. They also noted that with treatment, which consisted of tonsillectomy/adenoidectomy often followed by tracheostomy, many of these problems improved. David Gozal (38) was one of the first to present strong evidence that OSA affects academic performance in children. While working at Tulane University and establishing a sleep laboratory for children, he evaluated 297 first-graders for sleep apnea and noted that 54 children had OSA and an additional 62 snored loudly. Knowing that OSA could affect cognitive function in children, he offered children with OSA free treatment with tonsillectomies and adenoidectomies of which 24 children/parents consented. The results of his study published in Pediatrics in 1998 were profound; the children treated surgically experienced significant improvement in overall mean grades during the second grade, one year following treatment. The children with untreated OSA had no significant academic improvement over this time period. Gozal took his hypothesis of OSA affecting scholastic performance one step further when he and Dennis Pope (39) examined the computerized databases of schools in Jefferson County, Kentucky; this began an influential study published in the journal Pediatrics in 2001. They found 1000 adolescents aged 13 and 14 years whose scholastic performance was significantly poorer than that of their peers and then selected a group of adolescents with similar sex, age, ethnic background, school attended, and street of residence, but whose school grades were high. A detailed questionnaire was sent to the parents of these 2000 adolescents and asked whether the adolescents had snored while asleep (as a measure of OSA) between the ages of two and six, whether they had undergone tonsillectomy because of snoring, and whether they snored now. Analysis of the data revealed that 13% of the poor-performance adolescents had snored loudly “almost daily” during infancy, compared
History
23
with 5% of the high-performance adolescents. Twenty-four percent of the underperformers had undergone a tonsillectomy in infancy “due to snoring,” compared with only 7% of the high-performers. This study suggested that OSA in early childhood causes long-lasting adverse cognitive consequences. Ron Chervin (40) at the University of Michigan was one of the first to demonstrate that obstructive sleep apnea is associated with attention-deficit disorder in children. He determined this by administering extensive questionnaires regarding sleep-disordered breathing, inattention, and hyperactivity to over 800 children being evaluated in general pediatric clinics. This study, published in Pediatrics in 2002, showed that inattention and hyperactivity were associated with increased daytime sleepiness and measures of sleep-disordered breathing, specifically snoring, especially in boys younger than eight years of age. In 2005, Ron Chervin’s group (41) published an article in Sleep suggesting that OSA leads to hyperactive behavior in the pediatric population. In this study, the parents of over 200 children were surveyed about sleep-disordered breathing and hyperactivity initially, and then four years later. The results of this study showed that snoring and other features of sleep-disordered breathing are strong risk factors for the emergence of hyperactive behavior four years later. OSA is now recognized to be a common, important, and treatable disorder in children. In 2002, nearly three decades after Guilleminault and Dement first published pediatric cases of OSA, the American Academy of Pediatrics published a guideline stating that all children who snore regularly should undergo polysomnography for evaluation of OSA. CORNERSTONES OF MODERN TREATMENT FOR OBSTRUCTIVE SLEEP APNEA Colin Sullivan, an Australian physician whose specialty is respiratory medicine, pioneered the treatment of OSA by inventing and developing continuous positive airway pressure (CPAP). In 1972, Sullivan started working as a physician in Sydney. He did his doctoral studies under the physiologist David Read and his research originally focused on the etiology of crib death in children, which was believed to be related to sleep-disordered breathing. Sullivan first became interested in adult sleep apnea after seeing an overweight truck driver named Albie C., admitted through the hospital emergency room. Albie was almost unconscious, suffering from respiratory failure and high serum levels of carbon dioxide. This patient would frequently present to the hospital in a similar condition but would make a miraculous recovery after being intubated for several hours. Sullivan, an astute clinician, was the first to realize that Albie’s respiratory failure was the result of OSA. In 1981, while doodling a sketch of the upper airway on a sheet of paper, Sullivan came up with the idea of entering pressurized airflow via the nostrils to prevent obstructive apneas during sleep. Using a variable speed motor from a vacuum cleaner as an air pump, he attached it to a pipe with soft plastic tubes at its end, which were made to fit in a person’s nostrils. Sullivan then connected another tube for exhalation and made the system airtight with liquid adhesive. In June of that same year, Sullivan first used his machine on a patient with OSA. He attached the soft plastic tubes to the OSA patient’s nostrils and, while the patient slept, he adjusted the motor speed and pressure to eliminate obstructive breathing events. “The change was absolutely amazing,” Sullivan recalled years later. “Before we even had a chance to understand what had happened, the patient
24
Zupancic and Lavie
was already in REM sleep.” When the patient awoke in the morning he was completely alert for the first time in several years and remained alert throughout the day. Later that year Sullivan published a paper (42) in the Lancet describing the successful treatment of five OSA patients with CPAP. The creation of this innovative and noninvasive treatment for OSA represents a true milestone in sleep apnea history. Soon after this initial report other sleep disorder centers were creating CPAP machines and using them as an effective treatment modality. Though these first CPAP devices developed barely 25 years ago were undeniably crude, they paved the way for the lightweight, sophisticated devices that now provide automatic and bilevel pressure, as well as adaptive servo-ventilation. Today, CPAP is considered the most effective and most frequently prescribed treatment for patients with OSA. It is considered the “gold standard” treatment. Upper airway surgery as a treatment for OSA began with early work by the Japanese surgeon Shiro Fujita (43) of Detroit, Michigan, who published the first report of uvulopalatopharyngoplasty (UPPP) in 1981. In this procedure, the surgeon removes the uvula, soft palate tissue, redundant lateral pharyngeal mucosa, and tonsils in order to enlarge the upper airway. Fugita et al. showed that UPPP successfully decreased snoring, apneas, and hypopneas, and improved the clinical symptoms of many OSA patients. Though this procedure was the first successful surgical treatment for OSA, aside from tracheostomy, it had a relatively high failure rate and often did not “cure” OSA. Interestingly, though Fujita popularized this procedure for the treatment of OSA in the West, it was initially performed and invented in Japan by the surgeon T. Ikematsu (44) for the treatment of chronic snoring. Since then, surgical treatment has expanded considerably to include such techniques as mandibular osteotomy with genioglossus advancement, hyoid myotomy, and bimaxillary advancement, many of which were pioneered by Robert Riley and Nelson Powell at Stanford. With these newer techniques Riley and Powell (45) have shown that up to 95% of their OSA patients have been successfully treated with surgery. Other techniques such as osteogenic distraction, radiofrequency ablation, oral appliances, and bariatric surgery represent other treatments for OSA; even more therapeutic advances are anticipated, perhaps involving stem cells or other genetic/ molecular techniques, in the not too distant future. CONCLUSIONS Today skepticism of the existence and importance of OSA has faded considerably from the medical community. OSA is now a recognized disorder to patients and physicians alike. It is interesting that such an obvious disease had been ignored for so many years, but thanks to the diligent efforts of many dedicated sleep medicine physicians and researchers, OSA is now recognized as an important disease with serious consequences that can be successfully treated or cured. REFERENCES 1. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328(17):1230–1235. 2. Shakespeare W. The Caxton edition of the complete works of William Shakespeare/with annotations and a general introduction by Sidney Lee. London: Caxton, 1910–1914. 3. Dickens C. The Posthumous Papers of the Pickwickian Club. London: Chapman and Hall, 1837.
History
25
4. Osler W. The Principles and Practice of Medicine: Designed for the Use of Practitioners and Students of Medicine/by William Osler. New York: D. Appleton and Co., 1894, c1892. 5. Catlin G. The Breath of Life. New York: Wiley, 1861. 6. Cheyne J. A case of apoplexy in which the fleshy part of the heart was converted into fat. Dublin Hospital Report 1818; 2:216–222. 7. Stokes W. The Diseases of the Heart and Aorta. Dublin, Ireland: Hodges & Smith, 1854. 8. Broadbent WH. On Cheyne-Stokes’ respiration in cerebral haemorrhage. The Lancet 1877; 109(2792):307–309. 9. Canton R. Case of Narcolepsy. Clin Soc Trans 1889; 22:133–137. 10. Morrison A. Somnolence with cyanosis cured by massage. Practitioner 1889; 22:133–137. 11. Bickelmann AG, Burwell CS, Robin ED, Whaley RD. Extreme obesity associated with alveolar hypoventilation -a pickwickian syndrome. Am J Med 1956; 21(5):811–818. 12. Gerardy W, Herberg D, Kuhn HM. Comparative studies on pulmonary function and the electroencephalogram in 2 patients with Pickwick’s syndrome. Z Klin Med 1960; 156:362–380. 13. Drachman DB, Gumnit RJ. Periodic alteration of consciousness in the “pickwickian” syndrome. Arch Neurol 1962; 6:63–69. 14. Jung R, Kuhl W. Neurophysiological studies of abnormal night sleep and the pickwickian syndrome. In: Akert K, Bally C, Schade JP, eds. Prog Brain Res: Sleep Mechanisms, Vol. 18, Amsterdam: Elsevier, 1965:140–159. 15. Gastaut H, Tassinari CA, Duron B. Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the pickwick syndrome. Brain Res 1966; 1:167–186. 16. Lugaresi E, Coccagna G, Mantovani M, Cirignotta F, Ambrosetto G, Baturic P. Hypersomnia with periodic breathing: Periodic apneas and alveolar hypoventilation during sleep. Bulletin of Physiopathologic Respiration (Bulletin de Physiopathologic Respiratoire) 1972; 8:1103–1113. 17. Lugaresi E, Coccagna G, Mantovani M, Brignani F. Effect of tracheostomy in hypersomnia with periodic respiration. Electroencephalogr Clin Neurophysiol 1971; 30:373–374. 18. Kryger M, Quesney LF, Holder D, Gloor P, MacLeod P. The sleep deprivation syndrome of the obese patients: A problem of periodic nocturnal upper airway obstruction. Am J Med 1974; 56:531–539. 19. Guilleminault C, Eldridge FS, Simmons B, et al. The Sleep Apnea Syndromes. Annual Review Medicine 1976; 27:465–484. 20. Guilleminault C, Liebhaber M, Navelet Y, et al. Proceedings: Sleep-induced apnea syndrome in six children. Electroencephalogr Clin Neurophysiol 1975; 39(4):432. 21. Guilleminault C, Eldridge FL, Dement WC. Insomnia with sleep apnea: A new syndrome. Science 1973; 181:856–858. 22. Guilleminault C, Dement WC. 235 cases of excessive daytime sleepiness. Diagnosis and tentative classification. J Neurol Sci 1977; 31(1):13–27. 23. Phillipson EA, Murphy E, Kozar LF. Regulation of respiration in sleeping dogs. J Appl Physiol 1976; 40:688–693. 24. Phillipson EA, Sullivan CE, Read DJ, Murphy E, Kozar LF. Ventilatory and waking responses to hypoxia in sleeping dogs. J Appl Physiol 1978; 44(4):512–20. 25. Phillipson EA. Control of breathing in sleep. Am Rev Respir Dis 1978; 118:909–939. 26. Weitzman ED, Pollak C, Borowiecki B, Burack B, Shprintzen R, Rakoff S. The hypersomnia sleep-apnea syndrome: Site and mechanism of upper airway obstruction. Trans Am Neurol Assoc 1977; 102:150–153. 27. White DP, Cadieux RJ, Lombard RM, et al. The effects of nasal anesthesia on breathing during sleep. Am Rev Respir Dis 1985; 132(5):972–975. 28. Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest 1992; 89(5):1571–1579. 29. Lavie P. Incidence of sleep apnea in a presumably healthy working population: a significant relationship with excessive daytime sleepiness. Sleep 1983; 6(4):312–318. 30. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleepdisordered breathing and hypertension. N Engl J Med 2000; 342(19):1378–1384.
26
Zupancic and Lavie
31. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163(1):19–25. 32. Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleepdisordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006; 173(8):910–916. Epub 2006 Jan 19. 33. Ronald J, Delaive K, Roos L, et al. Health care utilization in the 10 years prior to diagnosis in obstructive sleep apnea syndrome patients. Sleep 1999; 22(2):225–229. 34. Findley LJ, Unverzagt ME, Suratt PM. Automobile accidents involving patients with obstructive sleep apnea. Am Rev Respir Dis 1988; 138(2):337–340. 35. Teran-Santos J, Jimenez-Gomez A, Cordero-Guervara J. The association between sleep apnea and the risk of traffic accidents. N Engl J Med 1989; 320(13):847–851. 36. Juniper M, Hack MA, George CF, et al. Steering simulation performance in patients with obstructive sleep apnoea and matched control subjects. Eur Respir J 2000; 15(3):590–595. 37. Guilleminault C, Eldridge FL, Simmons FB, et al. Sleep apnea in eight children. Pediatrics 1976; 58(1):23–30. 38. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics 1998; 102(3 Pt 1):616–620. 39. Gozal D, Pope DW Jr. Snoring during early childhood and academic performance at ages thirteen to fourteen years. Pediatrics 2001; 107(6):1394–1399. 40. Chervin RD, Archbold KH, Dillon JE, et al. Inattention, hyperactivity, and symptoms of sleep-disordered breathing.Pediatrics 2002; 109(3):449–456. 41. Chervin RD, Ruzicka DL, Archbold KH, et al. Snoring predicts hyperactivity four years later. Sleep 2005; 28(7):885–890. 42. Sullivan CE, Issa FG, Berthon-Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 1(8225):862–865. 43. Fujita S, Conway W, Zorick F, et al. Surgical correction of anatomic abnormalities in obstructive sleep apnea syndrome: uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg 1981; 89(6):923–934. 44. Ikematsu T. Study of snoring, fourth report: Therapy. Nippon Jibiinkoka Gakkai Kaiho 1964; 64:434–435. 45. Riley RW, Powell NB, Guilleminault C. Obstructive sleep apnea syndrome: a review of 306 consecutively treated surgical patients. Otolaryngol Head Neck Surg 1993; 108(2):117–125.
3
Epidemiology Kin M. Yuen Stanford University Center of Excellence for Sleep Disorders, Stanford, California, U.S.A.
INTRODUCTION With technological advances, remaining “connected” has become part of our lives. Remaining alert and attentive increases productivity, but what is being sacrificed in the end? It is with good reason that there is increasing interest in sleep and sleep disorders, since inattention and insufficient sleep have become the norm in our society, rather than aberrancies. In April of 2006, the National Highway Traffic Safety Administration (NHTSA) (1), found that driving while drowsy apparently increased one’s crash or near-crash risk four- to six-fold. In National Sleep Foundation’s 2005 Sleep in America poll, there was a trend to sleeping less on weekdays and weekends. Among 1506 adults surveyed, 40% reported sleeping less than seven hours weeknights, and a majority (71%) were sleeping less than eight hours weeknights (2). More importantly, 34% of those surveyed were found to be at risk of having a sleep disorder. Of the existing sleep disorders, obstructive sleep apnea (OSA) is one of the better known. OSA describes the periodic pauses in breathing and choking sensations in sleep. Earliest reports described a Pickwickian syndrome as presumed obesityrelated hypoventilation syndrome that produced daytime somnolence. Cases affecting children were published as early as the 1960s, but the term “sleep apnea syndromes” was not coined until 1978 (3), and it was not until 1981 that apnea treatment with nasal continuous positive airway pressure (CPAP) was initiated (4). Nowadays, despite the rapid advances of technology and understanding of OSA during the past decades, a cure for OSA remains elusive. However, the treatment options have dramatically increased. The quality of life for OSA-afflicted patients has correspondingly improved (5). In this chapter, the epidemiology of snoring, OSA and its comorbidities are discussed. SNORING While OSA commonly afflicts those who snore frequently, occasional snorers do not necessarily have OSA. Furthermore, amongst the snorers, while some complain of daytime symptoms, others do not. This section discusses the current known relationship between snoring and OSA. A cross-sectional study of 4648 responders (ages 20–69 years) in Northern Sweden, from 1991–2000, found that the prevalence rate of snoring, presenting as a problem, or enough to cause concern to the participants’ relatives, was 17.9% for men and 7.4% for women. Furthermore, the relatives were concerned about witnessed apneas in 11% of men, and 2.4% of women (6). Other epidemiologic studies support these data. In 1996, a large cross-sectional study found that 33% of men and 19% of women snored loudly among 5201 adults age 65 and older (7). 27
28
Yuen
Snoring was associated with excessive daytime sleepiness (EDS) in a large population study (8). The authors found that those who snored regularly had a higher prevalence of EDS [defined as an Epworth sleepiness scale (ESS) score > 11]: 39% of those who snored six to seven nights weekly, compared to 15% of “neversnorers.” This relationship was reported to be seen at all levels of apnea-hypopnea index (AHI) when documented by unattended polysomnography (PSG) at subjects’ homes. Recent studies from Australia as well as France suggested that truncal obesity and smoking were key determinants of loud, habitual snoring in their subjects (9,10). Of 850 French male subjects, 149 (17.5%) were habitual loud snorers. Studies have also shown that there is lower quality of life amongst those who snore, their bed partners and those with frank OSA (11,12). Whether one transitions from habitual snoring to development of OSA is still under investigation. There are likely multiple factors modifying one’s risks of developing OSA. Recent research has explored whether age, obesity, gender differences, ethnicity, and other comorbid conditions may predispose someone to become symptomatic of OSA. The following sections will discuss the prevalence of OSA, and possible contributing factors as outlined above. OBSTRUCTIVE SLEEP APNEA PREVALENCE Early epidemiological studies reported variable prevalence rates of OSA due to differences in study design and definitions of respiratory events. In an effort to standardize the definition of OSA, the American Academy of Sleep Medicine issued guidelines in 2001 (13) which further expanded the diagnostic criteria. The second edition of the International Classification of Sleep Disorders (ICSD2) includes not only PSG-determined respiratory-related arousals into the AHI, but also considers upper airway resistance as part of the continuum of OSA (14). Additionally, there is now a more detailed, stand-alone definition of pediatric OSA. In 1993, Young et al. (15) reported in their landmark article an estimated OSA prevalence rate of 2% and 4% in middle-aged women and men, respectively in the Wisconsin cohort. These individuals had an AHI ≥ 5 plus daytime sleepiness. The estimation was based on baseline evaluations of 1490 state employees 30 to 60 years of age. The subset of habitual snorers was then prospectively studied at four-year intervals with in-laboratory PSG. Of 626 subjects, 24% men, and 9% women had an AHI ≥ 5, whereas 9% men and 4% women had an AHI ≥ 15, but without daytime symptoms. Bixler et al. (16) in 1998 also reported an effect of age in the prevalence of OSA. After a telephone survey of a random sample of 4364 men (ages 20–100 years), 741 were studied by in-laboratory PSG. They found an OSA prevalence rate of 3.3%, when OSA was defined by an AHI ≥ 20 and the presence of daytime symptoms. OSA was most prevalent in the middle-aged group (45–64 years). Also, based solely on laboratory criteria, the prevalence of OSA (obstructive AHI ≥ 20) showed a similar age distribution to OSA diagnosed by laboratory and clinical criteria. The prevalence of any type of sleep apnea (central and obstructive) increased with age, with central apnea accounting more for this increase. However, “severity of sleep apnea, as indicated by both number of events and minimum oxygen saturation, decreased with age when any sleep apnea criteria were used and when controlling for body mass index (BMI).” Thus, the authors argued that the prevalence of sleep apnea tended to increase with age, but that the clinical significance (severity) of apnea decreased.
Epidemiology
29
Thereafter, Zamarron et al. (17) chose a random sample of 76 subjects, 50 to 70 years of age, from the electoral census in a small study in 1999. It was found that 28.9% of those surveyed had an AHI ≥ 5, and there were no differences between men (28%) and women (30%). However, “sleep apnea syndrome” was found more commonly in men (6.8%, five cases) than in women (zero cases) (p = 0.0521). Further studies followed which examined the specific effects of gender on OSA presentation. After performing two in-home studies in two years for 47 participants, Tischler et al. (18) found a five-year incidence rate of OSA to be 7.5% for moderately severe OSA and 16% (or less) for mild-to-moderately severe OSA. OSA criteria were: AHI of at least 10 (mild to moderate) or of at least 15 (moderate). Moreover, the incidence of OSA was determined to be independently influenced by age, sex, BMI, waist–hip ratio, and serum cholesterol concentration. The investigators concluded: “Predominance in men diminishes with increasing age, and by age 50 years, incidence rates among men and women are similar. The effect of BMI also decreases with age and may be negligible at age 60 years.” In summary, aging is associated with higher OSA prevalence; however, it is unclear if OSA in the elderly as compared to middle-aged adults represents the same disorder. Obesity alone is independently associated with more severe OSA, but may be less important with advanced age. Gender Early epidemiological and empirical data showed that OSA affects more men than women. However, after menopause, women and men seem to have equal prevalence. Thus, further population studies were conducted to evaluate the gender differences in OSA presentation and progression. Joaquin Durán et al. (19) evaluated gender differences in the prevalence of habitual snoring and OSA in the general population in Basque Country, Spain in a two-phase cross-sectional study. First, a random, stratified sample of 30- to 70-yearold participants was recruited by mail or telephone. There were 2148 subjects (76.9%) who each completed a home survey, blood pressure recording, and a portable respiratory recording in Phase I. Of these subjects, 1050 were men, and 1058 were women. Thereafter, 442 subjects diagnosed with OSA by home recordings, and 305 subjects (subgroup of 1706) who had normal results were invited to undergo in-laboratory PSG. A total of 555 subjects underwent PSG: 390 with suspected OSA, and 165 with previously normal home studies. Within these study subjects, 35% had habitual snoring, and 6% had OSA. More men presented with both problems, and there was an increased trend with age. EDS was reported in 18% of the subjects, but interestingly, was not associated with OSA. Furthermore, an AHI > 10 was found in 19% of men and 15% of women. If OSA is defined as AHI > 5, then its prevalence increased with age in both sexes, with an odds ratio (OR) of 2.2 for each 10-year increase. In 2002, the Sleep Heart Health Study (SHHS) Research Group found that among 5615 community-dwelling men and women aged between 40 and 98 years, those who reported habitual snoring, loud snoring, and frequent breathing pauses were three to four times more likely to have an AHI ≥ 15 or greater versus an AHI ≤ 15 (as detected by in-home PSG) (20). To further explore the gender differences in the prevalence of OSA, other studies examined if there is an intrinsic gender difference in upper airway collapsibility (21). Seventy-one consecutive patients with an AHI ≥ 5 events per hour were enrolled into the study. The median (range) AHI was 20 (5–132)
30
Yuen
events/hr. In addition, measurements of upper airway dimensions were made, using an acoustic reflectance method. OSA was much more positional and severe in men than women as indicated by the higher AHI in the supine position compared with sleeping on their sides (difference between supine and side AHI: 43.7 ± 5.2 [standard error of mean (SEM)] events/hr in men versus 10.7 ± 7.6 events/hr in women, p = 0.0015). The author concluded: “Men tend to have a larger but more collapsible airway during mandibular movement than women and this, in part, may play a role in the positional dependency and severity of OSA in men.” A retrospective tertiary university medical center-based study, which analyzed 130 randomly selected women with OSA against 130 men with OSA matched for age, body mass index, AHI (in-laboratory PSG studies), and ESS scores (22). The mean age was 48.0 years for women versus 47.6 years for men. Both women and men were morbidly obese with high BMI (40.4 kg/m2 for women vs. 40.0 kg/m2 for men), severe OSA with AHI > 30 (36.8 per hour for women vs. 36.0 per hour for men), and elevated ESS scores (12.45 for women vs. 12.84 for men). The authors discovered that women more often described their main presenting symptoms as insomnia [OR, 4.20; 95% confidence interval (CI), 1.54–14.26] and were much more likely to have a history of depression (OR, 4.60; 95% CI, 1.71–15.49) and hypothyroid disease (OR, 5.60; 95% CI, 2.14–18.57). Women presented less often with a primary complaint of witnessed apnea (OR, 0.66; 95% CI, 0.38–1.12), consumed less caffeine per day (3.3 cups in women vs. 5.2 cups in men; p = 0.0001), and admitted to less alcohol consumption (OR, 0.36; 95% CI, 0.18–0.70). There have been only a few studies remarking on possible gender differences of rapid eye movement (REM) sleep-related OSA. O’Connor et al. (23), in a retrospective study of 830 patients with OSA (diagnosed by PSG), found that the female subjects had “milder” OSA because of fewer events in non-REM (NREM) sleep. Women also had more REM sleep-related events than men. REM OSA occurred in 62% of women and 24% of men with OSA. But OSA was more common in men in the supine position than in women. The men predominated in the “severe” spectrum (AHI > 50/hour) with a male:female ratio of 7.9:1. The authors argued that these findings might reflect differences between the sexes in upper airway function during sleep in patients with OSA. International efforts have since produced the following literature in support of these theories. In Italy, 20 severely obese women exhibited more disturbances in sleep architecture and more OSA in REM sleep compared to 25 age- and weightmatched men (24). Women had significantly more wake time after sleep onset (WASO) 92.6 ± 52.4 versus 58.2 ± 45.2 min (p < 0.05), total wake time 104.8 ± 51.4 versus 67.8 ± 47.4 min (p < 0.05), and number of awakenings 15.5 ± 3.6 versus 10.2 ± 6.215 ( p < 0.001) compared to men. Women also had OSA that occurred almost exclusively during REM sleep (REM OSA) 35% versus 4%, (p < 0.05). Whether these findings persist into larger population studies remains to be seen. Nonetheless, in studies of the sleep of perimenopausal to postmenopausal women reported by a National Institutes of Health (NIH) panel, more frequent arousals and decreased sleep efficiency were noted (25). Similarly, poorer sleep quality and a higher REM sleep AHI were found in women in a retrospective study of 1010 Greek patients (844 males, 166 females) diagnosed with severe OSA (mean AHI of 42.4 ± 28.2 events/hr for men vs. 33.2 ± 27.7 events/hr for women, p < 0.001) by overnight PSG (26). In this study, OSA was five times more common in men than in women. Forty percent of men had AHI-REM sleep > AHI-NREM sleep, compared to 62% of women. Sleep quality was
Epidemiology
31
reportedly worse in female than in male patients: sleep efficiency index was lower (79.4 ± 16.1 vs. 85.1 ± 12.5%, p < 0.001), sleep onset latency was longer (27.7 ± 27.7 vs. 17.9 ± 18.1 min, p < 0.001), REM onset latency was longer (161.5 ± 76.2 vs. 145.7 ± 71.4 min, p < 0.018), and WASO was greater (42.6 ± 46.5 vs. 30.7 ± 34.9 min, p < 0.003) in women compared to men. Thus, it appears that, although men and women experience higher prevalence of OSA as they age, women might be more selectively affected by sleep fragmentation, poorer sleep quality, and more REM-related respiratory events. The mechanism involved is unclear, but seems to involve more than hormonal differences between the genders. Menopause As described in the section above, with the onset of menopause women experience a higher OSA prevalence than before menopause. Menopause has been defined as the complete cessation of menses for one year. This effect may be accounted for purely by aging as suggested by the Pennsylvania group. Bixler et al. (27), examined the effects of menopausal status on OSA in the community with a two-phase study in Southern Pennsylvania. Phase I was comprised of telephone interviews of 12,219 randomly selected women and 4364 men (age range of 20–100 years) from the general population. Phase II was comprised of 1000 women and 741 men randomly drawn from the phase I subjects. They all had one night of an in-laboratory sleep study. The authors reported a low OSA prevalence rate of 0.6% in premenopausal women, and 0.5% in postmenopausal women treated with hormonal replacement therapy (HRT), whereas the prevalence rate was 2.7% (p = 0.02) in postmenopausal women not on HRT. As compared with premenopausal women, the Wisconsin cohort also saw a higher OR ( CI) for menopausal women with an AHI ≥ 15: menopausal women on HRT, 1.5 (0.5-4.0); menopausal women without HRT, 2.8 (1.2-6.4) (28). The sample was comprised of 541 women, 30 to 60 years of age, and it was adjusted for confounders, such as age and body habitus. Current research in progress hypothesize that the fluctuations in hormonal levels, not limited only to estradiol and progesterone, months to years preceding the cessation of menses might yield further understanding of the natural progression of OSA in women (28,29). Currently, hormonal replacement is recommended on a case-by-case basis for the treatment of vasomotor dysfunction and nocturnal sleep disruptions (25). Future research into this very interesting area will undoubtedly shed more light into why the menopausal transition tips the balance towards higher OSA prevalence for women. Pre-eclampsia There have been recent reports about a possible association between pre-eclampsia and snoring/OSA in pregnancy. Franklin et al. (30), in Sweden performed a retrospective, cross-sectional study of consecutive cases of 502 women with singleton pregnancies. The prevalence rate of nightly snoring during the last week of pregnancy was 23%, while only 4% reported snoring before pregnancy. Hypertension developed in 14% of snoring women, compared with 6% of nonsnorers (p < 0.01). Significantly more of the snorers developed pre-eclampsia (10%) than nonsnorers (4%) (p < 0.05). Furthermore, infants born to habitual snorers had lower Apgar scores (≤ 7). A significantly higher percentage of infants (7.1%) were small for gestational age at birth of the infants of snoring mothers compared to that of nonsnoring
32
Yuen
mothers (2.6%) (p < 0.05). Because habitual snoring independently predicted hypertension (OR, 2.03; p < 0.05) and growth retardation (OR, 3.45; p < 0.01) in a logistic regression analysis after controlling for weight, age, and smoking, the authors concluded that snoring was associated with risk of pre-eclampsia. A French study, of 438 postpartum women with singleton deliveries, surveyed obstetrical history, sleep disorders during their last trimester, snoring and ESS scores (31). Forty-five percent of the patients reported habitual snoring during pregnancy. Among these, 85% were nonsnorers before pregnancy. The prevalence of pregnancy-induced hypertension (PIH) was found to be 4.5%, with two apparently independent risk factors: BMI (OR = 1.1) and an association between snoring and impaired vigilance (OR = 2.6). No statistical difference was found concerning intrauterine growth retardation (IUGR). The authors concluded that OSA symptoms were frequent during pregnancy, and snoring appeared to be linked with PIH. However, there was no conclusive PSG evidence to suggest direct relationships. Furthermore, there was a case report in 2004 of a 25-year-old woman, gravida four para two, at 37 weeks gestation in Missouri who had a documented apneic episode with maternal oxygen desaturation and concurrent fetal heart rate deceleration during a nocturnal recording (32). She subsequently delivered an infant that was small for gestational age. These findings suggest that hypoxemia during apneic events is directly linked to fetal distress, and is associated with an increased risk of IUGR. Edward et al. (33), in Australia found more autonomic pressor responses among pregnant women with pre-eclampsia and OSA than their counterparts with OSA, but no hypertension before or during pregnancy. Therefore, the authors suggested that the augmented pressor responses in pre-eclamptic women occurred as a result of maternal endothelial damage induced by the pre-eclampsia disease process. The blood pressures above baseline for control OSA patients versus pre-eclamptic OSA patients were 21 ± 2/12 ± 1 mmHg and 38 ± 5/25 ± 4 mmHg, respectively, p = 0.005/0.005. In contrast, there was no difference in heart rate responses between the two groups of subjects (34 ± 5 beats/min and 49 ± 13 beats/min above baseline in control OSA and pre-eclamptic OSA patient groups, respectively, p = 0.326). Since obesity might predispose women to OSA, a Finnish case-control study examined 11 obese pregnant women (mean prepregnancy BMI > 30 kg/m2) against 11 normal pregnant controls (mean BMI, 20–25 kg/m2) for evidence of OSA and IUGR (34). Overnight PSG was performed during early (after 12 weeks) and late (after 30 weeks) pregnancy. Obese mothers had significantly higher AHIs (1.7 vs. 0.2 events per hour; p < 0.05), 4% oxygen desaturations (5.3 vs. 0.3 events per hour; p < 0.005), and snoring times (32 vs. 1%; p < 0.001) during early compared to late pregnancy. These differences between the groups persisted in late pregnancy with further increases in snoring time in the obese mothers. Pre-eclampsia and mild OSA were diagnosed in one obese mother. Another obese mother delivered a baby showing growth retardation [weight 3 standard deviations (SD) below the mean]. Thus, the authors affirmed that OSA was more prevalent among obese mothers. Izci et al. (35), had serial reports about snoring in pregnancy in Edinburgh, Scotland. Fifty women in the third trimester of pregnancy, and 37 women with preeclampsia were recruited consecutively from the antenatal service and matched with 50 nonpregnant female controls. Upper airway dimensions were measured using acoustic reflection. Significantly more pregnant preeclamptic women (75%) reported snoring as compared to their pregnant nonpre-eclamptic counterparts
Epidemiology
33
(28%) and nonpregnant female controls (14%) (p < 0.001). Women with preeclampsia had upper airway narrowing in both upright and supine postures. Oropharyngeal junctional area in the seated position was less (p < 0.01) in pre-eclamptic women (mean ± SD, 0.9 ± 0.1 cm2) than either pregnant women (1.3 ± 0.1cm2) or nonpregnant female controls (1.1 ± 0.1 cm2). Supine oropharyngeal junctional area was less in the women with preeclampsia than in the nonpregnant female controls (0.8 ± 0.1 vs. 1.0 ± 0.1cm2; p = 0.01), but similar in women with pre-eclampsia and pregnant women (0.9 ± 0.1cm2; p > 0.3). Perhaps the smaller upper airway in pre-eclamptic women predisposes them to OSA or vice versa. A follow-up study by this group involved 167 healthy and 82 pre-eclamptic women in the third trimester of pregnancy (at about 36 weeks gestation) and 160 nonpregnant women. Subjects and their partners completed a sleep questionnaire (36). Preeclamptic women were heavier than pregnant and nonpregnant women and had higher BMIs than pregnant women before pregnancy (all p < 0.05). A significantly higher prevalence rate of snoring was found among pre-eclamptic women: 32% of control, 55% of pregnant and 85% of preeclamptic women snored (p < 0.001). Although prepregnancy snoring rates were similar amongst the groups, the prevalence of snoring was quite high: pre-eclamptic women 36%, healthy pregnant women 27%, and nonpregnant women 32% (p > 0.7). Sleepiness was reported by 15% of pre-eclamptic women, 23% of pregnant women, and 12% of nonpregnant women (p < 0.04), but nonpregnant women had significantly lower mean ESS scores than both pregnant and pre-eclamptic groups (p < 0.001). “Snoring was correlated with (p = 0.002), but explained only < 2% of, the variance in sleepiness.” Therefore, the authors concluded that “snoring and sleepiness increased in the third trimester of pregnancy, particularly in patients with preeclampsia.” However, the study suggests that sleepiness in pregnancy is predominantly the result of factors other than snoring or breathing pauses. Alternatively, the ESS might not fully reflect sleepiness in the pregnant state. Ethnicity An increased risk of OSA has been reported among African-Americans, Latinos and Asians (37,38). Craniofacial features that may contribute to higher prevalence rates amongst the minority groups have been reported in the following studies. A collaborative prospective study between Hong Kong and Vancouver of 239 consecutive patients (164 Asian and 75 white subjects) with an AHI of ≥ 5/hr on full overnight PSG revealed that a crowded posterior oropharynx and a steep thyromental plane predicted OSA across two different ethnic groups with varying degrees of obesity (39). After controlling for ethnicity, BMI and neck circumference, patients with OSA were older, had larger thyromental angles, and higher Mallampati scores than nonapneic subjects. In Malaysian population, Wong et al. (40), found that those with moderate-tosevere OSA had shorter maxillary and mandibular lengths. In their study, 34 men (11 Malay, 11 Indian and 12 Chinese), ages 27 to 52 years, were diagnosed with OSA by overnight PSG. Rhinomanometry and standardized lateral cephalometric radiographs were used to record linear and angular dimensions of their jaw structures. Malay subjects with moderate-severe OSA had a shorter maxillary and mandibular length when compared with a mild OSA reference sample (p < 0.05). The hyoid bone was located more caudally in the Chinese moderate-severe subjects (p < 0.05), and may be a useful diagnostic indicator for severity in this racial group.
34
Yuen
Undoubtedly, more research will clarify this new development. Another area of interest is the occurrence of OSA in children. Children Like adults, many snoring children are affected by OSA as well. Nieminen et al. (41), described the factors they found helpful in predicting OSA in Finnish children . Of the 78 snoring children who underwent overnight PSG, 29 children had a mean apnea index (AI) ≥ 1.55 (range 0–15), while 49 had a normal PSG. Parental report of nightly detectable apneic episodes correlated most with the occurrence of OSA [relative ratio (RR) 3.6, 95% CI 1.7–7.7]. Nighttime “constant snoring” (RR 1.5, CI 1.0–2.1) and restless sleep (RR 2.1, CI 1.1–4.0) were also predictive of OSA. A history of adenoidectomy (RR 1.7, CI 1.1–2.7) and tonsillar enlargement (RR 1.4, CI 1.1–1.8) also correlated significantly with OSA. The absence of excessive sleepiness was negatively correlated with OSA (RR 0.3, CI 0.1–1.0). Thus, a more thorough history in the aforementioned areas highly enhances the chances of a child being diagnosed with OSA on PSG studies. In Louisville, Kentucky, a more recent study was conducted on 122 preschoolers and 172 children in the five to seven year range to measure the predictive value of parental observations (42). The investigators found that parental report of frequent snoring based on questionnaire scores was “highly sensitive and specific for both age groups” compared to the presence of snoring on PSG. Moreover, when multiple measures of child behavior were added, the predictability value increased further. The authors concluded that the sleep questionnaire used was sufficient as a screening tool when the above domains were taken into account. A large epidemiological study in Tucson, Arizona found that “snoring, EDS, and learning problems are each highly specific, but not sensitive, for sleep-disordered breathing (SDB) in 6- to 11-year-old children” (43). This was a communitybased cohort of children 6 to 11 years of age (50% boys, 42.3% Hispanic, and 52.9% between the ages of six and eight years) using in-home monitoring. Of 480 recordings performed, boys were twice as likely as girls to have an RDI ≥ 1 (p < 0.01). Surprisingly, “witnessed apnea, ethnicity, age, obesity, and airway size (based on clinical evaluation) were not significantly different between those with SDB and without SDB.” A cross-sectional study of 829 children, eight to 11 years old (50% female, 46% Black, and 46% former preterm birth) with SDB assessed by either parental report of habitual snoring or unattended in-home overnight cardiorespiratory recordings was performed on school-aged children. Forty (5%) children were classified as having OSA (median AHI, 7.1/hr; inter-quartile range, 3.1–10.5), 122 (15%) had primary snoring without OSA, and the remaining 667 (80%) had neither snoring nor OSA. Children with relatively mild SDB, ranging from primary snoring to OSA, “had a higher prevalence of problem behaviors, with the strongest, most consistent associations for externalizing, hyperactive-type behaviors” (44,45). Another cross-sectional, population-based, cohort study evaluated thirdgraders in 27 primary schools in Hannover, Germany (46). Of 1760 eligible children, a representative sample of 1144 parents and their children (49% were girls) participated. Among these, 114 (10.1%) were habitual snorers (HS): 51 boys and 63 girls. There were 1015 (89.9%) nonsnorers: 524 boys and 491 girls. Of the habitual snorers, 80 were available during follow-up at about one year (mean interval, 13.5 months). Thirty-nine continued to snore (14 boys, 25 girls), 39 snored only occasionally, and two stopped snoring. Of the 41 “ex-habitual snorers,” four had
Epidemiology
35
ear, nose, and throat (ENT) surgery on adenoids and/or tonsils. Furthermore, this study found that independent risk factors for habitual snoring were a BMI > 90th percentile (OR, 3.5; 95% CI, 1.8–7.1), low maternal education (OR, 2.3; 95% CI, 1.1– 4.7), regular daytime mouth breathing (OR, 7.4; 95% CI, 3.5–15.6), and a higher frequency of sore throats (OR, 17.6; 95% CI, 6.4–48.8). The association of low maternal education and HS was higher in boys than girls (OR, 4.4; 95% CI, 1.5–13.6; vs. OR, 1.2; 95% CI, 0.4–3.6; respectively), while that of sore throats and HS was higher in girls than boys (OR, 52.7; 95% CI, 6.0–460.2; vs. OR, 13.3; 95% CI, 3.0–58.5, respectively). Therefore, it appeared that socioeconomic status, obesity, signs of nasal obstruction, and pharyngeal problems were independent risk factors for HS in these primary school children. More importantly, the authors suggested that the expression of HS varied considerably over time. Though a full review of this area is beyond the scope of this chapter, with more research into this expanding area of interest, our understanding of childhood snoring and sleep-disordered breathing will be more complete. It is also worth emphasizing that pediatric OSA was described alongside adult cases in the 1960s. Awareness of advances in understanding pediatric OSA furthers our understanding of adult OSA, and is essential to practicing good medicine.
NEW DIRECTIONS Metabolic Syndrome Just like the diagnosis of OSA preceded the availability of alternative treatments, clinical observations of OSA, obesity, and insulin resistance led to the study of the “metabolic syndrome.” A Chinese study of 270 consecutive subjects (197 male) without known history of diabetes mellitus in Hong Kong were evaluated by PSG, and 185 were found to have OSA with an AHI ≥ 5 (47). OSA subjects had higher levels of fasting serum insulin (p = 0.001); they were also older and more obese. Both obesity and SDB (AHI and minimum oxygen saturation) were independent determinants of insulin resistance. However, the association between OSA and insulin resistance was seen in both obese and nonobese subjects. An early study in Iowa showed some intriguing results. The authors prospectively studied 32 male patients (43 ± 2 years) with OSA who were “newly diagnosed and never treated and who were free of any other diseases” (48). There were 32 obesity-matched control male subjects (38 ± 2 years). Despite significantly higher levels of leptin in obese OSA subjects (13.7 ± 1.3 ng/mL) compared to those without OSA (9.2 ± 1.2 ng/mL) (p = 0.02), OSA subjects gained more weight the year before diagnosis (5.2 ± 1.7 kg vs. 0.5 ± 0.9 kg in OSA and obesity control subjects, respectively; p = 0.04). Thus, it appeared that the OSA subjects were resistant to the weight-reducing effects of leptin. Thirty obese patients with severe OSA (21 men, 9 women) with a mean BMI of 38.6 kg/m2 and a mean AHI of 40.5 per hour underwent overnight PSG and oral glucose tolerance testing in Italy (49). Controls included 27 weight-matched patients (12 males and 15 females; AHI, 2.15) and 20 normal subjects. The insulin sensitivity index composite value was significantly lower in OSA (1.71 ± 1.41) than in obese (3.08 ± 0.27) and in normals (6.1 ± 0.4) even after adjustments for age, BMI and waist-to-hip ratio. Therefore, obese OSA patients appeared to be insulin resistant independently of the degree and distribution of adiposity. Other important work has revealed the possible association of metabolic syndrome and cardiovascular disease in OSA. A study in Liverpool, United Kingdom
36
Yuen
assessed glucose, insulin, lipids, and blood pressure (BP) of 61 male subjects with OSA and 43 controls (50). “Subjects with OSA were more obese, had higher BP and fasting insulin, were more insulin resistant, had lower high-density lipoprotein (HDL) cholesterol, and an increased incidence of metabolic syndrome (87% vs. 35%, p < 0.0001).” Metabolic syndrome was 9.1 (95% CI, 2.6 – 31.2, p < 0.0001) times more likely to be present in subjects with OSA. In 2005, there was a succinct review discussing the possible mechanism of OSA and metabolic syndrome by Vgontzas et al. (51). In this article, the authors proposed that the elevated cytokines interleukin-6 (IL-6) and tumor necrosis factoralpha (TNF-alpha) were linked to disorders of EDS. Subsequent studies demonstrated that IL-6, TNF-alpha, and insulin levels were elevated in sleep apnea independently of obesity and visceral fat. Furthermore, women with the polycystic ovary syndrome (PCOS) were much more likely than controls to have sleepdisordered breathing and daytime sleepiness, suggesting a pathogenetic role of insulin resistance in OSA. Thus the combination of all these factors, along with menopausal status in women and aging, all contribute to the development of metabolic syndrome, which is highly linked with inflammatory cytokine production and cardiovascular morbidities in OSA. Additionally, recent literature regarding stroke occurrence and OSA illuminates this concept further (52). Severe OSA was associated independently with extracranial artery disease (EAD) as well as peripheral artery disease (PAD) in 395 stroke survivors. Interesting results were seen in a case-control series study in a hospital population in the United Kingdom. There were 181 patients admitted to hospital with first-ever stroke and community control subjects matched individually for age, sex, and general practitioner (53). The association between snoring alone and stroke was not statistically significant [OR (95% CI), 1.44 (0.88– 2.41)]. Daytime sleepiness was, however, significantly associated with stroke: OR 3.07 (1.65 – 6.08). Multiple logistic regression showed that hypertension, current smoking, taking alcohol regularly (negatively) and a higher ESS score were independently associated with stroke. In this study, there was more sleepiness prestroke, the cause of which is unclear, although OSA is a possible candidate. CONCLUSIONS Obviously more research is ongoing. It is still unclear how OSA serves to trigger various physiological consequences. What is clear, however, is that the cascade of events continues to cost individuals alertness, concentration, quality of life, societal economic losses, and loss of lives in the form of work-related and traffic accidents. While genetic predisposition may not be reversible, many symptoms and signs are readily recognizable, and easily treatable. It behooves all of us to alert not only the medical community, but also the world at large to the latest findings regarding OSA. REFERENCES 1. Administration NHTS. The impact of driver inattention on near-crash/crash risk: an analysis using the 100-car naturalistic driving study data: U.S. Department of Transportation; 2006 April. 2. Research WAM. 2005 Sleep in America Poll. Washington, D.C. National Sleep Foundation ; 2006. 3. Dement C, Carskadon M, Richardson G. Excessive daytime sleepiness in the sleep apnea syndromes. In: Guilleminault C, We D, eds. Sleep Apnea Syndromes. New York: Alan R Liss 1978:23–46.
Epidemiology
37
4. Sullivan CE, Issa FG, Berthon-Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 1(8225):862–865. 5. Moyer CA, Sonnad SS, Garetz SL, et al. Quality of life in obstructive sleep apnea: a systematic review of the literature. Sleep Med 2001; 2(6):477–491. 6. Larsson LG, Lindberg A, Franklin KA, et al. Gender differences in symptoms related to sleep apnea in a general population and in relation to referral to sleep clinic. Chest 2003; 124(1):204–211. 7. Enright PL NA, Wahl PW, Manolio TA, et al. Prevalence and correlates of snoring and observed apneas in 5201 older adults. Sleep 1996; 19(7):531–538. 8. Gottlieb DJ, Yao Q, Redline S, et al. Does snoring predict sleepiness independently of apnea and hypopnea frequency? Am J Resp Crit Care Med 2000; 162(4 Pt 1):1512–1517. 9. Knuiman MW, James AL, Divitini ML, et al. Correlates of habitual snoring and witnessed apnoeas in Busselton, Western Australia. Aust N Z J Public Health 2005; 29(5):412–415. 10. Teculescu D, Benamghar L, Hannhart B, et al. Habitual loud snoring. A study of prevalence and associations in 850 middle-aged French males. Respiration; international review of thoracic diseases 2006; 73(1):68–72. 11. Parish JM, Lyng PJ. Quality of life in bed partners of patients with obstructive sleep apnea or hypopnea after treatment with continuous positive airway pressure. Chest 2003; 124(3):942–947. 12. Reda M, Ullal U, Wilson JA. The quality of life impact of snoring and the effect of laser palatoplasty. Clin Otolaryngol 2000; 25(6):570–576. 13. AASM Clinical Practice Review Committee. Hypopnea in sleep-disordered breathing in adults. Sleep 2001; 24:469–470. 14. AASM. International Classification of Sleep Disorders, coding and diagnostic manual. 2nd ed. Westchester, 2005. 15. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328(17):1230–1235. 16. Bixler EO, Vgontzas AN, Ten Have T, et al. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998; 157(1):144–148. 17. Zamarron C, Gude F, Otero Y, et al. Prevalence of sleep disordered breathing and sleep apnea in 50- to 70-year-old individuals. A survey. Respiration; international review of thoracic diseases 1999; 66(4):317–322. 18. Tishler PV, Larkin EK, Schluchter MD, et al. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA 2003; 289(17):2230–2237. 19. Duran J, Esnaola S, Rubio R, et al. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001; 163(3 Pt 1):685–689. 20. Young T, Shahar E, Nieto FJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: The Sleep Heart Health Study. Arch Intern Med 2002; 162(8): 893–900. 21. Mohsenin V. Effects of gender on upper airway collapsibility and severity of obstructive sleep apnea. Sleep medicine 2003; 4(6):523–529. 22. Shepertycky MR, Banno K, Kryger MH. Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. Sleep 2005; 28(3):309–314. 23. O’Connor C, Thornley KS, Hanly PJ. Gender differences in the polysomnographic features of obstructive sleep apnea. Am J Respir Crit Care Med 2000; 161(5):1465–1472. 24. Resta O, Carpanano GE, Lacedonia D, et al. Gender difference in sleep profile of severely obese patients with obstructive sleep apnea (OSA). Respir Med 2005; 99(1):91–96. 25. National Institutes of Health State-of-the-Science Conference statement: Management of menopause-related symptoms. Ann Intern Med 2005; 142(12 Pt 1):1003–1013. 26. Vagiakis E, Kapsimalis F, Lagogianni I, et al. Gender differences on polysomnographic findings in Greek subjects with obstructive sleep apnea syndrome. Sleep Med 2006; 7(5):424–430. 27. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001; 163(3 Pt 1):608–613.
38
Yuen
28. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165(9):1217–1239. 29. Eichling P, Jyotsna S. Menopause related sleep disorders. J Clin Sleep Med 2005; 1(3):291–300. 30. Franklin KA, Holmgren PA, Jonsson F, et al. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest 2000; 117(1):137–141. 31. Calaora-Tournadre D RS, Meurice JC, Pourrat O, et al. Obstructive sleep apnea syndrome during pregnancy: prevalence of main symptoms and relationship with pregnancy inducedhypertension and intra-uterine growth retardation. Rev Med Intern 2006; 27(4):291–295. 32. Roush SF, Bell L. Obstructive sleep apnea in pregnancy. J Am Board Fam Pract 2004; 17(4): 292–294. 33. Edwards N, Blyton DM, Kirjavainen TT, et al. Hemodynamic responses to obstructive respiratory events during sleep are augmented in women with preeclampsia. Am J Hypertens 2001; 14(11 Pt 1):1090–1095. 34. Maasilta P, Bachour A, Teramo K, et al. Sleep-related disordered breathing during pregnancy in obese women. Chest 2001; 120(5):1448–1454. 35. Izci B, Riha RL, Martin SE, et al. The upper airway in pregnancy and pre-eclampsia. Am J Respir Crit Care Med 2003; 167(2):137–140. 36. Izci B, Martin SE, Dundas KC, et al. Sleep complaints: snoring and daytime sleepiness in pregnant and pre-eclamptic women. Sleep Med 2005; 6(2):163–169. 37. Ip MS, Lam B, Lauder IJ, et al. A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong. Chest 2001; 119(1):62–69. 38. Scharf SM, Seiden L, DeMore J, et al. Racial differences in clinical presentation of patients with sleep-disordered breathing. Sleep & breathing = Schlaf & Atmung 2004; 8(4):173–183. 39. Lam B, Ip MS, Tench E, et al. Craniofacial profile in Asian and white subjects with obstructive sleep apnoea. Thorax 2005; 60(6):504–510. 40. Wong ML, Sandham A, Ang PK, et al. Craniofacial morphology, head posture, and nasal respiratory resistance in obstructive sleep apnoea: an inter-ethnic comparison. Eur J Orthod 2005; 27(1):91–97. 41. Nieminen P, Tolonen U, Lopponen H, et al. Snoring children: factors predicting sleep apnea. Acta Otolaryngol 1997; 529:190–194. 42. Montgomery-Downs HE, O’Brien LM, Holbrook CR, et al. Snoring and sleep-disordered breathing in young children: subjective and objective correlates. Sleep 2004; 27(1):87–94. 43. Goodwin JL, Kaemingk KL, Mulvaney SA, et al. Clinical screening of school children for polysomnography to detect sleep-disordered breathing—the Tucson Children’s Assessment of Sleep Apnea Study (TuCASA). J Clin Sleep Med 2005; 1(3):247–254. 44. Rosen CL, Storfer-Isser A, Taylor HG, et al. Increased behavioral morbidity in schoolaged children with sleep-disordered breathing. Pediatrics 2004; 114(6):1640–1648. 45. Pelayo R, Sivan Y. Increased behavioral morbidity in school-aged children with sleepdisordered breathing. Pediatrics 2005; 116(3):797–798. 46. Urschitz MS, Guenther A, Eitner S, et al. Risk factors and natural history of habitual snoring. Chest 2004; 126(3):790–800. 47. Ip MS, Lam B, Ng MM, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165(5):670–676. 48. Phillips BG, Kato M, Narkiewicz K, et al. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol 2000; 279(1):234–237. 49. Tassone F, Lanfranco F, Gianotti L, et al. Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables. Clin Endocrinol (Oxf) 2003; 59(3):374–379. 50. Coughlin SM, Mawdsley L, Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25(9):735–741. 51. Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev. 2005; 9(3):211–224. 52. Nachtmann A, Stang A, Wang YM, et al. Association of obstructive sleep apnea and stenotic artery disease in ischemic stroke patients. Atherosclerosis 2003; 169(2):301–307. 53. Davies DP, Rodgers H, Walshaw D, et al. Snoring, daytime sleepiness and stroke: a case-control study of first-ever stroke. J Sleep Res 2003; 12(4):313–318.
4
Ontogeny Timothy F. Hoban The Michael S. Aldrich Sleep Disorders Center, Departments of Pediatrics and Neurology, University of Michigan, Ann Arbor, Michigan, U.S.A.
Donald L. Bliwise Sleep Disorders Center, Department of Neurology, Emory University Medical School, Atlanta, Georgia, U.S.A.
INTRODUCTION At first glance, describing the ontogeny of obstructive sleep apnea (OSA) across the human life span would appear to be a simple and straightforward matter. It has long been recognized that OSA exhibits clear age-related changes, beginning as a childhood condition, most closely associated with adenotonsillar hypertrophy or craniofacial deformity and evolving into a disorder of adults more strongly linked to obesity, age, and male sex. Recent research, however, suggests that the obvious age-related changes in OSA, are accompanied by more complex aspects that are equally important to the understanding and diagnosis of this disorder. For example, children with OSA are more likely to have chronic partial obstruction as the primary mode of respiratory disturbance during sleep as opposed to the discrete apneas or hypopneas usually exhibited by adults (1,2), which limits the sensitivity of standard polysomnography (PSG) for diagnosis in some cases. Disturbances of learning, attention, and behavior are the most common daytime symptoms for children with OSA in contrast to the excessive somnolence demonstrated more frequently by adults (3,4). Age-related changes in the clinical presentation and epidemiology of OSA have also been identified during later adulthood, including increased prevalence for OSA in women following menopause (5), and evidence that OSA among individuals older than age 65 is less strongly associated with sleepiness and hypertension than it is for middleaged individuals (6,7). These and other data suggest that the ontogeny of OSA is in fact complex, incompletely understood, and characterized by profound changes in clinical manifestations and pathophysiology at different ages (Table 1). This chapter reviews current concepts regarding age-related changes of OSA, in broad strokes, with focus upon how clinical manifestations, prevalence, risk factors and morbidity evolve across the human lifespan. Detailed review of the epidemiology and pathophysiology of OSA is provided in other chapters of this text; however selected aspects are briefly discussed when necessary for adequate elucidation of the age-related mechanisms involved in the ontogeny of OSA. INFANCY Infants with OSA are usually described as having noisy breathing during sleep that sometimes is more strident in character than the snoring exhibited by older children and adults with OSA. Mouth breathing, excessive waking, and night sweats are also 39
Infancy
Absent or intermittent Failure-to-thrive
Unknown
Secondary symptoms Daytime sleepiness Neurobehavioral
Cardiovascular
Note: ?, questionable association; ↑, increase.
Prolonged or intermittent Arousal with obstruction Variable Sleep architecture Normal or fragmented
Pathophysiology Mode of obstruction
Neck hyperextension
Other
Symptoms during sleep Breathing Stridor or snoring Mouth breathing
Prolonged or intermittent Variable Normal to fragmented
Less frequent Normal > fragmented
Hypertension Rare cor pulmonale
More common Inattention Hyperactivity Behavioral disturbance
Restlessness Nocturia
Snoring with observed pauses
Obesity
Male > female Not identified Obese > normal
Older adults
More frequent Fragmented > normal
Intermittent > prolonged
Intermittent > prolonged More frequent Fragmented > normal
Very common Variable Subtle cognitive Limited data impairments Increased rates of motor vehicle and occupational accidents Frequent hypertension Limited data ? ↑ risk of stroke ? ↑ risk of cardiovascular morbidity
Restlessness Nocturia
Snoring with observed pauses
Obesity Male sex Menopause ? Pregnancy
Obesity Adenotonsillar hypertrophy Craniofacial anomalies Snoring with or without pauses Mouth breathing Restlessness Perspiration
Male > female 40–60 years Obese > normal
Adulthood
? Male > female Not identified Obese > normal
Adolescence
Prolonged > intermittent
Hypertension Rare cor pulmonale
Absent or intermittent Inattention Hyperactivity Behavioral disturbance
Snoring often continuous Mouth breathing Restlessness Perspiration
Male = female 3–6 years Usually normal, occasionally obese Adenotonsillar hypertrophy Craniofacial anomalies Obesity
Childhood
Ontogenetic Aspects of Obstructive Sleep Apnea at Different Ages
Physical and demographic characteristics Gender Male > female Peak age Not identified Body weight Normal or failure-to-thrive Major risk factors Craniofacial anomalies Prematurity Adenotonsillar hypertrophy
TABLE 1
40 Hoban and Bliwise
Ontogeny
41
commonly seen during the sleep of affected infants, although observed pauses in respiration are only occasionally reported by parents and caregivers. Daytime symptoms during infancy are often subtle unless significant anatomic airway obstruction results in noisy breathing, mouth breathing, or labored respiration while awake. Excessive sleepiness is rarely evident except in the most severe cases, perhaps related to the fact that the frequent napping that normally occurs at this age might limit recognition of mild or moderate degrees of sleepiness. On occasion poor weight gain or failure to thrive may be the most obvious presenting symptoms of infant OSA (8–10). A specific anatomic cause of airway obstruction can be identified for the majority of infants diagnosed as having OSA (9,11–13). Craniofacial conditions (Table 2) and adenotonsillar obstruction represent the two most commonly identified causes of symptomatic obstruction in this age group. Choanal atresia, Pierre TABLE 2 Syndromes and Medical Conditions Predisposing to Obstructive Sleep Apnea in Children and Adolescents Craniofacial syndromes associated with significant mandibular or maxillary hypoplasia Apert syndrome Crouzon syndrome Goldenhar syndrome (hemifacial microsomia) Hallerman-Streiff syndrome Pierre Robin syndrome (Robin sequence) Rubinstein-Taybi syndrome Russell-Silver syndrome Treacher Collins syndrome Other syndromes featuring prominent craniofacial involvement Achondroplasia Klippel-Feil syndrome Larsen syndrome Saethre-Chotzen syndrome Stickler syndrome Velocardiofacial syndrome Conditions associated with macroglossia Beckwith-Wiedemann syndrome Down syndrome Hypothyroidism Mucopolysaccharide storage disorders (e.g., Hunter, Hurler syndromes) Conditions associated with anatomic airway obstruction Adenotonsillar hypertrophy Cleft palate and/or cleft palate repair Choanal atresia or stenosis Fetal warfarin syndrome Laryngotracheomalacia Nasal polyps or septal deviation Pfeiffer syndrome Vascular ring Neurologic disorders associated with weakness or impaired ventilatory control Cerebral palsy Cranial neuropathies (e.g., Mobius syndrome, poliomyelitis) Neuromuscular disorders (e.g., Duchenne, myotonic dystrophies) Structural brainstem lesions (e.g., Chiari malformations, syringobulbia) Conditions characterized by obesity Morbid obesity/metabolic syndrome Prader-Willi syndrome
42
Hoban and Bliwise
Robin sequence, and other conditions associated with severe micrognathia have the potential to cause particularly severe obstruction during early infancy. Although cleft palate in the absence of other anatomic defects is not universally considered to be a risk factor for infant sleep apnea, surgical closure procedures for cleft palate do appear to increase the risk for symptomatic obstruction (14–16). Obesity is only occasionally reported in association with OSA during infancy (17). Only limited data are available regarding the epidemiology of OSA during infancy, but symptomatic obstructive apnea is generally considered to be rare among infants born at term without predisposing medical conditions. There is some evidence that OSA is more frequent among infants born prematurely, with risk being highest until 43 weeks postconceptional age (18). Among 1023 term infants aged two through 27 weeks, occasional obstructive apneas were identified in 40% of subjects, primarily in babies younger than 12 weeks (19). The mean obstructive apnea index (AI) remained low at 0.1 for all age strata analyzed within this cohort, while average obstructive apnea duration declined from 5.5 seconds for younger infants (two to seven weeks) to 4.5 seconds for older ones (20–27 weeks). Other studies suggest that obstructive events are more frequent among male infants and often resolve by two months of age (20–22). The frequency with which infant OSA persists into childhood or adulthood remains unknown. It is interesting to note that the frequency of obstructive apneas is quite low in healthy term infants despite the presence of anatomic factors such as small airway size, high nasal resistance, and high chest wall compliance that would ordinarily appear to convey high risk for symptomatic obstruction. It is postulated that the presence of increased ventilatory drive and decreased airway collapsibility relative to older ages allows most normal infants to compensate for these potentially adverse influences (15). In addition, age-dependent ventilatory reflexes may provide partial explanation for the fact that the mode of sleep-related obstruction differs for infants compared to adults. Infants arouse less readily to hypercapnia than adults and do not normally compensate for increases in inspiratory resistive load during sleep (23–25). This may explain why infants are more likely to exhibit prolonged periods of obstructive hypoventilation than the cyclical, discrete apneas more commonly exhibited by adults. CHILDHOOD AND ADOLESCENCE Although symptomatic OSA is thought to be less common in children and adolescents than in adults, occasional obstructive apneas occur in normal children. Among 50 healthy children aged 1 to 18 years without symptoms of OSA, the mean obstructive AI was reported to be 0.1, with maximal durations of obstruction ranging between three and 10 seconds (26). Although this study helped define the frequency and character of obstructive events in healthy, asymptomatic subjects, and is the origin of the commonly used guideline that an obstructive AI of 0 to 1 is considered the “normal range” for pediatric PSG, the threshold at which an elevated apnea index (AI) or apnea-hypopnea index (AHI) becomes associated with clinically significant health consequences has not been established. Because childhood OSA is more commonly characterized by periods of prolonged obstructive hypoventilation with less frequent apneas and hypopneas than adults, it has been suggested that use of the AHI alone may not be sensitive for the diagnosis of childhood OSA (27). These concerns are in accordance with pediatric case series that have identified children with clinically-significant obstruction with mean AHIs below five events per hour (28).
Ontogeny
43
The prevalence of habitual snoring among children has been estimated to be 5 to 14%, with witnessed respiratory pauses reported in about 5% of children (29–34). Estimates regarding prevalence of OSA during childhood are varied, due to the lack of universally accepted diagnostic criteria for OSA in this age group, and because large population-based studies have not yet been performed. Most studies suggest a minimum prevalence of 1% to 3% (29,32,35,36). OSA during childhood demonstrates several unique epidemiologic characteristics. Case series suggest that the prevalence of OSA peaks between two and five years of age (12). Boys and girls exhibit comparable prevalence of OSA in contrast to the male preponderance seen during infancy and adulthood (29,30,32,37). Although obesity is a less frequent risk factor for OSA in children than for adults, obese children are more likely to have moderate or severe OSA than nonobese children (35,38). Limited data suggest that former premature infants and that specific ethnic groups may be at increased risk for OSA during childhood (35,39). Children and adolescents with OSA usually exhibit noisy respiration during sleep, although this may be only intermittently witnessed or the severity underestimated by parents. Snoring is often accompanied by prominent mouth breathing and sometimes by snorting or gasping noises. Witnessed respiratory pauses are less often seen in children than adults, consistent with evidence that chronic partial obstruction is more frequent than discrete obstructive apneas for many affected children. Children with OSA exhibit more frequent restlessness, diaphoresis, and enuresis than unaffected children and may be at increased risk for parasomnias (8,40,41). Unusual sleeping positions involving excessive extension of the head and neck are sometimes observed, potentially representing a compensatory mechanism for improving the patency of an obstructed airway. The daytime symptoms manifested by children with OSA are highly variable and are usually less obvious than the daytime sleepiness exhibited by affected adults. Children will sometimes report dry mouth, headache, or sore throat upon waking, but these symptoms are often mild and transient. Mouth breathing may be seen during wakefulness in children with significant adenotonsillar hypertrophy or other nasal obstruction. For preadolescent children with OSA, daytime somnolence is seldom prominent unless nocturnal obstruction is severe. Subtle or intermittent sleepiness may sometimes be seen, most often during sedentary activities such as automobile rides. In contrast, adolescents with OSA are more likely to present in an “adult” fashion where sleepiness represents a pervasive and easily recognizable symptom. Deficits involving learning, attention, and behavior represent the most common daytime symptoms of childhood OSA, and children with OSA may be initially misdiagnosed with attention deficit-hyperactivity disorder (ADHD). Significant learning disabilities, hyperactivity, and behavioral disturbances were reported in early case series of children with OSA, which documented relatively severe cases (12,13,42,43). More recent data suggest that even milder degrees of OSA may be associated with neurocognitive deficits. Neuropsychometric assessments of children with mild or moderate OSA suggest behavioral regulation and executive functioning may be affected to a greater degree than other objective measures (4,44). Neurobehavioral consequences involving similar domains have also been identified in children having snoring without OSA (45,46). Children with OSA exhibit characteristic physical features more often than affected adults. Tonsils and adenoids are largest in relation to upper airway size between two and eight years of age (47). Tonsillar size is easily verified during
44
Hoban and Bliwise
routine examination, whereas physical signs of adenoidal hypertrophy may consist only of mouth breathing or the elongated facial appearance of “adenoid facies”. Children with OSA sometimes exhibit a narrow, high-arched palate or other craniofacial abnormalities (48–50), however it is possible for the physical exam to be entirely normal in affected children. OSA in children is less frequently associated with obesity than in the adult population, however obesity still represents an identifiable risk factor for OSA throughout childhood and adolescence (51–53). In a large epidemiologic study, obesity represented the most prominent risk factor for moderate OSA, with an odds ratio of 4.5 for obese children compared to the nonobese (35). Obese adolescents may be at particularly high risk. In a series of 22 obese adolescents without specific sleep complaints, 10 (45%) had abnormal PSG and six (27%) were classified as having moderate or severe OSA (38). In this group, degree of obesity correlated significantly with AI, sleepiness, and nadir oxygen saturation. The long-term health consequences of OSA have been studied less rigorously for children than for the adult population. Hypertension has been reported in several case series of children with OSA (42,54,55), with other series reporting evidence of often asymptomatic pulmonary hypertension (56,57). Cor pulmonale now represents a rare complication of severe OSA which may resolve following treatment of obstruction (58–60). Recent reports suggest that children with OSA have increased rates of health care utilization (61) which decline substantially following adenotonsillectomy (62). The long-term effects of childhood OSA upon educational achievement, socioeconomic status, and mortality have not been established. As is the case for infants, higher arousal thresholds and failure to briskly compensate for increases in inspiratory resistive load are thought to represent the major reasons that children with OSA exhibit prolonged partial airway obstruction more often than the brief, cyclical apneas and hypopneas that characterize adult OSA (15). These mechanisms do not necessarily explain why the daytime symptoms of OSA differ so dramatically between children and adults. Differences in arousal frequency and associated disruption of sleep architecture between the two populations represent one potential mechanism that could underlie the differing clinical manifestations during wakefulness. It is also postulated that the extremely high degrees of daytime alertness exhibited by preadolescent children relative to adults (63) might modify the daytime expression of sleepiness and therefore account for the fact that inattention and hyperactivity are seen more often than overt somnolence in younger children with OSA. Since daytime alertness as measured by multiple sleep latency testing gradually declines to adult levels during adolescence (64,65), this postulated mechanism is consistent with the clinical observation that adolescents with OSA are more likely than younger children to exhibit daytime sleepiness as a prominent symptom. The differences in the pathophysiology of airway obstruction, arousal responses, and daytime symptoms between children and adults with OSA are sufficiently profound that there has been speculation that pediatric and adult OSA might represent two distinct disorders rather than a single disease with substantial age-dependent changes (15). This speculation notwithstanding, it is uncertain how often untreated childhood OSA persists into adulthood or whether the condition might improve or resolve for some children in the absence of treatment. Several case series do suggest that children successfully treated for OSA during early childhood sometimes exhibit recurrence during adolescence (66,67).
Ontogeny
45
ADULTHOOD AND OLD AGE Clinical Manifestations Adults with OSA demonstrate symptoms during sleep that are in some ways comparable to those exhibited by children. Prominent snoring is almost universal among affected patients, often accompanied by significant restlessness or perspiration during sleep. In many cases, bed partners or family members report audible pauses in respiration which often terminate with a snorting or gasping noise. Enuresis associated with OSA is less common for adults than for children, however repetitive awakenings to use the bathroom (nocturia) represent a common complaint (68,69) which may correlate with severity of obstruction (70). Insomnia as a presenting symptom of OSA is more frequently reported by women than men (71,72) The daytime symptoms of adult OSA differ considerably from those of children. Daytime sleepiness is one of the cardinal features of adult OSA as opposed to an occasionally observed symptom for affected children. Although self-reported measures of sleepiness are reported to correlate with the AHI in large epidemiologic studies of adults with OSA (73,74), many adults with OSA report little or no sleepiness, suggesting considerable variation in individual susceptibility to this symptom. Sleepiness, as an associated symptom of nonapneic snoring, was also reported in these cohorts. Fewer data are available with respect to other daytime symptoms of adult OSA. Several series have reported impairments of working memory, visual vigilance, attention span, and psychomotor efficiency in adults with OSA (75–77). Patients with OSA are also reported to have higher motor vehicle crash and occupational injury rates (78–80). Other occasionally reported daytime symptoms considered more common for adults than children include automatic behavior, hypnagogic hallucinations, and sleep drunkenness. The physical feature most strongly associated with adult OSA is obesity, in contrast to the adenotonsillar enlargement most frequently associated with childhood OSA. Physical findings in affected adults may also include septal deviation, maxillary hypoplasia, redundant pharyngeal tissue, small/retrognathic mandible, and large neck circumference (81). Age Dependence For the adult population as a whole, the prevalence for OSA of at least mild severity (AHI ≥ 5) is estimated to be 20% and the prevalence for OSA of at least moderate severity (AHI ≥ 15) is estimated to be 6.7% (27,82). Population-based studies suggest that prevalence is lowest among younger adults and increases during middle age. In a cross-sectional analysis of the Wisconsin Sleep Cohort Study (WSCS), prevalence for mild or worse OSA (AHI ≥ 5) among men was 17% at ages 30–39, rising to 25% at ages 40–49 and 31% at ages 50–60 (73). For moderate or worse OSA (AHI ≥ 15), prevalence rose from 6.2% at ages 30–39 to 11% at ages 40–49 and 9.1% at ages 50-60. Increased prevalence of OSA during middle age has been reported in other epidemiologic studies as well (83–85). Older adulthood represents a portion of the life span that is in some ways even more vulnerable to airway obstruction during sleep. As many as 24% of ambulatory, community-dwelling adults over the age of 65 demonstrate an AI in excess of five events per hour (86) and this prevalence figure is even higher (42%) in older and more infirm nursing home populations (87). For many years, the sleep apnea of elderly persons was thought to represent predominantly central, rather than
46
Hoban and Bliwise
obstructive, events, but many descriptive studies have shown that this is not the case (88). The distinction between central and obstructive apnea as the predominant subtype in elderly populations bears particular relevance for understanding the pathophysiology of sleep apnea in the elderly (see below). Elsewhere we have argued that although chronologic age per se can be a misleading construct (cf., physiologic age) when discussing OSA in aging (89), it can be a helpful framework to discuss potential similarities and differences between the OSA of middle-aged and older age groups. Figure 1 represents a hypothetical model employing arbitrarily defined chronologic age ranges that suggests that OSA in adulthood is likely to represent two separate phenomena, one age related (having a specific window of vulnerability perhaps in the middle 40s and early 50s) and one age dependent (more likely to occur with increasing age with the effect suspected to emerge in the mid-60s) (7). The reader must understand that assignment of specific chronological ages in the model is arbitrary, though undoubtedly heuristic and capable of hypothesis testing. The distinction between age-related and age-dependent conditions takes origin in research in aging processes (90), which indicates that many conditions constitute biomarkers of aging (i.e., they show age dependence). The reader is directed elsewhere to more detailed expositions of this framework (7,88,91). Here we will review selectively some literature that bears upon the model. Age dependence in OSA is demonstrable in three general domains: (i) risk factors, (ii) pathophysiology and (iii) disease outcomes. Risk Factors for OSA During Adulthood Case series and population-based studies have almost universally reported strong associations between adult OSA and most measures of excess weight, including body mass index and neck circumference (73,92–94). In a cross-sectional analysis from the WSCS, an increase of one standard deviation in the body mass index
FIGURE 1 Heuristic model suggesting sleep apnea as both an age-related and age-dependent condition with potential overlap of distributions in the 60- to 70-year-old age range. Cross-sectionally, note that the number of cases observed may remain high and increase with age, despite a presumed decrease in age-related sleep apnea. Source: From Ref. 88. Abbreviation: SA, sleep apnea.
Ontogeny
47
resulted in a threefold increase of risk for AHI ≥ 5 (73). A longitudinal analysis drawn from the same cohort suggested that a 10% weight gain over four years predicted a six-fold increase in risk for developing moderate or severe OSA (95). Specific craniofacial features may be associated with adult OSA, including retrognathia, maxillary retrusion, and altered mandibular size, although only mandibular body length has demonstrated significance for the prediction of adult OSA (96–98). Adults with OSA may have larger tongues, soft palates, and lateral pharyngeal walls than those without (99–101). It is thought that some of the soft-tissue enlargement within the upper airway of adults with OSA might result from chronic edema or inflammation caused by snoring (102,103). Adenotonsillar hypertrophy is identified much less often in adults with OSA compared to children. OSA is more frequent in men than in women at all ages during adulthood, with most population-based studies suggesting that men are at two to three times greater risk throughout the early and middle adult years (73). The prevalence of OSA in adult women appears to increase with advancing age in a manner comparable to men but female risk for OSA may additionally be impacted by such age-dependent factors as pregnancy and menopause (84). The extent to which pregnancy increases a woman’s risk for developing OSA is uncertain. Pregnancy-associated weight gain, pharyngeal edema, or vasomotor rhinitis represent factors that can potentially cause or worsen upper airway obstruction during sleep (104–106). Several series have reported increased snoring in the latter stages of pregnancy (106,107) which may resolve within several months following delivery (108). PSG-based data assessing sleep-related breathing disorders during pregnancy are scant. One small series studying women during the early third trimester of pregnancy found that 11 women with chronic snoring demonstrated abnormal esophageal pressure fluctuations indicative of increased airway resistance more often than 13 nonsnoring controls, however none of the subjects exhibited AHI ≥ 5 (108). The risk of developing OSA during pregnancy may be higher for women with obesity. In a case-control series assessing PSG changes from early-to-late pregnancy in obese women, mean AHI increased significantly (1.7 to 2.6 , p ≤ 0.05), with 1 of 11 subjects developing frank OSA (AHI > 10) (109). Improvement of pregnancy-associated OSA following delivery has been reported (110,111). Although menopause has long been suspected to be a risk factor for OSA in older adult women, population-based data have only recently provided objective support for this belief. The WSCS found that the odds ratio for AHI ≥ 5 relative to the premenopausal baseline increased to 1.2 during perimenopause and 2.6 with postmenopause after adjusting for obesity, age and other confounding factors (5). Hormone replacement therapy in postmenopausal women may be associated with reduced risk for OSA (112). Several medical and lifestyle risk factors potentially associated with OSA are age dependent insofar as they are more commonly identified in adults with OSA than in children. Hypothyroid states represent a common and independently treatable predisposing condition more commonly identified in women than in men or children (72,113,114). Although evening time consumption of alcohol has been found in many studies to have an acute deleterious effect upon respiration during sleep (115,116), the long-term effects of alcohol use upon adult OSA have not been systematically investigated. Cross-sectional studies have suggested positive associations between smoking and OSA as well (117,118), but these associations have not been confirmed via prospective assessment.
48
Hoban and Bliwise
Pathophysiology of OSA in Adults and the Elderly Age differences in the waking respiratory control system have long been known. Specifically, decreased hypercapnic ventilatory drive and diminished response to hypoxia (119) as a function of age have been demonstrated. The relevance of such changes in central and peripheral chemoreceptor sensitivity while awake, however, for age-dependent alterations during sleep is less well understood. Sleep is associated with mild CO2 retention with depressed hypercapnic response (120), and stable breathing in sleep is ensured by assumed decreases in chemoreceptor loop gain (121). Instability in breathing during sleep may result when loop gain is increased or “overshoots.” Elderly persons could be susceptible to unstable breathing during sleep because of relatively higher levels of ventilatory responsiveness during sleep, leading to periodic breathing and subsequent airway obstruction (122). There have been relatively few studies examining the ventilatory response to hypercapnia during sleep as a function of age. One early study reported absence of sleep-related decline in the hypercapnic ventilatory response in older subjects (123), consistent with increased loop gain as a function of age. In a more recent study, however, using continuous positive airway pressure (CPAP) to control for muscle activation induced by upper airway resistance (see below), Browne et al. (124) showed that the sleep-related decline in chemosensitivity to hypercapnia was preserved similarly in both young and older subjects without sleep apnea and that the magnitude of that decline was similar, arguing against the loop gain hypothesis. Krieger et al. (125) proposed that the reduced endoesophageal pressure generated during OSA in older subjects might reflect altered chemosensitivity but did not present data on hypercapnic or hypoxic ventilatory drive in those subjects. Other factors may also underlie altered chemosensitivity in the elderly in sleep. For example, frequent arousals during sleep, a characteristic feature of sleep in the elderly (126), might destabilize ventilation (127,128), by unmasking the hypocapnic apneic threshold induced by large breaths concurrent with termination of arousal (129). Studies evaluating this hypothesis have analyzed intrinsic variability in breathing during sleep as a function of age. Data on age differences are mixed. A number of early studies (130–132) failed to find age differences in the wake-tosleep transition of minute volumes during episodes of non-apneic breathing, but Hudgel et al. (133) reported that older subjects showed wide oscillations in tidal volumes during sleep that were inversely related to upper airway resistance. Browne et al. (134) reported similar coefficients of variation in tidal volumes of young and older subjects during periods of sleep without respiratory events. Taken together, these data present only a mixed picture that unstable breathing per se underlies the majority of OSA of the geriatric population, unless conditions predisposing to unstable ventilation (e.g., congestive heart failure) are also present. Increased compliance of the upper airway of elderly subjects (specifically men) in wakefulness was first noted over 20 years ago in several studies using rhinometry (135,136), and pharyngeal cross-sectional area, measured with acoustic reflection, also showed substantial decreases with aging (137), particularly when supine (138). These descriptions of upper airway structure generally have been supported by functional studies. Thurnheer et al. (139) noted that both the rapid eye movement (REM) and non-REM (NREM) sleep-related increase in total respiratory resistance was of greater absolute magnitude in middle-aged men relative to younger men. Some age differences were also seen in younger versus older women in both the REM and NREM pressure-flow relationships during latter stages of inspiration. It should be noted that any sleep-wake state instability may enhance collapsibility of the upper airway (140).
Ontogeny
49
Several studies have examined age differences in protrusion force of the major upper airway dilator, the genioglossus (GG). During waking, GG strength, but not endurance, decreased with age in both men and women (141,142); however, endurance measurements were made at submaximal pressures, which may have underestimated the force generated during sleep-related obstruction. No data were available on OSA in those subjects. A follow-up study (143) correlated waking tongue protrusion force to AHI and found a minimal relationship, but weak AHI/ age correlations decrease the relevance of this finding for understanding agedependent mechanisms. Alternative pathophysiologic investigations have examined spontaneously occurring activity among upper airway muscles. Elevated dilator activity has been recognized in OSA patients during wakefulness (144,145), and this is also seen during sleep, even when upper airway resistance is normalized with CPAP to eliminate the possible activation of negative pressure breathing (146). These findings can be interpreted as compensatory for a more compliant airway, at least among phasically active muscles such as the GG. The question then arises as to how enhanced collapsibility may be manifested in older individuals. Worsnop et al. (147) reported that the decline in ventilation at sleep onset in older relative to younger men was accompanied by a more precipitous drop in intra-muscularly recorded activity in both the GG and tensor palatini (TP), an upper airway dilator with more tonic activity throughout the respiratory cycle. Conversely, on awakening the increment in GG electromyographic (EMG) activity was greater in older subjects than in younger subjects. On the other hand, Fogel et al. (148) reported that although baseline levels of EMG activation in the GG were higher in older subjects, the magnitude of the reduction of EMG activity with sleep was comparable between age groups. In a later study, pulses of negative pressure breathing delivered during sleep via mask generated lower GG EMG responses in older relative to younger subjects (149). Animal studies of structure and function of the upper airway dilators provide a useful translational substrate for a discussion of age-dependent effects on muscle fatigue. Relative to other muscle groups (e.g., diaphragm), dilating muscles in the upper airway, such as the GG and sternohyoid (STH), are composed of a higher proportion of type II fast-twitch (fatigue resistant) fibers (150). Cantillon and Bradford (151) did not examine GG physiologically; however, they were unable to demonstrate in vitro age differences in endurance of the rat sternohyoid, though they noted that tension generated per unit of cross-sectional area in the geniohyoid (GH) was higher in older animals. Oliven et al. (152) found no age differences in the histochemical properties of upper airway dilators (GG, GH, and STH) when compared to non-dilating upper airway muscles (mylohyoid); however, when examined with a quantitative visual method sensitive to the oxidative status of muscle (succinate dehydrogenase densitometry), older animals showed substantial reductions, particularly in the GG. These changes were far more pronounced than age differences in the simple proportion of fast-twitch fibers in any of the muscle groups studied and suggest differences in GG function by age. Finally, a role for altered proprioception within the upper airway as a function of age cannot be discounted. Although recent studies of upper airway function during sleep have controlled for upper airway afferent stimulation by using nasal CPAP, the role of altered sensory input from the upper airway may play a role in the higher prevalence of OSA in old age. Reduction in both two-point discrimination (153) and detection of thermal gradients (154) have been noted in OSA, and similar deficits have been noted in the upper airway in older subjects who were not
50
Hoban and Bliwise
specifically evaluated for OSA (155,156). The longer duration of apneic events in REM and NREM sleep in older subjects has been interpreted partially as a function of reduced proprioception within the upper airway that otherwise triggers arousal and termination of breathing events (157). In summary, full consideration of the complex array of mechanisms accounting for airway obstruction in OSA suggests that the upper airway structure/function of older persons and, to a somewhat lesser extent, alterations in ventilatory control, bear more similarity than dissimilarity to those phenomena in younger adults with OSA. We should note that many of these studies have been limited to comparing men in their 20s and 50s, so some uncertainty remains regarding the applicability of the findings to women, as well as in advanced old age (i.e., over age 80). Outcomes and Comorbidities of OSA in Adults and the Elderly The morbidity associated with OSA has been examined more thoroughly for middleaged adults than for other age groups. Several avenues of investigation have suggested a strong association between OSA and hypertension in adults. Apneic episodes have been found to cause substantial but transient increases in blood pressure during sleep (158,159). Multiple population-based studies have reported significant associations between PSG-documented OSA and hypertension while controlling for potential confounding influences such as obesity, sex, and age (83,160,161). Although these cross-sectional studies could not demonstrate whether OSA predates or causes hypertension, the limited observational data available suggest that adult OSA represents an independent risk factor for the development of high blood pressure over time. A prospective study involving the WSCS found that an AHI of five to 14.9 at baseline doubled the risk for developing hypertension within four years and that baseline AHI ≥ 15 nearly tripled that risk (162). Other cardiovascular morbidity linked to adult OSA in cross-sectional studies and case series includes stroke, myocardial infarction, heart failure, cardiac dysrhythmia, and pulmonary hypertension (163–166). Because these conditions are also closely associated with hypertension—common in adults with OSA—prospective population-based studies will be required to determine whether OSA represents an independent risk factor in their pathogenesis. In contrast to data suggesting strong associations between OSA and cardiovascular morbidity in middle-aged adults, initial evidence appears weaker that putative adverse outcomes are associated with OSA in old age. Undoubtedly the study that has fostered the most widespread belief that OSA in older individuals has less clinical importance than in younger individuals is the retrospective study of He et al. (167). This classic study, although methodologically flawed because it was a nonrandomized, retrospectively conducted comparison of aggressively treated versus untreated sleep apnea patients, and showed that untreated patients had higher follow-up mortality relative to treated patients. More intriguing was the observation that this differential mortality was present only in patients under 50 years of age. Treatment had no bearing upon survival in patients over the age of 50. This study has often been cited as evidence that OSA in older patients is of less consequence than in younger patients, though it is undoubtedly confounded by selective survivorship among the older subjects. Lavie et al. (168) also reported that only younger OSA patients had elevated mortality rates relative to the age-matched general population; in older OSA patients (over age 70), mortality rates in OSA were significantly lower than for the elderly
Ontogeny
51
population as a whole. Not all clinical studies suggest, however, that OSA has decreased salience for elderly patients. A five-year follow-up among patients in the mid 60s to 70s hospitalized for coronary artery disease, some of whom were diagnosed with OSA, showed that untreated OSA was associated with mortality (169). These results were all based on clinical populations, who represent a highly biased health-care seeking sample of patients with higher prevalence of multiple diseases. As such, they cannot be used to draw valid inferences regarding mortality/morbidity associated with OSA as a function of age in the general population. Within the United States, data from the Sleep Heart Health Study (SHHS), a multi-site cohort composed of surviving members of epidemiologic studies of cardiovascular disease, have illuminated numerous issues related to age-dependent morbidity and OSA. Cross-sectional analyses of SHHS subjects have demonstrated that many morbidities associated with OSA, including hypertension (83,170), stroke (164), endothelial function (171), high-density lipoprotein cholesterol (93) and a vulnerable apolipoprotein genotype (172), diabetes (93) and even reported daytime sleepiness (74) show weaker magnitudes of relationships in the over-65 segment of the population relative to the under-65 year old population. At least one other major epidemiologic study, based in eastern Pennsylvania, has also shown weaker relationships between OSA and hypertension in older participants relative to younger subjects (160). These data argue that the OSA and associated morbidities of middle-aged populations be viewed as age-related phenomena and that of the older population as age-dependent and of far less consequence. Several comments should be offered regarding this perspective. First, because many of the elderly subjects in SHHS are survivors from previously defined cohorts, such as the Cardiovascular Health Study, they represent older persons of betterthan-expected health. Therefore, morbidities associated with OSA would be mitigated in the presence of such survival bias. Secondly, a blanket assumption of decreased associations with morbidities in older individuals with OSA may discourage attempts at intervention (e.g., CPAP or oral appliance therapy) in some individuals who may derive benefit from treatment. Finally, a closer examination of data from SHHS, in fact, does not always suggest that OSA/morbidity associations are weaker in older persons. In the analyses of hypertension for example, the fullyadjusted odds ratios for highest versus lowest quintile of AHI in the prediction of AHI showed a 64% excess risk in the < 65 population with the risk being nonsignificant for the over 65 population (83). However, when expressed as risk for the highest versus lowest quintile of cumulative percentage of sleep with SaO2 < 90%, older persons incurred a significant 44% excess risk, compared to a nonsignificant risk in the under-65 year old population (83). Similarly when individuals with concurrent evidence of cardiovascular disease were excluded from the analyses, the AHI was significantly associated with hypertension and diabetes in women both under and over the age of 65 (93), though men showed differential results by age. Taken together, these data suggest caution before attributing lack of importance to OSA in old age. Longitudinal studies of middle-aged populations who are presently being followed into old age, such as the WSCS, might be expected to provide somewhat better estimates of the risks and natural history of OSA with somewhat less influence of survivor bias. In fact, analyses from WSCS have demonstrated risks for hypertension associated with incident OSA that are somewhat higher than those based on the cross-sectional analyses from SHHS (162). Moreover, those relationships were independent of baseline age, which ranged from 30 to 60. In the Cleveland Family Study, older chronologic age at baseline was also a risk factor for incident
52
Hoban and Bliwise
OSA, which suggests age dependence, and the effect was stronger in women than in men (173). Other smaller cohort studies have portrayed an equivocal picture regarding associations between OSA and mortality in older populations. A suggestion of such relationships occurred in community-dwelling populations from northern (174) and southern (175) California and in a nursing home population (176). Confounders with chronologic age in analyses have made it difficult to tease out separate effects of OSA in such observational studies. We have argued that, to the extent that OSA represents a biomarker of aging, parceling the effects of chronologic age in such models represents an over-adjustment, because age serves as a proxy for all other competing mortality risks, which should be examined individually instead (89). Indeed when chronologic age was removed but competing morbidities were included in models in one of these studies, OSA predicted mortality at borderline significance (175). When viewed in combination, these studies suggest that agedependent OSA cannot be assumed to be of less consequence than OSA occurring in middle-aged adults. CONCLUSIONS The ontogeny of OSA exhibits clear age-related changes and yet its associations are exceedingly complex. Infants with OSA typically demonstrate noisy and/or mouth breathing, excessive waking, and night sweats, but daytime symptoms are often subtle. Craniofacial conditions and adenotonsillar obstruction are common causes of symptomatic airway obstruction in this age group, and there is evidence to indicate that OSA is more frequent in male infants and those born prematurely. For children with OSA, the apnea-hypopnea index alone may not be sensitive for the diagnosis of childhood OSA, since prolonged obstructive hypoventilation with less frequent abnormal breathing events than adults characterize this age group. Additionally, the peak prevalence of OSA in childhood is between two and five years of age with an equal gender distribution, and obese children are more likely to have more severe OSA than nonobese children. Noisy breathing, snoring with prominent mouth breathing, chronic partial obstruction, restlessness, diaphoresis, enuresis, and unusual sleeping positions are observed in children with OSA. Tonsillar and adenoidal hypertrophy as well as craniofacial abnormalities (e.g., elongated face; narrow, high-arched palate) may be observed. Daytime symptoms are highly variable in childhood OSA but most commonly present as deficits of learning, attention, and behavior. The differences between childhood and adult OSA with respect to pathophysiology, arousal responses, and daytime symptoms have prompted discussion as to whether pediatric and adult OSA are in fact two distinct disorders. Further research needs to explore this controversy, as well as the long-term health, educational, and socioeconomic consequences of childhood OSA. Adolescents with OSA are most likely to present in the adult form of OSA, which markedly differs from childhood OSA with respect to daytime sleepiness, representing a cardinal symptom in adults with OSA and only occasionally observed in affected children. Obesity, a large neck circumference, septal deviation, maxillary and mandibular deficiencies, and redundant pharyngeal tissue are common physical findings associated with OSA of adulthood. The prevalence of OSA rises from young to older adulthood, and risk factors for OSA in adults include excess body weight, specific craniofacial features, male gender (though pregnancy and menopause may increase female OSA risk), and hypothyroidism. Examination of the
Ontogeny
53
mechanisms for airway obstruction in OSA in the elderly indicate that upper airway structure/function and perhaps ventilatory control alterations are more similar than different when compared to those of younger adults with OSA. The association between cardiovascular morbidity and OSA appears to be stronger in middle-aged adults compared to older individuals, but these data may have methodological limitations. Thus, one should be cautious about attributing lack of importance to OSA in old age, and future work is clearly indicated to further explore this association. REFERENCES 1. Ward SL, Marcus CL. Obstructive sleep apnea in infants and young children. J Clin Neurophysiol 1996; 13(3):198–207. 2. Bower CM, Gungor A. Pediatric obstructive sleep apnea syndrome. Otolaryngol Clin North Am 2000; 33(1):49–75. 3. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics 1998; 102(3):616–620. 4. O’Brien LM, Mervis CB, Holbrook CR, et al. Neurobehavioral correlates of sleepdisordered breathing in children. J Sleep Res 2004; 13(2):165–172. 5. Young T, Finn L, Austin D, et al. Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2003; 167(9):1181–1185. 6. Ingram F, Henke KG, Levin HS, et al. Sleep apnea and vigilance performance in a community-dwelling older sample. Sleep 1994; 17(3):248–252. 7. Young T. Sleep-disordered breathing in older adults: is it a condition distinct from that in middle-aged adults?[comment]. Sleep 1996; 19(7):529–530. 8. Brouilette R, Hanson D, David R, et al. A diagnostic approach to suspected obstructive sleep apnea in children. J Pediatr 1984; 105(1):10–14. 9. Kahn A, Groswasser J, Sottiaux M, et al. Mechanisms of obstructive sleep apneas in infants. Biol Neonate 1994; 65(3-4):235–239. 10. Leiberman A, Tal A, Brama I, et al. Obstructive sleep apnea in young infants. Int J Pediatr Otorhinolaryngol 1988; 16(1):39–44. 11. Brouillette RT, Fernbach SK, Hunt CE. Obstructive sleep apnea in infants and children. J Pediatr 1982; 100(1):31–40. 12. Frank Y, Kravath RE, Pollak CP, et al. Obstructive sleep apnea and its therapy: clinical and polysomnographic manifestations. Pediatrics 1983; 71(5):737–742. 13. Guilleminault C, Korobkin R, Winkle R. A review of 50 children with obstructive sleep apnea syndrome. Lung 1981; 159:275–287. 14. de Serres LM, Deleyiannis FW, Eblen LE, et al. Results with sphincter pharyngoplasty and pharyngeal flap. Int J Pediatr Otorhinolaryngol 1999; 48(1):17–25. 15. Arens R, Marcus CL. Pathophysiology of upper airway obstruction: a developmental perspective. Sleep 2004; 27(5):997–1019. 16. Liao YF, Chuang ML, Chen PK, et al. Incidence and severity of obstructive sleep apnea following pharyngeal flap surgery in patients with cleft palate. Cleft Palate Craniofac J 2002; 39(3):312–316. 17. Kahn A, Mozin MJ, Rebuffat E, et al. Sleep pattern alterations and brief airway obstructions in overweight infants. Sleep 1989; 12(5):430–438. 18. Ramanathan R, Corwin MJ, Hunt CE, et al. Cardiorespiratory events recorded on home monitors: comparison of healthy infants with those at increased risk for SIDS. JAMA 2001; 285(17):2199–2207. 19. Kato I, Franco P, Groswasser J, et al. Frequency of obstructive and mixed sleep apneas in 1023 infants. Sleep 2000; 23(4):487–492. 20. Guilleminault C, Ariagno RL, Forno LS, et al. Obstructive sleep apnea and near miss for SIDS: I. Report of an infant with sudden death. Pediatrics 1979; 63(6):837–843. 21. Kahn A, Groswasser J, Rebuffat E, et al. Sleep and cardiorespiratory characteristics of infant victims of sudden death: a prospective case-control study.[see comment]. Sleep 1992; 15(4):287–292.
54
Hoban and Bliwise
22. Flores-Guevara R, Plouin P, Curzi-Dascalova L, et al. Sleep apneas in normal neonates and infants during the first three months of life. Neuropediatrics 1982; 13(suppl):21–28. 23. van der Hal AL, Rodriguez AM, Sargent CW, et al. Hypoxic and hypercapneic arousal responses and prediction of subsequent apnea in apnea of infancy. Pediatrics. 1985; 75(5):848–854. 24. Hedemark LL, Kronenberg RS. Ventilatory and heart rate responses to hypoxia and hypercapnia during sleep in adults. J Appl Physiol 1982; 53(2):307–312. 25. Purcell M. Response in the newborn to raised upper airway resistance. Arch Dis Child 1976; 51(8):602–607. 26. Marcus CL, Omlin KJ, Basinki DJ, et al. Normal polysomnographic values for children and adolescents. Am Rev Respir Dis 1992; 146(5 Pt 1):1235–1239. 27. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165(9):1217–1239. 28. Rosen CL, D’Andrea L, Haddad GG. Adult criteria for obstructive sleep apnea do not identify children with serious obstruction.[see comment]. Am Rev Respir Dis 1992; 146 (5 Pt 1):1231–1234. 29. Gislason T, Benediktsdottir B. Snoring, apneic episodes, and nocturnal hypoxemia among children six months to six years old. An epidemiologic study of lower limit of prevalence. Chest 1995; 107(4):963–966. 30. Teculescu DB, Caillier I, Perrin P, et al. Snoring in French preschool children. Pediatr Pulmonol 1992; 13(4):239–244. 31. Ali NJ, Pitson D, Stradling JR. Natural history of snoring and related behaviour problems between the ages of fourand seven years. Arch Dis Child 1994; 71:74–76. 32. Ali NJ, Pitson DJ, Stradling JR. Snoring, sleep disturbance, and behaviour in four to five year olds.[see comment]. Arch Dis Child 1993; 68(3):360–366. 33. Corbo GM, Forastiere F, Agabiti N, et al. Snoring in nine- to 15-year-old children: risk factors and clinical relevance. Pediatrics 2001; 108(5):1149–1154. 34. Castronovo V, Zucconi M, Nosetti L, et al. Prevalence of habitual snoring and sleepdisordered breathing in preschool-aged children in an Italian community. J Pediatr 2003; 142(4):377–382. 35. Redline S, Tishler PV, Schluchter M, et al. risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med 1999; 159(5 Pt 1):1527–1532. 36. Anuntaseree W, Kuasirikul S, Suntornlohanakul S. Natural history of snoring and obstructive sleep apnea in Thai school-age children. Pediatr Pulmonol 2005; 39(5): 415–420. 37. Corbo GM, Fuciarelli F, Foresi A, et al. Snoring in children: association with respiratory symptoms and passive smoking.[erratum appears in BMJ 1990 Jan 27; 300(6719):226]. BMJ 1989; 299(6714):1491–1494. 38. Marcus CL, Curtis S, Koerner CB, et al. Evaluation of pulmonary function and polysomnography in obese children and adolescents. Pediatr Pulmonol 1996; 21(3): 176–183. 39. Rosen CL, Larkin EK, Kirchner HL, et al. Prevalence and risk factors for sleep-disordered breathing in eightto 11-year-old children: association with race and prematurity. J Pediatr 2003; 142(4):383–389. 40. Guilleminault C, Palombini L, Pelayo R, et al. Sleepwalking and sleep terrors in prepubertal children: what triggers them? Pediatrics 2003; 111(1):e17–25. 41. Goodwin JL, Kaemingk KL, Fregosi RF, et al. Parasomnias and sleep disordered breathing in Caucasian and Hispanic children—the Tucson children’s assessment of sleep apnea study. BMC Med 2004; 2(1):14. 42. Guilleminault C, Eldridge FL, Simmons FB, et al. Sleep apnea in eight children. Pediatrics 1976; 58(1):23–30. 43. Brouillette RT, Fernbach SK, Hunt CE. Obstructive sleep apnea in infants and children. J Pediatr 1982; 100(1):31–40. 44. Beebe DW, Wells CT, Jeffries J, et al. Neuropsychological effects of pediatric obstructive sleep apnea. J Int Neuropsychol Soc 2004; 10(7):962–975. 45. O’Brien LM, Mervis CB, Holbrook CR, et al. Neurobehavioral implications of habitual snoring in children. Pediatrics 2004; 114(1):44–49.
Ontogeny
55
46. Kennedy JD, Blunden S, Hirte C, et al. Reduced neurocognition in children who snore. Pediatr Pulmonol 2004; 37(4):330–337. 47. Marcus CL. Sleep-disordered breathing in children.Am J Respir Crit Care Med 2001; 164(1):16–30. 48. Kawashima S, Peltomaki T, Sakata H, et al. Craniofacial morphology in preschool children with sleep-related breathing disorder and hypertrophy of tonsils. Acta Pediatr 2002; 91(1):71–77. 49. Shintani T, Asakura K, Kataura A. Evaluation of the role of adenotonsillar hypertrophy and facial morphology in children with obstructive sleep apnea ORL J Otorhinolaryngol Relat Spec 1997; 59(5):286–291. 50. Shintani T, Asakura K, Kataura A. Adenotonsillar hypertrophy and skeletal morphology of children with obstructive sleep apnea syndrome. Acta Otolaryngol Suppl (Stockh) 1996; 523:222–224. 51. Ng DK, Lam YY, Kwok KL, et al. Obstructive sleep apnoea syndrome and obesity in children. Hong Kong Med J 2004; 10(1):44–48. 52. Wing YK, Hui SH, Pak WM, et al. A controlled study of sleep related disordered breathing in obese children. Arch Dis Child 2003; 88(12):1043–1047. 53. Mallory GB Jr., Fiser DH, Jackson R. Sleep-associated breathing disorders in morbidly obese children and adolescents. J Pediatr 1989; 115(6):892–897. 54. Marcus CL, Greene MG, Carroll JL. Blood pressure in children with obstructive sleep apnea. Am J Respir Crit Care Med 1998; 157(4 Pt 1):1098–1103. 55. Serratto M, Harris VJ, Carr I. Upper airways obstruction. Presentation with systemic hypertension. Arch Dis Child 1981; 56(2):153–155. 56. Wilkinson AR, McCormick MS, Freeland AP, et al. Electrocardiographic signs of pulmonary hypertension in children who snore. Br Med J (Clin Res Ed) 1981; 282(6276): 1579–1581. 57. Tal A, Leiberman A, Margulis G, et al. Ventricular dysfunction in children with obstructive sleep apnea: radionuclide assessment. Pediatr Pulmonol 1988; 4(3):139–143. 58. Hunt CE, Brouillette RT. Abnormalities of breathing control and airway maintenance in infants and children as a cause of cor pulmonale. Pediatr Cardiol 1982; 3(3): 249–256. 59. Brown OE, Manning SC, Ridenour B. Cor pulmonale secondary to tonsillar and adenoidal hypertrophy: management considerations. Int J Pediatr Otorhinolaryngol 1988; 16(2):131–139. 60. Cox MA, Schiebler GL, Taylor WJ, et al. Reversible pulmonary hypertension in a child with respiratory obstruction and cor pulmonale. J Pediatr 1965; 67(2):192. 61. Reuveni H, Simon T, Tal A, et al. Health care services utilization in children with obstructive sleep apnea syndrome. Pediatrics 2002; 110(1 Pt 1):68–72. 62. Tarasiuk A, Simon T, Tal A, et al. Adenotonsillectomy in children with obstructive sleep apnea syndrome reduces health care utilization. Pediatrics 2004; 113(2):351–356. 63. Hoban TF, Chervin RD. Assessment of sleepiness in children. Semin Pediatr Neurol 2001; 8(4):216–228. 64. Carskadon MA, Dement W. Sleepiness in the normal adolescent. In: Guilleminault C, ed. Sleep and Its Disorders in Children. New York: Raven Press, 1987:53–66. 65. Carskadon MA. The second decade. In: Guilleminault C, ed. Sleeping and Waking Disorders: Indications and Techniques. Menlo Park: Addison Wesley, 1982:99–125. 66. Guilleminault C, Partinen M, Praud JP, et al. Morphmetric facial changes and obstructive sleep apnea in adolescents. J Pediatr 1989; 114:997–999. 67. Tasker C, Crosby JH, Stradling JR. Evidence for persistence of upper airway narrowing during sleep, 12 years after adenotonsillectomy. Arch Dis Child. 2002; 86(1): 34–37. 68. Hajduk IA, Strollo PJ Jr, Jasani RR, et al. Prevalence and predictors of nocturia in obstructive sleep apnea-hypopnea syndrome–a retrospective study. Sleep 2003; 26(1): 61–64. 69. Guilleminault C. Obstructive sleep apnea syndrome. A review. Psychiatr Clin North Am 1987; 10(4):607–621. 70. Kaynak H, Kaynak D, Oztura I. Does frequency of nocturnal urination reflect the severity of sleep-disordered breathing? J Sleep Res 2004; 13(2):173–176.
56
Hoban and Bliwise
71. Quintana-Gallego E, Carmona-Bernal C, Capote F, et al. Gender differences in obstructive sleep apnea syndrome: a clinical study of 1166 patients. Respir Med 2004; 98(10):984–989. 72. Shepertycky MR, Banno K, Kryger MH. Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. Sleep 2005; 28(3):309–314. 73. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328(17):1230–1235. 74. Gottlieb DJ, Whitney CW, Bonekat WH, et al. Relation of sleepiness to respiratory disturbance index. The sleep heart health study. Am J Respir Crit Care Med 1999; 159(2):502–507. 75. Kim HC, Young T, Matthews CG, et al. Sleep-disordered Breathing and Neuropsychological Deficits. A Population-based Study. Am J Respir Crit Care Med 1997; 156(6): 1813–1819. 76. Fulda S, Schulz H. Cognitive dysfunction in sleep disorders. Sleep Med Rev 2001; 5(6):423. 77. Redline S, Strauss ME, Adams N, et al. Neuropsychological function in mild sleepdisordered breathing. Sleep 1997; 20(2):160–167. 78. Young T, Blustein J, Finn L, et al. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep 1997; 20(8):608–613. 79. Masa JF, Rubio M, Findley LJ. Habitually sleepy drivers have a high frequency of automobile crashes associated with respiratory disorders during sleep. Am J Respir Crit Care Med 2000; 162(4 Pt 1):1407–1412. 80. Ulfberg J, Carter N, Edling C. Sleep-disordered breathing and occupational accidents. Scand J Work Environ Health 2000; 26(3):237–242. 81. Hoekema A, Hovinga B, Stegenga B, et al. Craniofacial morphology and obstructive sleep apnoea: a cephalometric analysis. J Oral Rehabil 2003; 30(7):690–696. 82. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 2004; 291(16):2013–2016. 83. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study [erratum appears in JAMA 2002 Oct 23-30; 288(16):1985]. JAMA 2000; 283(14):1829–1836. 84. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001; 163(3 Pt 1):608–613. 85. Bixler EO, Vgontzas AN, Ten Have T, et al. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998; 157(1):144–148. 86. Ancoli-Israel S, Kripke DF, Klauber MR, et al. Sleep-disordered breathing in community-dwelling elderly. Sleep 1991; 14:486–495. 87. Ancoli-Israel S, Kripke DF. Prevalent sleep problems in the aged. Biofeedback Self Regul 1991; 16:349–359. 88. Bliwise DL. Sleep in normal aging and dementia. Sleep 1993; 16:40–81. 89. Bliwise DL. Chronological age, physiologic age, and mortality in sleep apnea. Sleep 1996(19):275–276. 90. Brody JA, Schneider EL. Diseases and disorders of aging: An hypothesis. J Chronic Dis 1986; 39:871–876. 91. Ancoli-Israel S, Coy T. Are breathing disturbances in elderly equivalent to sleep apnea syndrome? Sleep 1994; 17:77–83. 92. Davies RJ, Ali NJ, Stradling JR. Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. Thorax 1992; 47(2):101–105. 93. Newman AB, Nieto FJ, Guidry U, et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 2001; 154(1):50–59. 94. Olson LG, King MT, Hensley MJ, et al. A community study of snoring and sleepdisordered breathing. Prevalence. Am J Respir Crit Care Med 1995; 152(2):711–716. 95. Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000; 284(23):3015–3021. 96. Miles PG, Vig PS, Weyant RJ, et al. Craniofacial structure and obstructive sleep apnea syndrome—a qualitative analysis and meta-analysis of the literature. Am J Orthod Dentofacial Orthop 1996; 109(2):163–172.
Ontogeny
57
97. Rivlin J, Hoffstein V, Kalbfleisch J, et al. Upper airway morphology in patients with idiopathic obstructive sleep apnea. Am Rev Respir Dis 1984; 129(3):355–360. 98. deBerry-Borowiecki B, Kukwa A, Blanks RH. Cephalometric analysis for diagnosis and treatment of obstructive sleep apnea. Laryngoscope 1988; 98(2):226–234. 99. Schwab RJ, Pasirstein M, Pierson R, et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med 2003; 168(5):522–530. 100. Ciscar MA, Juan G, Martinez V, et al. Magnetic resonance imaging of the pharynx in OSA patients and healthy subjects. Eur Respir J 2001; 17(1):79–86. 101. Do KL, Ferreyra H, Healy JF, et al. Does tongue size differ between patients with and without sleep-disordered breathing? Laryngoscope 2000; 110(9):1552–1555. 102. Hamans EP, Van Marck EA, De Backer WA, et al. Morphometric analysis of the uvula in patients with sleep-related breathing disorders. Eur Arch Otorhinolaryngol 2000; 257(4):232–236. 103. Sekosan M, Zakkar M, Wenig BL, et al. Inflammation in the uvula mucosa of patients with obstructive sleep apnea. Laryngoscope 1996; 106(8):1018–1020. 104. Pien GW, Schwab RJ. Sleep disorders during pregnancy. Sleep 2004; 27(7):1405–1417. 105. Holdcroft A, Bevan DR, O’Sullivan JC, et al. Airway closure and pregnancy. Anaesthesia 1977; 32(6):517–523. 106. Franklin KA, Holmgren PA, Jonsson F, et al. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest 2000; 117(1):137–141. 107. Loube DI, Poceta JS, Morales MC, et al. Self-reported snoring in pregnancy. Association with fetal outcome. Chest 1996; 109(4):885–889. 108. Guilleminault C, Querra-Salva M-A, Chowdhuri S, et al. Normal pregnancy, daytime sleeping, snoring and blood pressure. Sleep Med 2000; 1(4):289. 109. Maasilta P, Bachour A, Teramo K, et al. Sleep-related disordered breathing during pregnancy in obese women. Chest 2001; 120(5):1448–1454. 110. Kowall J, Clark G, Nino-Murcia G, et al. Precipitation of obstructive sleep apnea during pregnancy. Obstet Gynecol 1989; 74(3):453–455. 111. Hastie SJ, Prowse K, Perks WH, et al. Obstructive sleep apnoea during pregnancy requiring tracheostomy. Aust N Z J Obstet Gynaecol 1989; 29(3 Pt 2):365–367. 112. Shahar E, Redline S, Young T, et al. Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med 2003; 167(9):1186–1192. 113. Resta O, Pannacciulli N, Di Gioia G, et al. High prevalence of previously unknown subclinical hypothyroidism in obese patients referred to a sleep clinic for sleep disordered breathing. Nutr Metab Cardiovasc Dis 2004; 14(5):248–253. 114. Miller CM, Husain AM. Should women with obstructive sleep apnea syndrome be screened for hypothyroidism? Sleep Breath 2003; 7(4):185–188. 115. Tsutsumi W, Miyazaki S, Itasaka Y, et al. Influence of alcohol on respiratory disturbance during sleep. Psychiatry Clin Neurosci 2000; 54(3):332–333. 116. Scanlan MF, Roebuck T, Little PJ, et al. Effect of moderate alcohol upon obstructive sleep apnoea. Eur Respir J 2000; 16(5):909–913. 117. Jennum P, SjØL A. Snoring, sleep apnoea and cardiovascular risk factors: The MONICA II Study. Int J Epidemiol 1993; 22(3):439–444. 118. Wetter DW, Young TB, Bidwell TR, et al. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med 1994; 154(19):2219–2224. 119. Kronenberg RS, Drage CW. Attenuation of the ventilatory and heart rate responses to hypoxia with aging in normal men. J Clin Invest 1973; 52:1812–1819. 120. Douglas NJ, White DP, Weil JV, et al. Hypercapnic ventilatory response in sleeping adults. Am Rev Respir Dis 1982; 126:758–762. 121. Longobardo GS, Gothe B, Goldman MD, et al. Sleep apnea considered as a control system instability. Respir Physiol 1982; 50:311–333. 122. Onal E, Burrows DL, Hart RH, et al. Induction of periodic breathing during sleep causes upper airway obstruction in humans. J Appl Physiol 1986; 61:1438–1443. 123. Naifeh KH, Severinghaus JW, Kamiya J, et al. Effect of aging on estimates of hypercapnic ventilatory response during sleep. J Appl Physiol 1989; 66:1956–1964. 124. Browne HAK, Adams L, Simonds AK, et al. Aging does not influence the sleep-related decrease in the hypercapnic ventilatory response. Eur Resp J 2003; 21:523–529.
58
Hoban and Bliwise
125. Krieger J, Sforza E, Boudewijns J, et al. Respiratory effort during obstructive sleep apnea: role of age and sleep state. Chest 1997; 112:875–884. 126. Redline S, Krichner HL, Quan SF, et al. The effects of age, sex, ethnicity, and sleepdisordered breathing on sleep architecture. Arch Intern Med 2004; 150:481–485. 127. Pack AI, Silage DA, Millman RP, et al. Spectral analysis of ventilation in elderly subjects awake and asleep. J Appl Physiol 1988; 64:1257–1267. 128. Pack AI, Cola mf, Goldszmidt A, et al. Correlation between oscillation in ventilation and frequency content of the electroencephalogram. J Appl Physiol 1992; 72:985–992. 129. Dempsey JA, Smith CA, Harms CA, et al. Sleep-induced breathing instability. Sleep 1996; 19:236–247. 130. Krieger J, Turlot J-C, Mangin P, et al. Breathing during sleep in normal young and elderly subjects: hypopneas, apneas, and correlated factors. Sleep 1983; 6:108–120. 131. Shore ET, Millman RP, Silage DA, et al. Ventilatory and arousal patterns during sleep in normal and elderly subjects. J Appl Physiol 1985; 59:1607–1615. 132. Naifeh KH, Severinghaus JW, Kamiya J. Effect of aging on sleep-related changes in respiratory variables. Sleep 1987; 10:160–171. 133. Hudgel DW, Devadatta P, Hamilton H. Pattern of breathing and upper airway mechanics during wakefulness and sleep in healthy elderly humans. J Appl Physiol 1993; 74:2198–2204. 134. Browne HAK, Adams L, Simonds AK, et al. Impact of age on breathing and resistive pressure in people with and without sleep apnea. J Appl Physiol 2001; 90:1074–1082. 135. White DP, Lombard RM, Cadieux RJ, et al. Pharyngeal resistance in normal humans: influence of gender, age, and obesity. J Appl Physiol 1985; 58:365–371. 136. McGinty D, Littner M, Beahm E, et al. Sleep related breathing disorders in older men: a search for underlying mechanisms. Neurobiol Aging 1982; 3:337–350. 137. Brown IG, Zamel N, Hoffstein V. Pharyngeal cross-sectional area in normal men and women. J Appl Physiol 1986; 61:890–895. 138. Martin SE, Marthur R, Marshall I, et al. The effect of age, sex, obesity, and posture on upper airway size. Eur Resp J 1997; 10:2087–2090. 139. Thurnheer R, Wraith PK, Douglas NJ. Influence of age and gender on upper airway resistance in NREM and REM sleep. J Appl Physiol 2001; 90(3):981–988. 140. Series F, Roy N, Marc I. Effects of sleep deprivation and sleep fragmentation on upper airway collapsibility in normal subjects. Am J Respir Crit Care Med 1994; 150:481–485. 141. Crow HC, Ship JA. Tongue strength and endurance in different aged individuals. J Gerentol: Med Sci 1996; 51A:M247–M250. 142. Mortimore IL, Fiddes P, Stephens S, et al. Tongue protrusion force and fatiguability in males and female subjects. Eur Resp J 1999; 14:191–195. 143. Mortimore IL, Bennett SP, Douglas NJ. Tongue protrusion strength and fatiguability: relationship to apnoea/hypopnoea index and age. J Sleep Res 2000; 9:389–393. 144. Suratt PM, McTier RF, Wilhoit WC. Upper airway muscle activation is augmented in patients with obstructive sleep apnea compared with that in normal subjects. Am Rev Resp Dis 1988; 137:889–894. 145. Fogel RB, Malhotra A, Pillar G, et al. Genioglossal activation in patients with obstructive sleep apnea versus control subjects. Mechanisms of muscle control. Am J Respir Crit Care Med 2001; 164(11):2025–2030. 146. Fogel RB, Trinder J, White DP, et al. The effect of sleep onset on upper airway muscle activity in patients with sleep apneoa versus controls. J Physiol 2005; 564:549–562. 147. Worsnop C, Kay A, Kim Y, et al. Effect of age on sleep onset-related changes in respiratory pump and upper airway muscle function. J Appl Physiol 2000; 88(5):1831–1839. 148. Fogel RB, White DP, Pierce RJ, et al. Control of upper airway muscle activity in younger versus older men during sleep onset. J Physiol (Lond) 2003; 553(Pt 2):533–544. 149. Malhotra A, Huang Y, Fogel R, et al. Aging influences on pharyngeal anatomy and physiology: the predisposition to pharyngeal collapse. Am J Med 2006; 119(1): 72.e9–72.e14. 150. Van Lunteren E, Vafaie H, Salomone RJ. Comparative effects of aging on pharyngeal and diaphragm muscles. Respir Physiol 1999; 99:113–125. 151. Cantillon D, Bradford A. Effects of age and gender on rat upper airway muscle contractile properties. J Gerontol A Biol Sci Med Sci 2000; 55:B396–400.
Ontogeny
59
152. Oliven A, Carmi N, Coleman R, et al. Age-related changes in upper airway muscles: morphological and oxidative properties. Exp Gerontol 2001; 36:1673–1686. 153. Guilleminault C, Li K, Chen NH, et al. Two-point palatal discrimination in patients with upper airway resistance syndrome, obstructive sleep apnea syndrome, and normal control subjects. Chest 2002; 122(3):866–870. 154. Larsson H, Carlsson-Nordlander B, Lindblad LE, et al. Temperature thresholds in the oropharynx of patients with obstructive sleep apnea syndrome. Am Rev Resp Dis 1992; 146:1246–1249. 155. Calhoun KH, Gibson B, Hartley L, et al. Age-related changes in oral sensation. Laryngoscope 1992; 102:109–116. 156. Aviv JE. Effects of aging on sensitivity of the pharyngeal and supraglottic areas. Am J Med 1997; 103:74S–76S. 157. Ware JC, McBrayer RH, Scott JA. Influence of sex and age on duration and frequency of sleep apnea events. Sleep 2000; 23(2):165–170. 158. Okabe S, Hida W, Kikuchi Y, et al. Role of hypoxia on increased blood pressure in patients with obstructive sleep apnoea. Thorax 1995; 50(1):28–34. 159. Morgan BJ, Dempsey JA, Pegelow DF, et al. Blood pressure perturbations caused by subclinical sleep-disordered breathing. Sleep 1998; 21(7):737–746. 160. Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleepdisordered breathing. Arch Intern Med 2000; 160(15):2289–2295. 161. Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997; 157(15):1746–1752. 162. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleepdisordered breathing and hypertension.[see comment]. N Engl J Med 2000; 342(19): 1378–1384. 163. Grimm W, Hoffmann J, Menz V, et al. Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea. Am J Cardiol 1996; 77(15):1310–1314. 164. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001; 163(1):19–25. 165. Sanner BM, Doberauer C, Konermann M, et al. Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med 1997; 157(21):2483–2487. 166. Wolk R, Somers VK. Cardiovascular consequences of obstructive sleep apnea. Clin Chest Med 2003; 24(2):195–205. 167. He J, Kryger MH, Zorick FJ, et al. Mortality and apnea index in obstructive sleep apnea: experience in 385 male patients. Chest 1988; 94:9–14. 168. Lavie P, Herer P, Peled R, et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995; 18:149–157. 169. Peker Y, Hedner J, Kraiczi H, et al. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000; 162(1):81–86. 170. Haas DC, Foster GL, Nieto FJ, et al. Age-dependent associations between sleepdisordered breathing and hypertension. Circulation 2005; 111:614–621. 171. Nieto FJ, Herrington DM, Redline S, et al. Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 2004; 169:354–360. 172. Gottlieb DJ, DeStefano AL, Foley DJ, et al. APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study. Neurology 2004; 63(4):664–668. 173. Tishler PV, Larkin EK, Schluchter MD, et al. Incidence of sleep-disordered breathing in an urban adult population. JAMA 2003; 289:2230–2237. 174. Bliwise DL, Bliwise NG, Partinen M, et al. Sleep apnea and mortality in an aged cohort. Am J Public Health 1988; 78:544–547. 175. Ancoli-Israel S, Kripke DF, Klauber MR, et al. Morbidity, mortality, and sleep-disordered breathing in community dwelling elderly. Sleep 1996; 19:277–282. 176. Ancoli-Israel S, Klauber MR, Kripke DF, et al. Sleep apnea in female nursing home patients: increased risk of mortality. Chest 1989; 96:1054–1058.
5
Phylogeny and Animal Models: An Uninhibited Survey Todd D. Morgan Scripps Memorial Hospital, Encinitas, California, U.S.A.
John E. Remmers Respiratory Reasearch Group, University of Calgary, Calgary, Alberta, Canada
INTRODUCTION This chapter examines human obstructive sleep apnea (OSA) in relation to air breathing in vertebrates. It begins by examining the origins of air breathing and showing that the neuromuscular factors that were responsible for air breathing in the earliest terrestrial vertebrates play a key role in modern sleep-disordered breathing in man. The chapter considers the evolution of the pharynx in prehuman species, documenting trends in the structure of the facial framework and pharyngeal dimensions. We show that these trends in hominids underlie human speech but predispose Homo sapiens to sleep apnea. Finally, we review animal models of obstructive sleep apnea to discover why it is a uniquely human disorder. We label our survey uninhibited to emphasize its diversity of informational sources and to acknowledge the speculative nature of our discussion. Our lack of inhibition reflects our exuberance for the topic, which we hope is shared by the reader. TERRESTRIALITY AND EVOLUTION OF THE PHARYNX Evolution underwent a major transition 400 million years ago when animal life moved from the sea onto land. For animals, this allowed access to a new, oxygenrich convective media for ventilation of gas-exchange organs. The key and most fundamental aspect of this transition was the development of a lung and the means for ventilating it. Fish meet their aerobic demands by ventilating gills with water, a dense, viscous media with a limited capacity for carrying oxygen. The early terrestrial air breathers (Dipnoi) ventilated a lung, which was homologous with the highly partitioned mammalian lung (1). However, they used an oropharyngeal force pump to inflate their lung. This differed dramatically from the pumping mechanism, which was subsequently evolved in Amniota (Fig. 1). The lung fish, the modern descendant of one of the earliest air breathers, inflates the lung by first aspirating air into the oropharynx, then opening the pharynx and compressing the oropharyngeal gas, thereby inflating the lungs (2). The modern amphibia employs the same force pump mechanism (Fig. 2). Thus, from its inception, the oropharynx plays a fundamental role in ventilating the lungs by providing the neuromuscular mechanism used for lung inflation (3). Thus, respiratory oscillators of the early tetrapods generated outputs that projected to cranial motoneurons, including hypoglossal motoneurons, and over from the hypoglossal nerve to oropharyngeal muscles (Fig. 2). Of great interest is that in mammals these same neural pathways convey rhythmic inspiratory activity to pharyngeal dilator muscles and ultimately play a key role in stabilizing the pharynx of humans during sleep. 61
62
Morgan and Remmers
FIGURE 1 A cladogram depicting the phylogenetics of air breathing. Actinopterygii used a four-stroke mechanism to ventilate a lung that was probably not homologous with the modern lung. Dipnoi and Amphibia used a two-stroke force pump mechanism to ventilate a lung that was homologous with the modern lung. Source: From Ref. 3.
Development of an aspiration mechanism of lung inflation appeared in reptiles and was further perfected with the appearance of the diaphragm in the mammal (4). The development of the thorax allows inspiratory pump muscles to generate subatmospheric pressures that act directly on the surface of the lung. With the appearance of this method for inflating the lungs, the oropharynx was no longer used for gas pumping, and the single oropharynx of the amphibian (Fig. 3, left) was subdivided into three cavities, the nasal cavity, the oral cavity, and the pharynx in reptiles (Fig. 3, right) and in mammals (Fig. 4). In reptiles, a rudimentary soft palate separates the nasal cavity from the pharynx (Fig. 3, right). In mammals, the soft palate is well developed and partitions the pharynx from the oral cavity or nasal cavity (Fig. 4). As we shall see, the inspiratory activation of pharyngeal dilators was maintained; rather than assisting with lung inflation by creating a positive intrapharyngeal pressure, the actions of these muscles serve to prevent collapse of the nares and pharynx by subatmospheric pressures in the nose and pharynx during aspirative inspiration. What happened to the respiratory rhythmogenic process during the evolution of air breathing? Did the evolution of a vastly different ventilatory act, aspiration, require a new neural mechanism for generating tidal breathing? The answers to these questions hold interest for not only the neurobiologist. They also lend insight into motor control of the pharyngeal dilator muscles, and ultimately, to the genesis of obstructive sleep apnea. A paired, coupled oscillator drives breathing in the frog and comprises a buccal oscillator and a lung oscillator (2). The rhythmogenic mechanisms and timing of respiratory events in mammals bear a striking resemblance to those found in amphibia. As in the amphibian, paired, coupled, oscillators make up the fundamental rhythmogenic mechanism driving breathing. Too, a preinspiratory (pre-I) oscillator displays a burst of activity prior to mechanical inspiration, and it triggers activity in a second or inspiratory oscillator, the pre-Bötzinger (pre-Böt) oscillator, which activates inspiratory pump muscles (5).
Phylogeny and Animal Models: An Uninhibited Survey
63
FIGURE 2 Breathing in a frog. (A) Normal buccal breathing (left) and lung breathing (right). The former consists of tidal ventilation of the oropharynx and the latter consists of a large buccal dilation, opening of the larynx and compression of the oropharyngeal gas, forcing it into the lungs. (B) Efferent neurograms from cranial nerve (CN) V and from the hypoglossal (H) nerve illustrate buccal dilation (Bd) and buccal constriction (Bc), followed by a series of lung (L) inflations. Source: From Ref. 3.
FIGURE 3 Drawings of the nose and oropharynx. (A) The common oropharynx and rudimentary nasal cavity of the amphibian (frog). (B) A partitioning of the nose from the mouth by a hard palate in the reptile (alligator). Abbreviations: E, esophagus; H, hard palate; L, larynx; N, nose; O, oral cavity; P, pharynx; T, tongue; TR, trachea. Source: From Ref. 6.
64
Morgan and Remmers
FIGURE 4 Drawings of the upper airway configuration in mammals. (A) The linear airway of the dog. (B) The partially angulated airway of the ape with the mouth set more dorsally than in nonprimates. (C) Human infant with retroplaced mouth. (D) Human adult with severely angulated airway and retroplaced tongue. Note: The velo-epiglottal overlap is present in all except for the adult human. Source: Visible Productions, 2001.
The pre-I burst appears to activate pharyngeal dilators, particularly the genioglossus, which is innervated by the hypoglossal nerve. The mechanical action of the muscles innervated by the main branch of the hypoglossal nerve has changed during evolution. The hyoid and larynx migrate caudally and the supraglottic airway becomes angulated during evolution of mammals. Another important development that appeared with evolution of the mammalian pharynx was the appearance of the epiglottis. Unlike other pharyngeal cartilages (e.g., larynx and hyoid) the epiglottis was not derived from the original branchial arch skeletal tissue. The epiglottis is thought to play a role in infant suckling, as nonsuckling, egg-laying mammals (duck-billed platypus and anteater) lack this structure (6). During suckling the epiglottis covers most of the ventral wall of the oropharynx and extends upward above the free margin of the soft palate. This means that milk can flow from the oral cavity around the lateral margins of the epiglottis and into the esophagus without contacting the larynx (Fig. 4), thereby allowing simultaneous breathing and swallowing. In other words, air can pass from the nose into the larynx while milk is flowing from the oral cavity into the esophagus. Various authors have speculated that a mechanical linkage exists between the soft palate and the epiglottis. The evidence for this so-called “locking” of the two structures is highly inferential,
Phylogeny and Animal Models: An Uninhibited Survey
65
however. Nonetheless the overlap of the soft palate and epiglottis is a unique feature of the pharynx in all suckling mammals except for the human where it is present at birth but lost in childhood. In summary, the first major advance in the evolution of air breathing was the development of the modern lung, and the second was the development of the thorax and the muscles for ventilating it using aspiration. Mammals and reptiles developed a compartmentalized cavity: the nose, which allowed olfaction and conditioning of the inspirate, the mouth for mastication, and the pharynx for both airflow and alimentation. As well, the pharynx took on the role in sound communication by modulating sound generated in the larynx. The fundamental role of the larynx, protector of the pulmonary airway, remained unchanged in all terrestrial air breathers. EVOLUTIONARY PRESSURES INFLUENCE THE PHARYNX Walking, Talking, and Breathing: What Is the Problem? The advance of hominids through intellectual development, walking, and speech are paramount to the success of Homo sapiens. In this evolution, three factors have major implications for the upper airway and for breathing during sleep. These are: development of the brain, upright posture, and oral articulation. The location and function of the aero-digestive tract in our closest ancestors is well described within skeletal remains. By considering cranial base angles, the size and attachments of the hyoid, and the landmarks from which the larynx suspends, soft tissue models can be created that predict the acquisition of speech. In this section, we consider the possibility that an anatomic model for speech in prehistoric species provides insights for understanding of OSA as a uniquely human disease. Phylogeny reveals an elegant evolution of pharynx and its added complexity of function that mirrors brain growth and development of the human intellect. For articulate speech, we need a pharynx that has the length and flexibility necessary for sound modulation as well as the neural network necessary to respond to the brain’s instructions. The vocal-tract anatomy related to speech and the origin of language is quite distinct issues; one relates to mechanical function, while the other involves reorganization of the brain. Great apes, for example, are capable of symbolic thought, but do not have the neuro-mechanical features required for articulation and speech (7). The neural origins of speech appear to arise from a region within the inferior frontal gyrus, termed “Broca’s area.” Broca’s area may be home to mirror neurons that enable mimicking behavior and may also have undetected synaptic influence over the higher functions of pharynx involving the interplay of symbolic thought, syntax, and cortical interpretation (Fig. 5 displays one version of early human phylogeny). Homo erectus, a possible human ancestor alive two million years ago, had the expanded Broca’s area required for symbolic thought, as do all Homo genus lines. However, the anatomical fossil record fails to indicate that this species was capable of language. Hominids as far back as Homo heidelbergsis (600,000 years) ago displayed enough cranial base flexion and presumptive laryngeal length to have a potential for speech and, perhaps, OSA as well. However, no cultural evidence in the fossil record supports the acquisition of speech until 40,000 years ago, around the time when Cro Magnon (CM) displaced Neandertals in the Levant (8). In hindsight, CM brought with him the ultimate trump card: the aptitude and ability to finally fulfill the role of the pharynx in the communicative expression of associated thoughts that would enhance creativity and survival. In other words, the
66
Morgan and Remmers
FIGURE 5 (See color insert.) A proposed phylogenetic tree for hominids. A. Afarensis (reconstruction at right) is but one of many Australopithecine species known to science. Researchers disagree about exactly how these species are related to one another, but most presume that A. afarensis was a precursor to our own genus. Source: From Ref. 26.
potential for speech appears to have long existed in hominids but the actual use of language occurred relatively recently. For Homo sapiens, language became an ineluctable advantage over other species. Perhaps the length and collapsibility of the pharynx required for speech constituted a powerful countervailing disadvantage that limited the appearance of language until the ascendance of CM. Cleverness was the ultimate Homo sapiens survival strategy, and this development was intrinsically related to the development of speech and language. However, the development of language and speech as driving forces in evolution has apparently outpaced the development of compensatory reflexes or anatomic safeguards for the pharynx during sleep. While reflexes generated from pharyngeal mechanoreceptors effectively guard the patency of the pharynx driving wakefulness, these reflexes are lost or greatly suppressed during sleep (9). Thus, without a more linear airway, reinforced ventral pharynx, and the ligamentous “strutting effect” of the hyoid afforded to other vertebrates, hominids were left vulnerable to the night. As shown in Figure 4, we speculate that three features of the pharynx in Homo sapiens allowed this characteristic function of walking and talking, but severely limited the ability to breathe during sleep. These are: severely angulated airflow path (upright posture), lack of velo-epiglottal overlap (pharyngeal length) and loss of hyoidal strutting (pharyngeal compliance). Changes in the Craniofacial Relationships Comparison of the chimpanzee and man reveals striking differences in the ratio of the horizontal oral length and the vertical pharyngeal height (Fig. 6). As well, the relationship between the cranial vault and the facial framework differs strikingly among nonhuman primates, hominids and Homo sapiens (Fig. 7). The facial bones can be seen to move dorsally as one compares the great apes, Australopithecus, H. sapiens, H. neanderthalensis, and modern man. In essence, the facial structures (nasal, oral, and pharyngeal cavities) rotate dorsally in relation to the skull so that in
Phylogeny and Animal Models: An Uninhibited Survey
67
FIGURE 6 Comparison of oral/pharyngeal dimensions in the chimpanzee and man from sagittal drawings. Note that in relation to the horizontal pharynx to incisor, the vertical laryngeal to oropharyngeal distance is much greater in modern man (left) than in the Neandertal (right) or chimpanzee (center). Source: Visible Productions, 2001.
Homo sapiens, they become positioned under the temporal and frontal bones rather than ventral to them (Fig. 7). This change can be quantitated as a decrease in the midsagittal angle between the line connecting the auditory meatus to the supraorbital torus and a facial skeleton strut connecting the supraorbital torus to the postorbital bar (values presented in Fig. 7). This rearrangement of the craniofacial relationship can also be assessed by the cranial base angle (CBA), the angle between precordal and postcordal planes. This is measured as the angle between a line connecting the centre of the sella turcica to the basion and the line from the centre of the sella turcica to the foramen cecum (Fig. 8, left). A decrease in the CBA is referred to as “flexing” of the cranial base. Leiberman and McCarthy (12) measured the CBA in mature Pan troglodytes and Homo sapiens to be 156° and 134°, respectively. This indicates flexion of the cranial base in humans compared to nonhuman primates, allowing less space for the facial framework. Also of interest are the CBA changes with development in these two species as shown in Figure 8 (right), the CBA decreases with age in Homo sapiens and increases in Pan troglodytes. During development the relative positioning of the cranium and the facial structures change in opposite directions in the two species, that is, during development in the human the cranial base flexes and in the nonhuman primate it extends.
FIGURE 7 Drawings of the skull and facial bones of the gorilla (G), Australopithecus africanus (A), H. neanderthalensis (N), and Homo sapiens (H). The values indicating the angle from the base of the skull to the anterior facial bones decrease progressively with evolution of the human craniofacial structure documenting the downward and backward rotation of the facial framework. Source: From Ref. 23.
68
Morgan and Remmers
FIGURE 8 The measurement of the cranial base angle (CBA) in man is shown in the left panel. The right panel shows the CBA during development for the chimpanzee P. troglodytes (open symbols) and man H. sapiens (closed symbols). Note that the CBA is longer in the young chimpanzee than the human and that, during development, the two diverge. Source: From Ref. 27.
Changes in the Maxilla “Descent of larynx is attributable to upright posture in man” (10). Upright posture matched a coordinated and (relatively) rapid rotation of growing forebrain upon a retreating facial framework, while the nasal airway became diminished in size and function. Flexion of CBA required compression of the maxilla, both in volume and surface area, effectively reducing paranasal sinus size and olfaction acuity. The net effect of this change in maxilla creates the flatter and longer face that differentiates human appearance from primates. Further, this decrease in nose volume may increase in “upstream” resistance to airflow and further aggravate the potential for collapse in a newly acquired oropharynx. Later hominids were no longer obligate nose breathers and upon exertion they would transition to oral breathing. Potentially, this may have contributed to changes in mandibular posture, downward migration of tongue base and further descent of the hyoid. Increases in time spent mouth breathing implies a reduction in time spent with teeth in contact, negating the tongue’s postural influence upon the palate (Fig. 9). The upshot: a diminished potential for horizontal growth of the maxilla, narrowing of the palate and increasing facial height (Figs. 10 and 11). The most robust cephalometric predictors of OSA are related to this backward rotation of maxilla and mandible (11). Akin to this, Kushida described a morphometric formula for predicting OSA based on the constriction of horizontal growth, relating to the palatal distance between the first molars (12). Oropharyngeal Compression Evidence for a more recent continuing trend in facial height elongation is demonstrated, when we compare maxillae in prehistoric and modern skulls (Fig. 12). Note the considerable narrowing of the maxillary arch and posterior nasal
Phylogeny and Animal Models: An Uninhibited Survey
69
FIGURE 9 (See color insert.) Closed mouth posture: the relationship of tongue, teeth, and buccinator muscles is shown in the coronal depiction of the mouth of modern humans; the tongue assumes a resting posture in proximity to the palate. The teeth are interposed between the tongue and buccinators, thereby allowing growth of the arch in relation to the relative dilating (genioglossus) and compressive (buccinator) forces, creating a “balance of forces.” Source: Courtesy of B. Palmer, DDS.
aperture in modern specimens. Like other mammals that display only minute differences in occlusion within species, this prehistoric specimen displays a broad palatal arch with room for 32 aligned teeth. Constriction of maxillary horizontal growth and the modern “V” shaped dental arch may account for our modern struggle with malocclusion, dental caries and a constricted oropharyngeal inlet (Fig. 13). While an astute clinician may be inclined to blame a “foreshortened” mandible for the clinical observation of an overbite and crowded dentition, an underdeveloped maxilla is likely the root cause. In recent decades, modern orthodontic theory has shifted paradigmatically to allow an orthopedic “first phase” of treatment intended to create horizontal expansion of maxilla. Maxillary expansion devices help to compensate for horizontal growth that was lost to an imbalance of muscle forces, commonly tendered by underlying negative postural influences secondary to nasal airway constriction (Fig. 14). Perhaps early recognition of abnormal tongue posture can lead to intervention with maxillary expansion devices, in order to allow the full potential for horizontal growth of maxilla.
FIGURE 10 (See color insert.) Open mouth posture: oral breathing drives the tongue downward and maxillary constriction occurs, increasing facial height. Source: B. Palmer, DDS.
70
Morgan and Remmers
FIGURE 11 (See color insert.) Dental models of a mouth breather. Source: B. Palmer, DDS.
LANGUAGE, SPEECH, AND BRAIN GROWTH Altricial Brain Growth in Mammals Climatic changes and a warming of the Earth following the Ice Age produced a transition from preponderant rain forests to drier tundra, and may have driven the advance of orthograde posture and bipedalism. As open spaces began to allow for nomadic travel and dispersal of species, hominids’ new strategy for survival would include entry into the carnivore guild. These new early foragers found an abundant, new calorie-rich food source in animal carcasses, and a new diet supplemented with
FIGURE 12 (See color insert.) Comparison of palate width in hominid (left) and modern humans (right). Source: B. Palmer, DDS.
Phylogeny and Animal Models: An Uninhibited Survey
71
FIGURE 13 (See color insert.) Comparison of a broad (top) versus a narrow upper dental arch (bottom). Source: B. Palmer, DDS.
bone marrow fat and protein, which enabled accelerated brain growth that maternal lactation alone could not support. Changes in weaning patterns of early hominids advanced a unique pattern of altricial-type of brain growth not seen in mammals (13). A further increase in the size of the human infant brain is dependent on a continuation of fetal brain growth, which can only be supported by a transition to adult foods at an earlier age. A new diet supplemented with bone marrow fat and protein enabled a “secondarily altricial” pattern of brain growth that maternal lactation alone could not support, while “buffing up” neural mass and adding weight atop the cervical spine.
FIGURE 14 (See color insert.) Maxillary expansion devices correct for lost horizontal growth, increasing size of choanae and nasal airway.
72
Morgan and Remmers
Infant energy requirements begin to exceed milk production levels in the second half of the first year. An average woman can produce 1000 mL/day of milk that provides 487 kcal/day and is relatively low in protein when compared to bovine milk. Despite the risks to child survival, selection pressure may have favored early weaning and a shift toward adult foods in order to support the child during a critical time in neurological development, enabling full potential for brain size and intellect. For example, brain size of P. troglodytes and humans at birth are both about one-third of their adult size. However, in terms of absolute size, the chimpanzee brain would only need to grow about 300 mL more to reach adult volume, whereas the human brain would grow to 900 mL; both brains reach their final growth potential at six to seven years. This advanced pattern of human brain growth is “expensive,” in that developing children must devote as much as 80% of their basal metabolic rate to the brain, compared to 25% for adults (14). Despite this adaptive risk to early survival and an altered mortality rate for young adults, who are now competing with carnivores for prey (15), foraging hominids begin to leave their offspring with groups to hunt and procure a rich food source. Brain growth in size and weight may have driven the concomitant postural changes needed to satisfy a new cranial “balancing act.” Spinal mechanics, notably cervical spine curvature, are adapted from head posture and favor upright stance, bipedalism, and horizontal vision. Unlike other mammals, who remained quadrupeds, upright posture would drive changes in cervical spine, relocate the tongue base to the pharynx and influence the development of a new compartment, oropharynx. Cerebral Control Over Pharynx In addition to the tasks of respiration and deglutition, speaking humans would require exquisite neural control to manage the pharyngeal airway in this motor act. Control of voluntary respirations and speech are closely held within the frontal lobes of the brain—the most recent evolutionary development. The first step toward managing a common aero-digestive tract requires relay of afferent information related to pharyngeal contents. Indeed, the pharyngeal mucosa and its juxtaposed layers of interwoven and specialized muscle fibers are innervated with extremely dense terminal nerve branches (Fig. 15). Banding patterns of these fibers and their variety and types of motor endplates allude to specialization within constrictors and the upper esophageal sphincter in humans. Further, the presence within these muscle groups of unusual myosin heavy chain isomers, including low-tonic and alpha-cardiac types, has been demonstrated (16). The appearance of multiple isomers within the pharynx and some other cranial muscles is thought to be associated with unique functional requirements that require precise control. Acquisition of Speech Predisposes to Obstructive Sleep Apnea Understandably, anthropological studies focus primarily on the “vocal tract” rather than respiratory control and speech-related behaviors. Our goal is to surmise and infer functional behavior from studies of fossils. During hominid evolution, the descent of the hyoid/larynx, rotation of the facial framework, and flexion of cranial base angle lead to progressive pharyngeal constriction and susceptibility to OSA. We speculate that these changes are principally related to the development of the motor act of speaking. A variety of models have been proposed to define the characteristics of the pharynx required for acquisition of speech.
Phylogeny and Animal Models: An Uninhibited Survey
73
FIGURE 15 (See color insert.) Cricopharyngeus muscle with multiple innervations and motor endplates to muscle fibers. Source: From Ref. 16.
Debate continues as to whether early hominids, and particularly Neandertals, had the pharyngeal height necessary to form essential vowel sounds. Is there a predictive value and correlation between the collapsibility of the pharynx in OSA and proposed models for the predicted acquisition of speech? By performing skull base reconstructions of H. neanderthalensis from La Chapelle-aux-Saints, Lieberman and Crelin (17) predicted a position and length for larynx that was not compatible with the accepted requirements for speech (Fig. 7). In their model comparing Neandertals, chimpanzee and the human infant, they advanced the hypothesis that an anatomic basis for speech, based on a minimum laryngeal descent, precluded all three species from producing the essential vowel sounds (i) (a) (u) due to reduced pharyngeal space. A new model for predicting total pharyngeal height and basis for speech proposed by Boe et al. (18) in 2002, contrasts with the previous findings of Lieberman and Crelin. New reconstructions of La Chapelle-aux-Saints and of a newer specimen of Neandertal, La Ferrassie 1, which had an intact hyoid show that the Neandertal skull base did not differ significantly from modern humans, leading to the supposition that there has been little or no change in the position or shape of hyoid in the last 60,000 years of evolution. Based on cephalometric landmarks, Boe et al. were able to develop a laryngeal height index from palatal distance and laryngeal height. Application of their model to Neandertal and young humans predicts that Neandertals were capable of speech. However, if we assume that a measurement of laryngeal height mirrors the modern cephalometric measures, we conclude that the speech predisposition of Neandertals is low, based on this phonetic/anatomic model (Fig. 6). The hyoid bone may provide an important clue regarding the collapsibility of the pharynx in hominids. In nonhuman mammals, a complete, “strutted” hyoid provides a mechanical anchoring of the epiglottis, and, thereby, of the ventral wall of the pharynx in the presence of substantial velo-epiglottal overlap. This provides pharyngeal stabilization in the absence of neuromuscular reflex control of pharyngeal muscles during sleep. By contrast, the “floating” hyoid of the human implies that the position of the ventral pharyngeal wall depends principally on neuromuscular forces. Although this provides for a highly compliant pharynx, a requirement for speech and tone modulation, it
74
Morgan and Remmers
FIGURE 16 Logarithmic plot of hyoid height versus depth for G. gorilla, P. troglodytes, H. sapiens, and the fossil from A. afarensis. Note that the shape of the A. afarensis hyoid is ape-like and differs substantially from the hyoid of modern man. Source: From Ref. 28.
also allows the opportunity for easy collapse of the pharynx during sleep when muscular forces acting on the hyoid are greatly reduced. Thus, we are fairly bequeathed a new fate (sleep apnea) that squares our debt to unparalleled success as a species provided by speech and language. Two hyoid bones have been found in hominids. The more ancient one (3,300,000 years old), a spectacularly well-preserved child skeleton of Australopithecus afarensis reveals a large, cup-shaped hyoid (25). As shown in Figure 16, the dimensions and shape of this hyoid are compatible with an ape-like hyoid and differ clearly from modern man. This suggests that A. afarensis had pharyngeal air sacks and a noncompliant pharynx, consistent with an apelike pharynx and vocal system. The second hyoid specimen is from a 60,000-year old Neandertal skeleton and is an incomplete or “floating hyoid.” Life History and Emergence of Obstructive Sleep Apnea What about neural control of pharynx during nocturnal breathing? Snoring was not an evolutionary advantage for Homo sapiens, albeit, some predators may have been alarmed by the world record of 112 decibels (19). One may argue that as life history changed for our immediate ancestors, we had no need to guard against OSA. A least until life span (only recently) increased beyond 40 to 50 years. Thus, the need to develop protective reflexes would be gratuitous and conspicuously absent in all upright hominids. Despite a lack of safeguards for our nocturnal respirations, a further descent of hyoid and expansion of oropharynx, along with the acquisition of the cortical equipment needed for speech, allowed a significant intellectual leap ahead of rival species. The natural history of a disease may, or may not, impact evolutionary selection processes depending on the timing and emergence of clinical symptoms or death. Assuming that early hominids lived no more than a few decades at best, and assuming a body habitus consisting of predominately lean muscle, little evolutionary pressure might be brought to bear with regard to OSA. Indeed, selection may have favored the male with a deeper voice (lower hyoid) and robust, threatening tones. Alternatively, even with a life span beyond 50 years, if OSA was not an issue
Phylogeny and Animal Models: An Uninhibited Survey
75
during childbearing years, there would be no selective pressure for the inheritance of protective guards against pharyngeal collapse. ANIMAL MODELS OF OBSTRUCTIVE SLEEP APNEA Obesity and Bony Abnormalities Animal models of human disease have often provided interesting insights into mechanisms of, or, therapy for the disorder in the human counterpart. Since obesity play a key role in the pathogenesis of human OSA, one might a priori assume that an obese animal would exhibit OSA. Surprisingly, this has not proven to be the case. As we shall see, this puzzling failure of obesity to produce OSA is a clue to one of the features of the pharynx in the human that is pivotal in the genesis of the human illness. Several strains of obese rodents exist and these have been examined for the presence of OSA. These studies have failed to find OSA. Another species known to become obese is the pig, and while one initial report of sleep apnea in obese pigs appeared to reveal OSA (20), subsequent investigations failed to confirm this finding (21). The one confirmed example of OSA in nonhuman species is the English bulldog. This animal experiences apnea, shown to be obstructive, during rapid eye movement (REM) sleep. The distinctive feature of this animal is its brachiocephalic “retropositioning,” which results in dorsal placement of the maxilla and mandible. The consequence of this bony “malformation” is a reduction in oral volume and narrowing of the retropalatal space. While awake and during non-rapid eye movement (NREM) sleep, activation of various pharyngeal dilators maintain a patent airway. This activity is eliminated during REM sleep and OSA results. In summary, the English bulldog appears to be the only naturally occurring animal model of OSA. In this model, OSA results from bony malformations that include underdevelopment of the maxilla and/or mandible. A striking finding relates to what does not exist, that is, obese nonhuman mammals do not experience OSA. While the massively obese Vietnamese potbelly pig does not have OSA, it displays features of the “Pickwickian syndrome,” that is, daytime somnolence, respiratory failure, and, probably, cardiac failure aptly dubbed by one wag, the “pig-wickian syndrome.” While these animals do not display sleep apnea, their breathing during sleep fits the pattern of high upper airway resistance (HUAR), wherein inspiratory flow limitation occurs during consecutive breaths for prolonged periods (Fig. 17). This leads to alveolar hypoventilation during both REM and NREM sleep. Why the obese pig displays HUAR and not OSA is probably explained by observations of the mechanics of the passive pharynx. To evaluate this, lean and obese pigs were studied under general anesthesia and with complete muscular paralysis (Fig. 18). The observed static pressure-area relationships of the passive pharynx revealed several dramatic findings. First, the closing pressure in lean and fat pigs was in the range of −15 to −20 cmH2O, much lower than that observed for normal humans (−2 to −4 cmH2O) and for patients with OSA (+2 to +4 cmH2O). This means that a higher transmural pressure is required in order to completely close the pharynx in the pig, even the obese pig, than in humans. Another feature that distinguishes the pig from the human pharynx is the shape of the pressure–area relationship, the pig being linear and the human being exponential. This means that in the pressure range 2–4 cmH2O above closing pressure, the passive pharynx of the pig is much less compliant than its human
76
Morgan and Remmers
FIGURE 17 Tracings from an obese unanesthetized Vietnamese pot-bellied pig. Airflow (L/sec) and transpulmonary pressure (cmH2O) are recorded while awake, and in non-rapid eye movement (NREM) and rapid eye movement (REM) sleep. Note that no apnea is recorded but that resistance is high in all conditions and inspiratory flow limitation appears during REM sleep. Source: From Ref. 29.
counterpart. A region of high compliance allows dynamic collapse of the pharynx and the development of inspiratory flow limitation in the human. The second distinctive anatomic feature of humans is the nonarticulated or “floating” hyoid. The pig and other mammals have a U-shaped hyoid that attaches dorsally. Together, these two features could stabilize the pharynx in nonhuman mammals. Dorsal movement of the hyoid is prevented by strutting, and through the aryepiglottic ligament, this limits dorsal rotation of the epiglottis, thereby stabilizing the oropharynx and velopharynx through the velo-epiglottal overlap. Rhesus Monkey Model of Nasal Constriction “Elimination of nasal airway interferences followed by a change from oral to nasal respiration may result in improvement of certain aspect of facial and dental deviations” (22). The first attempt to investigate the relationship between nasal obstruction
Phylogeny and Animal Models: An Uninhibited Survey
77
FIGURE 18 Pressure-area relationships of the passive pharynx are derived from data on humans and pigs and illustrate the differences in shape between the two species as well as the differences in effect from obesity. Abbreviation: OSA, obstructive sleep apnea.
and aberrant facial development made only casual reference to OSA. However, this early work did provide evidence for a link between the influence of environmental factors upon tongue posture and, as a corollary, the final position of jaws, dentoalveolar structures, and by the nature of their juxtaposition, the upper airway. In studies using the developing rhesus monkey as a model for obstructed nasal breathing, Harvold and others have observed and shown significant changes in normal respiratory physiology and functional form (22). Findings demonstrate compensatory recruitment of accessory muscles and a significant influence upon tongue posture that led to disruption of the natural balance between buccinators and genioglossus upon the developing alveolar arches, leading to malocclusion and downward mandibular posture. Compared to controls, changes in subjects with nasal airway occlusion consistently demonstrated increased facial height, posterior rotation of the mandible and malocclusions. It was postulated that differences in the degree of aberrant change may be explained by which muscles were recruited by each subject and how they were used for deviant respiration. Following removal of the obstruction, some monkey subjects did not reacquire normal posture and facial form. Similar changes are seen in children that display habitual mouth breathing posture and are at high risk of sleep-disordered breathing. Changes in these monkey subjects closely mimic reports from orthodontic literature dating back to the 1950s, when Brash described unfavorable changes in craniofacial growth in mouth breathing children (23). Descent of Hyoid: Chimpanzees Mirror Human Ontogeny Theories of speech physiology and the evolution of language in Homo species hold as a prerequisite the possession of adequate supraglottic space to produce sibilant and vowel sounds with enough resonance and force to form words. The “uniqueness” of the human oropharynx and our laryngeal ratio of 1:1 provide the platform necessary for these functions. But comparisons using magnetic resonance imaging (MRI) to study young chimpanzees in their early developmental stages have shown a similarity to humans with the brief appearance of an oropharynx, which may hold a clue as to why a common ancestor of extant hominids found an evolutionary path toward flatter faces, a descending hyoid and eventually, sleep-disordered breathing. However, it is unlikely that the acquisition of speech drove the secondary descent of
78
Morgan and Remmers
hyoid in humans. Rather, postural shifts along with progressive curvature of the cervical spine compelled the dynamic descent of the pharynx and our final susceptibility to OSA. In nonhuman mammals, the distance from incisors to velum (horizontal growth) is always greater than distance from velum to glottis (vertical growth) (Fig. 6). The greater the ratio becomes, the more we depart from potential for a collapsible pharynx. In humans and chimpanzees alike, early development depicts similarities between species in the development of upper airway anatomy. During early infancy, both species display similar growth patterns in both of these dimensions, with an apparent shift in growth during late infancy that emphasizes laryngeal descent in humans, and horizontal growth of the oral cavity in chimpanzees (24). In 2006, Nishimura (24) studied three chimpanzee subjects during their early development with sagittal tomographic images across ages four months to five years in order to identify cephalometric landmarks that corresponded to human landmarks in a similar study by Lieberman et al. in 2001 (25) spanning one month to 13.9 years of age in children. Dental emergence was used to adjust chronological age between the two species. In early infancy, these chimpanzees displayed a rapid growth and laryngeal descent that mimicked human growth pattern, decreasing vocal tract ratio in both species. Thereafter, the direction of change in the ratio increases in chimpanzees, where a dominant growth in palatal length continues until adulthood. Humans continue to grow in the vertical dimension of larynx throughout later infancy, childhood, and puberty, permanently separating the larynx into its three distinctive compartments—velopharynx, oropharynx, and hypopharynx. The brief emergence of an analogous oropharynx in chimpanzees, however, may lend clues to a common evolutionary thread between species, lending credibility to postural pressure as a driving force toward pharyngeal elongation, and a case for descent of the larynx and hyoid prior to divergence of the human from the chimpanzee lineage. Or, at least, that descent of the larynx is not “unique” to human lineage. In all other mammalian species, the hyoid remains firmly strutted to the laryngeal skeleton and thus precludes the formation of a collapsible segment. At what point then, did a “floating” hyoid become incorporated within the complex functional matrix of the larynx and become a competitive advantage for extant hominids? Cephalometric studies have demonstrated that a clear predisposition for OSA is found with a greater mandibular plane to hyoid bone (MP-H) distance, a measure of hyoid descent. Separation of the velum from epiglottis carries with it profound hazards and must command new levels of cerebral and functional control over the pharynx in order to ensure species survival. Therefore, early human species must have found any associated advantages, such as orthograde posture, to be paramount long before the advent of sophisticated articulation and language. A yet undiscovered common ancestor to distant hominids may hold the key to understanding how modern species came to acquire and appreciate a vulnerable airway. CONCLUSIONS The first terrestrial air breathers developed novel techniques to process oxygen in a new environment that allowed for an explosion of successful quadruped species. The evolution and development of the respiratory tract in land animals demanded precise control over an inflating mechanism, a nasal/oral cavity, and most recently, a highly partitioned pharynx. Phylogeny allows us to draw comparisons and define
Phylogeny and Animal Models: An Uninhibited Survey
79
the differences among many species that display specialized form and function, whereas natural selection favors traits that secure survival and propagation of species. The elongation and increased flexibility of the pharynx in early man ushered in speech, but the birth of syntax and language would call upon our uniquely human capacity to combine symbolism and abstract thoughts together, ultimately summoning the question... “What if?” Cleverness in scrimmage with other species engendered a foundation for life extension. However, these advances concealed a dark side that tends to “only come out at night” in the form of pharyngeal obstruction during sleep. Despite our unique susceptibility to OSA and its burgeoning expression in recent history, the utility of our collapsible pharynx has, somehow, outweighed all other selection pressures in species Homo sapiens. Will future evolution find us further uninhibited … and drowsy? REFERENCES 1. Maina JN. Functional Morphology of the Vertebrate Respiratory Systems. Engield, NH & Plymouth, U.K.: Science Publishers, Inc, 2002. 2. McMahon BR. A functional analysis of aquatic and aerial respiratory movements of an African lungfish, Protopterus aethiopicus, with reference to the evolution of the lung ventilation mechanism in vertebrate. J Exp Biol 1969; 51:407–430. 3. Vasilakos K, Wilson RJA, Kimura N, Remmers J. Ancient gill and lung oscillators may generate the respiratory rhythm of frogs and rats. J Neurobiol 2005; 62(3):369–385. 4. Tenny SM. A synopsis of breathing mechanisms. In: Wood SC, Lenfant C, eds. Evolution of Respiratory Process. A Comparative Approach. New York and Basel: Marcel Dekker, 1979:51–106. 5. Mellen NM, Janczewski WA, Bocchario CM, Feldman JL. Opioid-induced quantal slowing reveals dual networks for respiratory rhythm generation. Neuron 2005; 37:821–826. 6. Crelin ES. The human vocal tract: anatomy, function, development, and evolution. New York: Vantage Press, 1987. 7. Cantalupo C, Hopkins WD. Asymmetric Broca’s area in great apes. Nature 2001; 414:505. 8. Tattersol I. Monkey in the Mirror: Essays on the Science that Make Us Human. New York and Oxford: Oxford University Press, 2002. 9. Fogal RB, Malhotra A, White DP. Sleep 2: Pathophysiology of obstructive sleep apnoea/ hypopnoea syndrome. Thorax 2004; 59:159–163. 10. Wind J. Primate evolution and the emergence of speech. In: de Grolier E, Lock A, Peters CR, Wind J, eds. The Origin of Evolution of Language and Speech. New York: Harwood Academic, 1983. 11. Lowe AA, Fleetham JA, Adachi S, Ryan CP. Cephalometric and computed tomographic predictors of obstructive sleep apnea severity. Am J Orthod Dentofacial Orthop 1995; 106(6):589–595. 12. Kushida C, et al. A predictive morphometric model for the OSAS. Ann Intern Med 1997; 127(8):581—587. 13. Kennedy GE. From the ape’s dilemma to the weanling’s dilemma: early weaning and its evolutionary context. J Hum Evol 2005; 48:123–145. 14. Aiello L, Wheeler P. The expensive-tissue hypothesis: the brain and the digestive system in human and primate evolution. Curr Anthropol 1995; 36:199–221. 15. Berger T, Trinkaus E. Patterns of trauma among the Neandertals. J Archaeol 1995; 22:841–852. 16. Upperairwayproject.com. 17. Lieberman P, Crelin ES. On the speech of Neanderthal man. Linguist Inquiry 1971; 2:203–222. 18. Boe LJ, Heim JL, Honda K, et al. The potential Neandertal vowel space was as large as that of modern humans. Journal of Phonetics 2002; 30:465–484. 19. Guiness Book of World Records (2001).
80
Morgan and Remmers
20. Lonergan RP III, Ware JC, Atkinson RL, Winter WC, Suratt PM. Sleep apnea in obese miniature pigs. J Appl Physiol 1998; 84(2):531–536. 21. Tuck SA, Dort JC, Olson ME, Remmers JE. Monitoring respiratory function and sleep in the obese Vietnamese pot-bellied pig. J Appl Physiol 1999; 87(1):444–451. 22. Harvold EP, Tomer BS, Vargervik K, et al. Primate experiments on oral respiration. American Journal of Orthodontics 1981; 79(4):359–372. 23. Brash JC. The etiology of irregularity and malocclusion of teeth. Dental Board of the United Kingdom, 1956. 24. Nishimura T, Mikami A, Suzuki J, et al. Descent of the hyoid in chimpanzees: evolution of face flattening and speech. J Hum Evol 2006; 51:244–254. 25. Lieberman DE, McCarthy RC, Hiiemae KM, Palmer JB. Ontogeny of postnatal hyoid and larynx descent in humans. Arch Oral Biol 2001; 46(2):117–128. 26. Wong K. Lucy’s baby: an extraordinary new human fossil comes to light. September 20, 2006, www.scientificamerican.com. 27. Lieberman D, McCarthy RC, The ontogeny of cranial base angulation in humans and chimpanzees and its implications for restructuring pharyngeal dimensions. J Hum Evol 1999; 36:487–517. 28. Alemseged Z, Spoor F, Kimbel WH, et al. A juvenile early hominin skeleton from Dikika, Ethiopia. Nature 2006; 443(7109):296–301. 29. Tuck SA, Remmers JE. Mechanical properties of the passive pharynx in Vietnamese pot-bellied pigs: 1 Statics. J Appl Physiol 2002; 92(6):2229–2244.
6
Upper Airway Anatomy Avery Tung University of Chicago Hospitals, Chicago, Illinois, U.S.A.
INTRODUCTION If one were to design a living organism needing to breathe, eat, and communicate from scratch, one would be unlikely to ask a single body structure to fulfill these apparently mutually incompatible functions. It would clearly be simpler (as well as safer and more efficient) to separate the breathing and eating orifices, and relegate communication to a different structure altogether. That humans perform all of these tasks (and others) using a single structure is an impressive feat of engineering, and reflects the deceptive complexity of the upper airway and its anatomy. Serving not only the neurologic system (via speech, taste, and smell), but also the gastrointestinal and respiratory systems, the upper airway is nearly unique among body structures in merging multiple diverse functions into an efficient multipurpose whole. A list (Table 1) of functions of upper airway structures demonstrates this remarkable versatility. At any given time (and often nearly simultaneously), the upper airway must act as a humidified, heating and cooling conduit for inspired gases, a sensory organ, a speech generator, and a passageway for food. Enough of these functions are both complex and mutually incompatible (e.g., speaking and eating) that the relative lack of common diseases involving malfunction of the upper airway is surprising. Of the potential ways that the upper airway can malfunction, it then comes as somewhat of a surprise to realize that the relatively simple “gas conduit” role can be the source of significant morbidity and mortality. After all, a straightforward snorkel seems to serve this role admirably well in recreational divers. Yet, it is clear that in obstructive sleep apnea (OSA), a combination of anatomical and neurological control abnormalities that occur during sleep can combine to consistently restrict, or even completely prevent gas flow into the lungs. This chapter will review the anatomy of the upper airway, identify areas that have been implicated as playing a role in sleep apnea, and briefly discuss how abnormal function of the upper airway can generate the obstruction to airflow during sleep that plays an integral role in OSA. ANATOMY OF THE UPPER AIRWAY The upper airway is defined as the passageway for gas and food beginning at the mouth and nose and ending at the epiglottis and vocal cords. It can best be thought of as an “X” shape, with two distinct entry points from the outside (mouth and nose) which join together in the middle (pharynx) before splitting apart again to form the larynx and esophagus. As a result, describing the upper airway involves exploring the anatomy of two entry passages, a set of joined structures shared between them, areas where passages merge and bifurcate, and a 90° change in direction from posterior to caudal that occurs where the arms of the “X” join together. To best describe the anatomy and function of the separate parts of this complex 81
82
Tung
TABLE 1 Functions of the Upper Airway Mastication Communication Breathing Swallowing Taste Smell
structure, this chapter will consider each relevant structure as it would be encountered by gas initially entering the mouth or nose, traversing the relevant structures, and exiting via the trachea. OVERVIEW Gas entering the upper airway must first traverse either the nasal passages or the oral cavity. Gas entering through the nostrils first moves posteriorly through the nasal passage, and is warmed, filtered, and humidified. After passing through the nasal cavity, gas exits under an arch of lymphoid tissue (adenoids) into a separate cavity called the nasopharynx, which makes a 90° turn downward and joins up with air entering the mouth, passing posteriorly through the oral cavity, and entering the oropharynx. The nasopharynx and oropharynx join together to form a single passage which then progresses caudally as the pharynx and hypopharynx before bifurcating again below the glottic aperture, creating the posteriorly located esophagus and the anteriorly located trachea. The trachea is protected both by the epiglottis, which folds down to cover the airway during swallowing, and the vocal cords, which close when abnormally stimulated from above. The esophagus has no such flap, but instead a muscular sphincter that separates the digestive system from the airway. A detailed description of each structure follows below. Nose Anterior Nasal Cavity The nose serves to warm, moisten, and filter air entering the respiratory system. The upper third of the nose receives support from paired nasal bones and the maxilla, and the lower two-thirds is supported by cartilage. The nasal valves, situated in the anterior portion of the nose, provide resistance to control nasal airflow and are divided into external and internal portions. The external nasal valve is comprised of the columella, the nasal floor, and the nasal rim [inferior border of the lower lateral cartilage (alae nasi)] (Fig. 1). The internal nasal valve, which is responsible for the majority of airflow resistance, is situated at the junction of the superior aspect of the nasal septum and the upper lateral cartilage. Although the nostrils are oriented downwards, they serve as the opening to a nasal cavity whose major dimension is oriented anteriorly and posteriorly (Fig. 2). The nasal cavity is the most superior structure in the upper airway, and is located directly above the oral cavity. The hard palate separates the nasal cavity from the oral cavity, forming the floor of the nasal cavity and the ceiling of the oral cavity. Unlike the oral cavity, there is no structure like the tongue, which can change shape and cause obstruction. As a result, the nose is rarely implicated in the pathogenesis of OSA. Nevertheless, in normal patients nasal obstruction increases the number of apneas and hypopneas (1), and can induce both subjective and objective disturbances in sleep (2). While nasal pathology can
83
Upper Airway Anatomy
FIGURE 1 (See color insert.) External nasal valve. Source: Photograph courtesy of Kannan Ramar, MD.
clearly shift airflow to the oral cavity, increasing dependence on a patent oral airway, specific surgical or medical treatment of nasal obstruction does not clearly improve OSA (3). Nevertheless, nasal positive pressure devices appear to have therapeutic efficacy in OSA, and are currently considered a mainstay of nonsurgical therapy (4). Laterally, the outer walls of the nasal cavity is bounded by the inner surfaces of the maxillae, which form a sloping wall with three scroll-shaped turbinates oriented anteroposteriorly one above the other. The space below the inferior turbinate is termed the inferior meatus, with the middle meatus located between the inferior and middle turbinates, and the superior meatus situated above the middle turbinate. The opening of the Eustachian tube lies in the lateral wall of the nasopharynx below the inferior turbinate. Sensory innervation of the nasal mucosa
Nasal Cavity Nasopharynx Adenoids
Hard Palate
Soft Palate Palatine Tonsils Oral Cavity Oropharynx Tongue
Lingual Tonsils Epiglottis
Genioglossus